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  Triplex-forming oligonucleotides (TFOs) have been the subject of extensive 
research in recent years.  They have potential applications in many areas; such as 
gene-based therapies, site-directed mutation and as biochemical tools.  However, 
triplex technology has been hampered by several problems, including low stability 
due to electrostatic repulsion between strands.  This thesis has investigated 
combinations of four methods for stabilising triplex DNA; these include 
incorporation of the positively charged thymine analogues bis-amino-U and 
propargylamino-dU in TFOs.  Also modified TFO’s containing anthraquinone 
derivatives have been tested.  Further, the free-intercalating agent 
naphthylquinoline has been used to modulate TFO binding. 
  A TFO containing six consecutive BAU molecules has previously been 
shown to interact with non-target sites.  The pH dependence of this TFO was 
investigated.  These experiments showed that considerably higher TFO 
concentrations were needed to generate a footprint as the pH was increased.  The 
TFO had a high affinity for the exact template (tyrT) at pH 5.0 and 6.0 and showed 
some evidence of binding even at 30 µM at pH 7.0.  These gels also showed 
evidence of the secondary binding seen in previous studies; this was considerably 
more evident at pH 5.0, however, suggesting that the secondary binding may be 
more sensitive to pH than the primary binding. 
  Secondary binding sites for TFOs were examined by ‘Restriction 
Endonuclease Protection, Selection and Amplification’ or REPSA.  REPSA has 
been used to select for DNA templates that are bound by the 9mer TFO containing 
six bis-amino-U residues.  Fourteen of the sequences which emerged from 
REPSA were chosen for footprinting with TFOs containing BAU, propargylamino-
dU or T.  The BAU-TFO produced clear footprints on all but one of the REPSA 
templates tested, indicating that the REPSA process was successful in selecting 
for sequences which are bound by the TFO.  Significantly higher concentrations of 
the P-TFO were required, and magnesium chloride and / or the triplex binding 
ligand naphthylquinoline were needed to promote binding.  Despite the differences 
in template sequence there does not appear to be a strong pattern in the binding 
intensities of the TFOs on the different templates.  However, all templates do 
contain a run of four to eight A’s.  Surprisingly it appears from these data that the 
BAU TFO discriminates better than the P-TFO against non-exact binding sites 
  The selectivity of TFOs containing anthraquinone modifications was also 
investigated.  Anthraquinone intercalates between DNA bases in duplex DNA and 
can be tethered to the end of a TFO to increase stability.  The specificity of five 
TFOs with different anthraquinone modifications was examined by footprinting 
against fragments containing mismatches.  A doubly modified TFO bound with the 
highest affinity and was most tolerant of mismatches.  Mismatches at the centre of 
the template had a lesser effect on binding affinity than mismatches at the 3’ end.  
The effect of a 3’ mismatch was also greater if the anthraquinone was at this end.  
The presence of an S-base at the 3’ end allowing intercalation of the 
anthraquinone at a YpR step increased the binding affinity on the exact template in 
comparison to TFO 3 which did not contain the S-base.  The TFO containing the S 
base did not bind quite as well as the doubly modified TFO however.    
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A    adenine 




APP    (6-(3-aminopropyl)-7-methyl-3H-pyrrolo[2,3-d]pyrimidin-2(7H0-one)) 
BAU    bis-amino-U 
bp    base pairs 
C    cytosine 
D3    (1-(2-deoxy-β-D-ribofuranosyl)-4-(3-benzamidophenyl)imidazole 
dATP    deoxyadenosine triphosphate 
DNA    deoxyribonucleic acid 
DNase I  deoxyribonuclease I 
ds    double-stranded 
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EDTA   ethylenediaminetetracetic acid 
G    guanine 
IPTG    isopropylthio-β-D-galactoside 
MeP    3-methyl-2-aminopyridine 
mRNA    messenger RNA 
N    deoxynebularine 
P    propargylamino-dU 
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Chapter 1: Introduction 
 
The double helical structure of DNA which is so well known today was first 
elucidated by James Watson and Francis Crick in 1953, supported by Franklin and 
Gosling's X-ray diffraction image taken the year before (1).  DNA has since 
become the ‘central dogma’ of molecular biology and has been vital to its 
progression ever since.  Investigations into triplex DNA have opened the door to a 
new way of manipulating the genome, and this technology is becoming a powerful 
tool for future applications of molecular biology. 
 
1.1  Triplex DNA 
 
  A triple helical DNA structure was first observed in 1957 by Felsenfeld and 
Rich (2).  The idea of triplex DNA had been suggested by Pauling in 1952; 
however his model was later proven to be incorrect.  Felsenfeld and Rich used 
fibre diffraction and UV melting to show that if polyribonucleotides polyU and polyA 
were mixed in a 2:1 ratio in the presence of magnesium chloride, a triple helical 
structure was formed (2).  Further experiments showed that a similar structure 
could be created using polyC and polyG (3).  In the years since the initial 
discovery of triplex DNA, many different structural variants of DNA and RNA triple 
helices have been shown to exist, including inter- and intra-molecular triplexes in 
parallel and antiparallel conformations (4-11).  The work in this project however 
will focus on intermolecular parallel DNA triplexes. 
  Felsenfeld and Rich discovered that a DNA triple helix is created when 
three strands of DNA come together; two form a classic double helix, consisting of 
the usual GC and AT base pairs, while the third forms hydrogen bonds with the 
donor and acceptor groups found in the major grove of the two duplex DNA 
strands (2). 
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Figure 1.1: Models of a DNA triple helix. 
Top: Molecular model of a DNA triple helix.  The Y strand is the pyrimidine strand of the 
duplex DNA template and the R strand is the purine strand.  The purine (R) strand is 
shown bound to the third strand in yellow to form the triplex structure.  Adapted from 
reference (12). 
Bottom: Space fill model of an intermolecular triple helix.  Adapted from reference (13) 
 
  Although DNA triple helices were discovered over 50 years ago it was not 
until 1987, 30 years after this initial discovery, that the true potential of triplex 
technology was realised.  This was due to the discovery that short oligonucleotides 
could be used to bind duplex DNA and form a triplex (8).  It was immediately 
obvious that these Triplex Forming Oligonucleotides (TFOs) could be used to 
inactivate specific genes (14;15).  It was also at this point that the idea of H-DNA 
or intramolecular triplexes first appeared and these were suggested to have a role 
in gene regulation within cells (16). 
 
  Minor Groove 
Major Groove Chapter 1: Introduction 
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Since their discovery it has also been shown that triplexes usually only form 
with a double helix containing only purines in one strand, with the third strand TFO 
comprised of either pyrimidines or purines (3;4).  The reasons behind this will be 
covered in more detail later.  The base pairs formed between the third strand and 
the duplex DNA were different from normal Watson-Crick base pairing and these 
became known as Hoogsteen base pairs (17;18).  The pattern of recognition sites 
in Hoogsteen base pairs differs from Watson-Crick bonding.  Hoogsteen bonds 
form without disrupting the Watson-Crick bonds between the duplex bases, 
although conformational changes have been shown to occur (13). 
 
1.1.1  Triplex conformations 
 
  Triplexes can be divided into two main categories; intermolecular and 
intramolecular.   An intermolecular DNA triple helix forms when a free strand of 
DNA (TFO), binds to one strand of a region of duplex DNA (shown in Figure 1.1). 
Intramolecular triplexes form when duplex DNA (for example a sequence of 
genomic DNA) partially unwinds and one strand folds back on itself to form a triple 
helix leaving an orphaned strand (Figure 1.2 below) (19-21).  Intramolecular 
triplexes can also be generated by synthetic oligonucleotides in which the three 




Figure 1.2: An intramolecular triple helix.  Taken from reference (22). 
 
Intramolecular triplexes are also known as H-DNA; they are stabilised by H
+ 
ions, and form most readily at acidic pH and under conditions of superhelical 
stress (10).  This category of triplexes is predominantly restricted to formation 
within a symmetrical homopurine:homopyrimidine mirror repeat sequence of DNA 
within plasmids.  The most stable natural triplets involve pyrimidines in the third 
strand binding to purines in the duplex; T binding to an AT pair and C binding to a Chapter 1: Introduction 
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GC pair.  They were first discovered by Mirkin et al in 1987; thirty years after the 
initial discovery of intermolecular triple helices in 1957 (20). 
These triplexes are generated under superhelical stress within plasmids, 
though they have been postulated to form in genomic DNA where they cause 
nuclease hypersensitive sites and are often associated with the regulatory regions 
of genes (16;23-25).  As triplex formation requires supercoiling it has been 
considered possible that intramolecular triplexes could have a role in transcription 
as RNA polymerase creates regions of supercoiled DNA (26). 
When part of the duplex DNA unravels to form the intramolecular triplex it 
leaves the other strand unpaired and this is then sensitive to S1 endonucleases 
and other chemical agents (27;28).  S1 sensitivity has been used as a tool to study 
triplexes in vivo (19;29;30), and S1 endonuclease hypersensitive sites have been 
discovered in the upstream regions of several eukaryotic genes, indicating 
possible triplex formation in vivo (22). 
There is a growing amount of evidence (31) to show that H-DNA plays an 
important role in regulation of genes and causes mutations in vivo.  There are 
many theories as to how this regulation occurs but it is unfortunately very difficult 
to studies these processes directly (22).  Although there are now several methods 
for identifying intramolecular triplexes in vitro it is very hard to detect them in vivo 
(32). Monoclonal antibodies have been used to probe for intramolecular triplex in 
vivo (33;34).  Also the single strand of DNA exposed when an intramolecular 
triplex forms can potentially be bound by a fluorescently-tagged complementary 
single strand of DNA (35). Both of these techniques have shown similar results but 
were not performed under physiological conditions; it remains difficult to detect 
triplex formation in living cells and it is still an open question as to whether they 
form in vivo. 
When a TFO binds to a duplex target it forms hydrogen bonds with one 
strand of the duplex.  This can be achieved in one of two orientations; parallel 
(14;36) or antiparallel (Figure 1.3) (37).  This classification refers to the direction of 
the TFO in relation to the strand that it’s binding to. This dictates the nature of the 
triplets that can form in each orientation (14). 
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  5’    3’    3’          5’    3’    5’ 
           Parallel             Antiparallel 
Figure 1.3: Representation of Antiparallel vs. Parallel intermolecular triplexes.  The third 
















































































































































































































































T.AT triplet (parallel)        C 







































































































































































































































































































































































        T.AT triplet (antiparallel) 
 
Figure 1.4: The most stable naturally forming parallel and antiparallel triplets.  Third strand 
bases in red. Chapter 1: Introduction 
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  As is shown in Figure 1.4 the third strand base only forms hydrogen bonds 
with one of the two duplex strands, the purine strand.  The strand that the TFO 
binds to therefore becomes the central strand of the triplex, so one side of the 
base binds the TFO and the other side binds the other duplex strand.  Binding to 
the TFO therefore involves a side of the central base which is not normally 
involved in hydrogen bonding and thus creates a different hydrogen bonding 
pattern from that found in duplex DNA.  
The most stable naturally-forming parallel triplets are T.AT (or U.AT) and 
C
+.GC; T (or U in RNA) in the TFO binds to A of AT in a duplex sequence, and C
+ 
binding to G of GC (5;7;14;38).  The third strand cytosine has to be protonated in 
order to form a second bond with guanine, and this will be covered in more detail 
later.  T.AT formation is favoured by high ionic strength and divalent cations, 
particularly magnesium; it is a pH neutral triplet (39).  Much less stable triplets 
formed using natural DNA bases include G.TA and T.CG; these have very 

























































Figure 1.5: Structure of G.TA and T.CG triplets. Third strand bases in red. 
 
G.GC and A.AT are the most stable natural antiparallel triplets, along with 
T.AT which can also form in this orientation (43;44).  In the antiparallel 
conformation the TFO thymine presents a different face for binding to adenine 
(45).  When intermolecular triplexes form in the antiparallel orientation, the 
hydrogen bonds are referred to as reverse-Hoogsteen bonds. 
Unlike parallel triplex formation a TFO composed of G and T bases binds in 
a relatively pH-independent fashion and the resultant complex is generally more 
stable than an equivalent parallel triplex, particularly at physiological pH (3;45-49).  Chapter 1: Introduction 
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The kinetics of antiparallel triplex formation also appears to be faster (50-53).  The 
stability of antiparallel triplexes varies widely however and is highly sequence 
dependent, partially due to the different triplets not being isohelical, resulting in 
local distortions in the TFO backbones (45). 
G-rich TFOs appear to form the most stable natural antiparallel triplexes, 
although they have a high tendency to form compact secondary structures such as 
G quadruplexes (13;54;55).  Also GA-rich TFOs can form homoduplexes which 
are stabilised by magnesium ions (56-58).  Both of these alternative structures can 
inhibit triplex formation (55;57). 
In common notation triplets can also be classed by the composition of the 
third strand; pyrimidine-rich TFOs form Y.RY triplets (usually parallel), while 
purine-rich TFOs form R.RY triplets (usually antiparallel).  In each case the first 
letter (Y for pyrimidine and R for purine) represents the TFO base, the next is the 
base in the duplex strand that the TFO binds to (usually a purine), and the third 
letter is the pyrimidine in the other strand of the duplex.  As previously mentioned, 
triplex formation generally requires a homopurine:homopyrimidine stretch of 
duplex DNA, either for a pyrimidine TFO to bind to, or to form H-DNA. 
 
1.1.2  Pyrimidine targeting 
 
Pyrimidines in duplex DNA cannot easily be targeted by third strands 
containing unmodified bases (37).  This is because any natural bases binding to 
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Figure 1.6: Standard duplex AT and GC pairing.  Blue circles indicate hydrogen bond 
acceptors and donors on the purine bases, red show those on the pyrimidine bases. While 
there are two possible acceptors/donors on both of the purine bases there is only one on 
each of the pyrimidines.  The green circle indicates a methyl group which interferes with 
recognition of thymidine by a TFO. 
 
  As shown in Figure 1.6 above the inability to target pyrimidines in the 
duplex DNA is due to a lack of hydrogen bond donors and acceptors on the duplex 
pyrimidine and steric hindrance from the methyl group on T.  This has presented 
problems when using TFOs targeted to mixed purine/pyrimidine sequences (37).  
The issue of pyrimidine recognition will be covered in more detail later. 
 
1.1.3  Structure 
 
  To obtain more knowledge about the exact structure of triplexes so that new 
nucleotide analogues could be designed, various NMR and X-ray crystallographic 
studies have been carried out (59-65).  The first X-ray crystal structure was finally 
attained in 1999 (65). 
It was initially thought that triplex formation caused the underlying DNA 
duplex to adopt an A type conformation, in contrast to normal double stranded 
DNA which is B-form (17).  However, it was later shown that triplex DNA has a 
completely separate conformation, which contains aspects of both A- and B-form, 
but is distinct from both (Figure 1.7) (65-68). 
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Top: Side on view, Bottom: top down view 
Left: A-form DNA (60) 
Middle: B-form DNA (60) 
Right: Parallel triplex structure, third strand shown in yellow 
Based on X-ray diffraction studies, taken from reference (69) 
 
To bind a third strand of DNA, the duplex template must unwind slightly to 
allow the third strand to fit within the major groove (the increase in helical twist is 
31º).  This causes the Watson-Crick bases to shift towards the minor groove, 
leading to nuclease hypersensitive sites appearing at the triplex/duplex junctions 
(42;70-72).  It also causes most of the sugars in the double stranded DNA to adopt 
an S-type pucker (42).  Despite this however the transition from duplex to triplex 
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1.1.4  DNA grooves 
 
The binding of a third DNA strand into the major grove of a duplex also 
causes the formation of a third groove in the DNA complex.  The three grooves are 
therefore re-named (see Figure 1.8 below); the minor groove from the original 
duplex (between the two duplex strands) becomes the Watson-Crick groove, the 
one between the central purine strand and the TFO becomes the Crick-Hoogsteen 
groove and between the TFO and the far pyrimidine strand the Watson-Hoogsteen 
groove (42;73). 
 
       
 
 
Figure 1.8: T.AT and C
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In a parallel triplex the Watson-Crick groove becomes slightly narrower 
upon TFO binding as the duplex major groove becomes wider to accommodate 
the third strand; in a typical triplex the Watson-Crick groove is around 6-7Å, slightly 
smaller than the normal minor groove of B-DNA.  However, the character of the 
Watson-Crick groove in triplex DNA has been shown to be very different to that of 
the normal minor groove, although it is still more similar to B- form than A-form 
DNA (42).  The Crick-Hoogsteen groove is also relatively narrow (2-3Å), but the 
Watson-Hoogsteen groove is quite wide (7-8 Å) and is highly hydrophobic due to 
the methyl groups of thymines in the TFO and duplex DNA (42;73).  
 
1.1.5  Phosphate groups 
 
All the triplets mentioned so far are much weaker than natural duplex base 
pairs.  The stability of triplexes is affected by several factors such as pH and ionic 
conditions, as well as the length of the third strand itself.  One of the main 
contributors to the low stability of triple helices is the negatively charged 
phosphate backbone of the DNA strands. 
In duplex DNA the two strands are spaced such that energetic repulsion 
between the phosphate groups in the backbones is minimised.  The negative 
charges are also counteracted partially by cationic screening.  However, when a 
TFO binds in the major groove of the duplex it forces the phosphate groups of its 
backbone into close proximity with those in the duplex.  Figure 1.7 on page 9 gives 
an indication of the different interactions of the duplex and triplex strands.  High 
concentrations of monovalent or divalent cations are often used to stabilise 
triplexes as they increase the ionic screening around the phosphates (14;39;74). 
 
1.1.6  Base stacking 
 
When considering the stability of triplex DNA molecules it is also important 
to take into account the effects of base stacking interactions.  This type of 
interaction is due to Van der Waals and hydrophobic bonding between the planar 
rings of the bases.  The alignment of the pyrimidine and purine rings above and 
below one another has a large effect on stability and any perturbations which 
disturb this alignment can cause the triplex to become unstable.  T.AT and C
+.GC 
are isohelical in parallel triplexes but the position of the backbone varies from 
other triplets and so will cause backbone distortions if different bases are used Chapter 1: Introduction 
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(75).  Stacking interactions are also an important consideration when designing 
new base analogues as they can dramatically reduce or increase the stability of 
the overall structure. 
Several groups have attempted to increase the base stacking potential of 
nucleotides by increasing the number of aromatic rings in the base.  For example 
pyrido[2,3-d]pyrimidine and its derivatives have been used for AT recognition (76).  
However it was demonstrated that when incorporated into a TFO, this analogue 
was no more stable than natural nucleotides (76).  Increasing base stacking 
therefore isn’t necessarily the best way to improve triplex stability, as extended 
ring systems may disrupt the structure or desired base overlap (45). 
 
1.1.7  Length 
 
The chain length of the TFO affects triplex stability.  Generally, in parallel 
triplex formation the longer the third strand the more stable the interaction with the 
duplex; though this also depends on the base composition of the TFO.  A higher 
proportion of more stable triplets within a DNA triplex will normally lead to more 
stable overall binding (45;77).  For example a short triplex comprised solely of 
T.AT triplets might be very unstable, whereas a triplex of the same length 
containing one or two C
+.GC triplets would have a higher stability at low pH.  
However once too many C
+.GC triplets are introduced it becomes unstable again 
as contiguous C
+.GC triplets are destabilising (30;78-81). 
It has also been shown that longer TFOs are more likely to bind to 
secondary binding sites as they have a greater potential to form intrachain loops 
and bulges (82).  When considering targeting sites within the human genome, 
TFOs need to be at least 16-17 bases in length in order to recognise a unique 
sequence (82).  Any TFOs shorter than this are likely to have more than one 
binding site, due to the length of the human genome (around 3 billion bases).  
Stable triplexes have been formed with TFOs as short at 9 bases however (83;84). 
 
1.1.8  Mechanisms of triplex formation 
 
The formation of a DNA triple helix most likely occurs via a nucleation-
zipper mechanism (85).  It is thought that 2 to 3 bases at the 3’ end of the TFO first 
associate and dissociate rapidly with random sites in the duplex DNA due to an 
unfavourable equilibrium until they find a complementary sequence.  At this point if Chapter 1: Introduction 
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the TFO has bound to the exact recognition site there is the chance for another 
nucleotide to bind the template.  If this happens then the nucleation point has 
formed and the rest of the TFO can then bind by 3-D wrapping in a zipper type 
movement.  However, if the sequence is incorrect the TFO dissociates and 
continues to create nucleation points until the exact site is bound (45;74).  This 
mechanism explains why triplex formation is faster at lower temperatures, since 
this stabilises the transient intermediates.  Triplex formation is about three orders 
of magnitude slower than duplex formation however (53;74;81). 
Electrostatic repulsion between the phosphate groups on the three strands 
plays a major role in the formation of the nucleation point.  Once a nucleation point 
is formed, base stacking interactions stabilise the complex and allow zippering 
(74).  Triplex formation also involves a conformational change in the duplex, the 
energetics of which must be overcome in order for the triplex to form (59).  This 
means that more bases are thought to be involved in the nucleation point of triplex 
formation compared with duplex DNA (74). Chapter 1: Introduction 
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1.2  Potential applications of triplexes 
 
Despite the discovery of triple helices by Gary Felsenfeld in 1957 it wasn’t 
until 30 years later that their true potential was realised.  Around this time it was 
found that TFOs could be used to ‘read’ duplex DNA and this recognition 
specificity renewed interest in triplex DNA technology (9;45).  A potential biological 
role for triplexes was first observed in 1968; this was an in vitro assay looking at 
inhibiting transcription by RNA polymerase using an RNA TFO (4).  In 1994 it was 
shown that if a homopurine:homopyrimidine sequence that was capable of forming 
an intramolecular triplex was inserted into SV40 it caused fork stalling in vivo, 
demonstrating the importance of triplexes for biological purposes (86). 
Polypurine tracts in the human genome capable of forming intramolecular 
triplexes have been linked with disease causing genetic mutations; indicating that 
triplex formation alone could be enough to cause mutation of the target sequence 
(87-90).  It appears that triplex formation may cause double strand breaks (DSBs) 
in the template DNA and it is during repair of these that mutations occur (91).  It is 
still unclear however exactly how these DSBs are created (22). 
Potential binding sites for TFOs have been found to be more common than 
expected in the human genome and particularly in promoter sequences 
(25;92;93).  They were also found to be more common in genes involved in cell 
signalling and cell communication (94).  The genes containing these sequences 
are also more susceptible to chromosomal translocations, more likely to undergo 
alternative splicing and are expressed at relatively low levels (94).  It’s therefore 
thought that intramolecular triplexes might play a role in transcription (21;47). 
The use of TFOs in gene therapy has several advantages over other 
methods; they can be extremely specific and easily designed providing the DNA 
sequence of interest is known and there are fewer binding sites per cell than if 
RNA or protein species were being targeted, allowing lower concentrations of the 
TFO to be used (45).  The high specificity and potentially low concentrations 
needed for action also make toxic side effects in vivo less likely.  Potential triplex 
formation sites are also often associated with high numbers of SNPs, opening up 
the possibility for individually-tailored therapies (25).  It has been repeatedly 
suggested that triplexes could be used to target one specific site in the entire 
human genome (95;96). 
This section looks at the different areas where triplex DNA is being utilised, 
as well as the many challenges involved with this technology. Chapter 1: Introduction 
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1.2.1  Anti-gene technology 
 
Following the realisation that triplex forming oligonucleotides could interact 
with DNA in vivo, possibilities opened up for using TFOs to block the activation of 
specific genes by inhibiting protein-DNA binding (49;97-99).  Work has been 
carried out with the aim of blocking transcription, and hence protein production, 
this is called the anti-gene method.  In anti-gene technology a TFO is used to bind 
part of a gene such as the promoter region and thus prevent transcription (see 
Figure 1.9 below) (100).  For example a TFO could be targeted to part of a 
promoter or operator sequence containing the binding site for a protein involved in 
transcription, such as RNA polymerase or a transcription factor.  When the TFO 
binds to this sequence it would compete for and possibly inhibit binding of the 
protein and therefore prevent transcription of the gene (47;101-103).  There can 
be several problems with this method, however.  For example, the DNA ,may be 
inaccessible or the TFO may be degraded before reaching the target (see section 
1.2.4) (25).  This method was used in a study in 2004 to reduce the size of 




Figure 1.9: DNA/protein binding inhibition via the formation of a DNA triple helix.  The left 
side shows a protein binding to DNA in the normal way, on the right a TFO with a 
sequence complementary to the protein recognition site has bound to the promoter and 
prevented the protein from interacting with the DNA. 
 
As well as preventing the binding of proteins to DNA, TFOs can also be 
used to inhibit movement of proteins along DNA; for example inhibiting replication Chapter 1: Introduction 
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by blocking the progression of polymerases (105).  TFO binding has also been 
shown to provide a very strong block to Taq DNA polymerase and RNA 
Polymerases; this technique has been used to successfully inhibit the production 
of the c-MYC oncogene in vivo (106;107). 
 
1.2.2  Oligonucleotide-clamp technology 
 
A further method for gene inhibition using TFOs is a variation of anti-sense 
technology known as the oligo-clamp method.  A single-stranded homopurine DNA 
or RNA molecule is targeted by a TFO comprised of 2 strands which binds to both 
sides of the single strand forming a local, short triple helix (69).   This single 
stranded target could potentially be an mRNA molecule or part of a viral genome 
(108).  The targeted sequence becomes the central strand of the triplex, forming 
both Watson-Crick and Hoogsteen bonds with the 2 strands of the TFO; see 
Figure 1.10 below.  The linker between these 2 strands can either be a short 
nucleotide sequence or a flexible synthetic linker such as hexaethylene glycol (69). 
The triplex formed is more stable than a duplex sequence of the same length and 




Figure 1.10: Space-filling model of an oligo-clamp TFO (blue and green strands joined by 
a hexaethylene glycol linker in white) binding to a single strand (red).  First the blue strand 
forms Watson-Crick base pairs with the target single strand while the green strand 
becomes the third strand and forms Hoogsteen bonds with the red central target strand.  
Taken from reference (69). 
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This type of triplex formation is more sensitive to mismatches than anti-
gene technology as each target base is recognised on both sides by the TFO, 
rather than just one.  Joining the 2 strands of the TFO together rather than using 
separate strands can help to increase the stability of the complex, joining them at 
both ends to form a circular molecule increases stability even further, although this 
is more difficult to synthesise (69).  The covalent attachment of ligands to these 
complexes can also be used to further increase triplex stability.  Psoralen has 
been used in this way to ‘lock’ the triplex structure as it cross-links with both the 
target and TFO strands (108).  Additionally these types of TFOs are less prone to 
aggregation within cells, which has be found to be a problem with standard TFOs 
(109). 
 
1.2.3  Other applications 
 
As well as blocking transcription directly or using targeted oligo-clamp 
TFOs, there are several other ways triplex technology may be used.  To improve 
the likelihood of inactivating a gene various ligands and proteins can be attached 
to TFOs to target them to a particular site on a duplex DNA template.  In this way 
artificial endonucleases can be created by attaching nucleases to TFOs; these 
complexes can then be used to cleave at very specific sequences and this 
cleavage can lead to a high frequency of mutations during the repair process 
(25;36;95;96;109-112).  Unlike simply using a TFO to block transcription, this 
technique offers the advantage of permanently inactivating a gene and passing on 
the mutation. 
Addition of chemical groups such as psoralen allows careful timing of the 
mutagenic effect; i.e. after the TFO has bound its target, to minimise non-specific 
DNA damage.  Psoralen intercalates with the duplex DNA and causes mutations, 
again at very specific sites (113).  In 2000 this technique was used to introduce 
mutations into the genomic DNA of mice, demonstrating the effectiveness of this 
technology in whole organisms (114).  Anti-cancer drugs such as daunomycin 
have also been attached to TFOs.  Daunomycin intercalates with the DNA 
increasing stability although it does not appear to retain any anti-cancer activity 
(115;116). 
A different approach is to take advantage of potential intramolecular triplex 
formation sites in genes of interest.  These sites are common in promoter regions 
and are inherently recombinogenic and mutagenic; they may be able to be Chapter 1: Introduction 
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exploited in a wide variety of ways to control gene expression (22). The frataxin 
gene which is involved in Friedreich’s ataxia contains an H-DNA formation site 
which is known to affect protein production when a triplex is formed (117).  Ataxia 
is caused by transcriptional silencing of this gene which codes for the 210 amino 
acid frataxin (118).  This silencing is caused by expansion of a 5’ – GAA – 3’ triplet 
repeat which can then form a disease promoting intramolecular triplex and prevent 
transcription (119).  Destabilising this triplex could therefore potentially allow 
transcription to resume, providing an attractive therapy for this disease (118). 
Recently it has been shown that potential triplex DNA sequences are over 
represented in genes expressed in the brain, which has led to the theory that 
intramolecular triplex formation may play a role in the development of 
schizophrenia (94;120).  Interfering in some way with these triplex structures could 
therefore have an effect on the brain. 
 
1.2.4  Problems 
 
There are several problems that need to be overcome before the above 
triplex technology can become viable.  The main problems are: delivery and 
uptake to cells; stability within cells; secondary structure formation of TFOs; target 
binding affinity; displacement by cell components and inaccessibility of the target 
DNA.  TFOs have also been found to have unpredictable effects within , such as 
binding transcription factors and therefore not binding the target DNA (121). 
In vitro studies have shown that TFO binding can prevent transcription and 
that a triplex has comparable – and in some cases greater – stability than the 
transcription factor/DNA complex (12;122).  This can also be used to activate 
genes, for example if an inhibitor binding site is targeted.  Another approach is to 
attach proteins to the TFO such as transcription factors or inhibitor which are then 
targeted to a particular gene (123).  Some success at applying triplex technology 
in vivo has been documented, such as successfully injecting TFOs into mice, 
causing mutagenesis in specific genes (114). 
Endonucleases that act from ends or within DNA chains are prevalent in 
cells and these can rapidly degrade unmodified TFOs.  Oligonucleotides are also 
vulnerable to extracellular degradation (124;125).  Many nucleotide analogues 
have been synthesised, in order to increase specificity or selectivity whist making 
the TFO more nuclease resistant (45).  Some of these modifications such as 
backbone charge reduction also help to improve uptake of the TFO by cells Chapter 1: Introduction 
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(13;126;127).  Other modifications have been investigated to help prevent TFOs 
from adopting secondary structures such as G-quadruplexes within cells 
(55;128;129). 
Because TFOs are polyanions they cannot easily penetrate the lipid bilayer 
and enter cells, although there is evidence that oligonucleotides can reach their 
targets within the nucleus, possibly by receptor-mediated endocytosis (130;131).  
This process is very inefficient however and may be subject to cell-type specificity 
(124).  Viral delivery has been a popular technique used in clinical trials to 
overcome this problem although the body’s immune response to these is still an 
issue (132).  There are several reagents which have been found to improve 
cellular uptake of TFOs by cells.  These include: cationic lipids, cationic polymers, 
cell penetrating peptides and polycations such as polyethylenimine.  However 
these are not usually suitable for in vivo work (12;22;133-135).  One technique 
which has shown to be successful in vitro and in vivo is coupling TFOs to 
hydrophobic molecules like cholesterol since this aids passage through the 
nuclear membrane (136). 
Nucleotide analogues have also been synthesised to help with this problem 
such as polyamine analogues, cholesterol derivatives, nuclear targeting peptide 
conjugates, 6-phosphate-bovine serum albumin (BSA) and polypropylenimine 
dendrimers (136-140).  Some of these analogues may also allow the TFO to 
compete with chromatin and therefore access previously unavailable DNA targets.  
DNA packaging is a major obstacle for TFO technology to address as the target 
may be inaccessible when bound to chromatin proteins (12;141;142). 
One potential solution which has been investigated to improve TFO delivery 
is using in-vivo cell transcription to synthesis the TFO.  This would overcome 
problems involved with immunogenicity, uptake and dose, as well as the expense 
of synthesising large quantities of oligonucleotides (124). PNA (peptide nucleic 
acid) and LNA (locked nucleic acid) structures have also been successfully used 
to overcome many of these problems (143-154).  These will be covered in more 
detail later. 
 
1.2.5  TFOs as biochemical tools 
 
As well as looking at targeting genes triplex technology has also been used 
to create tools for molecular biology.  They can also be used for labelling DNA or 
as sensors or to target particular molecules to DNA sites for example.  TFOs have Chapter 1: Introduction 
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been used in various new biochemical assays that for example look at 
translocation of proteins along DNA (155) and investigating topoisomerase activity 
(156).  A TFO coupled to a topoisomerase I inhibitor has been used to target the 
topoisomerase action to a particular DNA sequence (157;158).  Another 
application is using triplex structures to recognise and purify specific DNA 
sequences from a pool.  The TFO can be attached to beads or an affinity column 
and if parallel triplexes are used binding can be controlled by pH (159-161).  
Because TFOs can compete with proteins for binding sites on a duplex target 
fluorescently labelled oligonucleotides can be used to investigate the interaction 
between DNA and protein (162).  This technique was used to identify the binding 
site of topoisomerase II (163).  It has also been used to study translocation of 
Type I restriction enzymes on DNA (164;165). 
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1.3  Problems and solutions 
 
  The investigation of DNA triple helix formation has brought to light various 
problems many mentioned above, which need to be considered when 
contemplating the use of TFOs in gene therapy.  The main problems that have 
been encountered alongside in-vivo challenges are pyrimidine recognition, pH 
dependence and stability.  Each of these problems will be examined in more detail 
along with examples of the methods which have been developed to overcome 
them. 
Much of the investigation into possible solutions has examined the use of 
modified nucleotides, where alterations have been made to the sugar, phosphate 
or base moieties.  Base modifications in particular have proved to be especially 
effective and they also display some unexpected benefits.  Some analogues have 
been shown to improve uptake by cells and help protect the TFO from 
degradation, others can be used to induce chemical reactions with the DNA and 
potentially be used as DNA probes (13). 
 
1.3.1  Pyrimidine recognition 
 
  The most stable parallel forming natural triplets are T.AT and C
+.GC.  Both 
of these involve the binding of a third strand pyrimidine to a duplex purine base 
and so rely on the presence of a purine tract in the target sequence.  For the 
targeting of biologically relevant sequences this limitation is impractical, although 
there does appear to be a higher than expected propensity of purines in many 
promoter sequences (166). 
  Synthetic TFOs could be a much more potent biological tool if it were 
possible to target any sequence; however there is a lack of potential hydrogen 
bond donor and acceptor sites offered by pyrimidine bases in the duplex target 
(Figure 1.6 page 8).  There is also the possibility of a steric clash between a TFO 
and the methyl group of thymine which protrudes into the major groove (37). 
The natural bases with the highest affinity for pyrimidines in the duplex are 
G, which binds TA via its 2-amino group, and T in the TFO binding to CG (see 
Figure 1.5 page 6) (40;41;167-170).  Although these natural bases can be used to 
recognise pyrimidines in duplex DNA they only form one hydrogen bond with the 
duplex base pair so the interaction is significantly weaker than T.AT and C
+.GC 
triplets which can form two bonds (170).  They also cause local backbone Chapter 1: Introduction 
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distortions, since they are not isomorphous with T.AT and C
+.GC (167).  The more 
pyrimidines that need to be recognised the worse the stability becomes.  For 
example, a TFO with two guanines for T recognition is 30 times less stable than a 
TFO with just one (171).  However, the stability of a G.TA triplet can be improved 
by having T.AT flanking triplets as these are more stabilising in this context than 
C
+.GC triplets (172).  This is due to the formation of an extra hydrogen bond with 
thymine in the 5’ adjacent triplet (167).  Recognition of alternating duplex AT tracts 
by GT-containing TFOs, forming alternating T.AT and G.TA triplets is also possible 
if these are tethered to a long region of T.AT triplets (41;173;174).  The stability 
can be increased further by adding a few C
+.GC triplets to the T.AT region (173). 
The T.CG triplet is even weaker than G.TA.  Thymine in the TFO forms one 
hydrogen bond between the C2 oxygen from T and the N4 of C, but again if 
multiple substitutions are made the stability is greatly reduced (37;175).  Like the 
T.AT triplet, T.CG can also form in a parallel or antiparallel conformation (170).  In 
contrast to the G.TA triplet T.CG is stabilised by a 3’ C
+.GC triplet, but like G.TA is 
destabilised by C
+.GC in the 5’ position. 
 
1.3.1.1  Analogues 
 
  The most promising solution to this problem is to design base analogues 
which can bind with higher stability and affinity to pyrimidines.  This can be 
achieved through the formation of additional hydrogen bonds.  Both purines and 
pyrimidine have been adapted to form these analogues, although there have been 
fewer successful nucleotides synthesised for TA recognition compared to CG (37).  





  D3 was one of the first synthetic bases designed to recognise pyrimidines 
(172).  This analogue has a functionalised benzimidazole central group and is 
selective for pyrimidines over purines in the duplex with a slight preference for CG 
over TA (69).  It will also bind at physiological pH and temperature and is known to 
stabilise mismatches (172).  However it was shown by NMR studies that it actually 
intercalates between bases rather than binding directly in the major groove 
(37;176;177).   Chapter 1: Introduction 
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(iv) AcPrC.CG           (v) AmPyC.CG 
 
Figure 1.11: Structures of some synthetic bases bound to their targets. 
(i) D3 (1-(2-deoxy-β-D-ribofuranosyl)-4-(3-benzamidophenyl)imidazole. 
(ii) N (deoxynebularine) bound to CG 





Adapted from reference (37). 
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D3 prefers to intercalate adjacent to TA or CG base pairs, i.e. into YpR steps which 
have been found to be the favoured site for intercalation.  In this conformation the 
three rings of D3 stack onto the bases of each of the three DNA strands (177). 
 
N and N
4 derivatives of cytosine 
 
N (deoxynebularine) binds to CG in the duplex in an anti-conformation and 
is more stabilising than a mis-match at the same position (178).  It discriminates 
well against TA and GC base pairs, but is not particularly specific for CG as it will 
bind AT with similar affinity (37). 
The N
4 derivatives of cytosine have been much more successful than D3 or 
N and are among the best analogues for recognition of CG base pairs (179-181).  
AcPrC for example has cytosine at its core and forms 2 bonds with the duplex 
bases.  However only one of these is to the duplex cytosine, the other is thought to 
form between the amine hydrogen on AcPrC and the O6 carbonyl of G (37).  This 
base is not stable opposite TA unlike D3 and N, but is compatible with GC, albeit 
with a lower affinity than for CG (37).  It has a flexible side chain as part of its 
structure and it has been suggested that a nucleotide with a more rigid structure 
might form a more stable triplex (37). 
AmPyC is similar to AcPrC but has an additional ring in place of the flexible 
linker (181).  Like AcPrC it forms 2 hydrogen bonds; one with C and one with G 
(181).  Modelling studies indicate that this monomer spans the major groove 
placing the 6-amino group of the AmPyC near O6 group of guanine; this is 
confirmed by experimental evidence which has shown that removing the 6-amino 
group prevents formation of the second bond (37;181).  This N analogue proved to 
be more stable than AcPrC and binds even at physiological pH, possibly due to 
increased stacking with the second ring.  AmPyC can also form a triplex with AT 
which is more stable than T.AT.  This is thought to be due to a third hydrogen 
bond being formed with the N7 group of adenine in the duplex (37).  Although this 
is useful in terms of binding strength, the loss of specificity is the down side. 
 
APP, S and S derivatives 
 
  Two of the most stable analogues for pyrimidine recognition synthesised to 
date are 
APP which binds C in duplex DNA, and S and its derivatives which bind T 
(182;183). Chapter 1: Introduction 
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(ii) S (N-(4-(3-acetamidophenyl)thiazol-2-yl-acetamide)). 
Third strand bases shown in red. 
Adapted from reference (182) 
 
Both S and 
APP have been shown to form stable triplets, and have even 
been combined with other analogues to achieve recognition of all four bases by 
one TFO (168;182-184;184).  The S base has been used in this thesis during the 
comparison of anthraquinone intercalation at different sites (see section 1.5.2). 
The S analogue is comprised of 2 unfused aromatic rings linked to the 
sugar via an acetamide group.  A single thymidine interruption in a duplex 
sequence, if targeted by S, does not significantly reduce the stability of the 
complex even at physiological pH (168).  S.TA triplets have been shown to have a 
melting temperature 5-8ºC better than any natural base for T recognition 
(166;168).  It is interesting to note that S is thought to form 3 base pairs with the 
duplex, but only one is with thymidine.  This bond forms with the 4-oxo group of T 
in a co-planar structure.  The other two bonds are with the N7 and 6-amino groups 
of adenine in the other duplex strand, forming an unusual triplex structure (166).  It 
has also been shown that this analogue is more stable if targeted to U rather than 
T, this is due to steric clash of S with the methyl group of T (166). Chapter 1: Introduction 
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Other derivatives of this nucleotide have also been designed with greater 
affinity for TA interruptions, such as 
2AES (183). The addition of an aminoethoxy 
group to the 2’ position of the ribose ring has been particularly beneficial to this 
and other analogues due to interactions of the positive charge with the phosphate 
backbones (185-188).  However in terms of specificity, S and its derivatives will 
tolerate CG interruptions in the duplex and at low pH S actually binds CG 
preferentially to TA, so could potentially reduce the stringency of a TFO (168;183). 
APP shows good selectivity for CG over TA or purine bases, but again these 
triplets are less stable than T.AT and C
+.GC triplets (182).  This is another 
example of an analogue containing a positive amino group; which goes some way 
to explaining its increased stability: the positive charge may interact with the 
negative phosphate backbone.  The bonding pattern of the 
APP analogue is 
unusual when compared with most other nucleotides.  As shown in Figure 1.12 on 
the previous page it is hypothesised that 
APP forms 2 hydrogen bonds with T in 
the duplex.  However, one of these bonds, rather than being a usual NH-O bond, 
is CH-O instead.  Although the stability of this complex suggests a second 
hydrogen bond may form, more evidence is needed to confirm this theory (184). 
Although these two synthetic nucleotides have gone a long way towards the 
aim of pyrimidine recognition they are overall still less stable than T.AT or C
+.GC.  
They also are not isomorphic with these triplets and so other methods have been 
investigated to overcome the problem of pyrimidine recognition (182). 
 
1.3.1.2.   Other methods 
 
  Rather than carefully designing specific nucleotides to recognise 
pyrimidines, another approach has been to use abasic linkers to effectively ‘skip’ 
these bases.  1,2-dideoxy-D-ribose is one of these.  However, this reduces the 
stability of the triplex compared to one without pyrimidines, especially if multiple 
substitutions are used, due mainly to loss of base stacking (189;190).  Placing a 
ligand such as acridine next to the abasic site can compensate somewhat for the 
loss of stability (191;192).  However, there is also the problem of loss of stringency 
with abasic sites.  The least destabilising abasic linker found to date is propanediol 
(193;194). 
  Another technique which has had more success for targeting pyrimidines is 
the alternate strand approach.  This involves switching which strand of the duplex 
is targeted in order to avoid a pyrimidine region, see Figure 1.13. Chapter 1: Introduction 
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Figure 1.13: Example of alternate strand targeting, taken from reference (195) 
 
  There are 2 conformations for this strategy, in which the two halves of the 
TFO chain have the same or opposite 5’-3’ polarities.  If the two halves are in the 
same polarity then they must alternate between a parallel and an antiparallel 
triplex (196).  TC-rich TFOs are used in this way to recognise one strand of the 
duplex in a parallel orientation; this is joined via a linker to a GT- or GA-rich TFO 
which binds in an antiparallel orientation to recognise the other strand of the 
adjacent sequence.  There are still sequence limitations: 2 or more consecutive 
polypurine tracks are needed in opposite orientation; however these don’t each 
need to be as long. 
  If the TFOs are in the opposite polarity then only parallel triplexes are 
formed (See Figure 1.13 above) (195;197).  These need a central linker to make 
the 3’ 3’ or 5’ 5’ connection. 1,3-propanediol, 1,2-dideoxyribose and a xylose 
moiety have all been used as linkers for alternate strand technology 
(195;197;198). 
  Another way this approach has been adapted is to use much longer, flexible 
linkers to join two TFOs which bind to the same strand of the duplex, ‘skipping’ a 
region of pyrimidines (199).  All of these types of triplex formation improve affinity 
relative to that of two separate TFOs due to cooperative binding of the two 
strands, and have much greater stability compared with triplexes which contain Chapter 1: Introduction 
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mismatches.  They can also improve specificity as longer stretches of the duplex 
can be targeted without the use of low affinity analogues or abasic sites. 
 
1.3.2  Low-pH Dependence 
 
  Another major problem that has arisen during the investigation of triplexes 
is the need for a low pH in order to create 2 hydrogen bonds between a third 
strand cytosine and duplex guanine.  This is necessary because a third strand 
cytosine can only form one hydrogen bond with guanine at physiological pH and 
requires protonation of the N3 atom in order to form a second bond and create a 




































(i)          (ii) 
 
Figure 1.14: 
(i) Natural unprotonated cytosine molecule. 
(ii) Protonated cytosine molecule in a C
+.GC triplet at low pH. 
 
1.3.2.1  Cytosine 
 
  The pKa of free cytosine is around 4.5 but may be greatly elevated within a 
triplex, particularly if positioned at the centre.  Since protonation of cytosine only 
occurs at low pH, this is impractical if TFOs are to be used in vivo (78).  The 
stability of TFOs containing C
+ therefore decreases as the pH increases, since 
without protonation the interaction of cytosine with guanine is drastically 
destabilised (7;79). Chapter 1: Introduction 
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  It is also interesting to note that not all of the increase in affinity that comes 
from protonation can be attributed to the extra hydrogen bond; having an extra 
positive charge in the triplex also helps to negate some of the repulsion between 
the phosphate backbones.  X-ray crystallography has even shown that the Crick-
Hoogsteen groove (between the TFO and central purine strand) is slightly 
narrower at C
+.GC triplets, presumably because of the attraction between the 
positive cytosine and the negative phosphates on the purine strand (65).  So 
protonated cytosine actually helps to increase the stability of triplex by reducing 
the repulsion between phosphates (78). However, runs of C
+.GC triplets have 
been shown to be destabilising due to repulsion between the positive charges, so 
this base is most stabilising when dispersed within a T-rich TFO (200). 
 
  1.3.2.2  Analogues 
 
In order to use TFOs in cells, cytosine needs to be able to bind guanine at 
physiological pH.  In order to achieve this goal several base analogues have been 
designed, some based on a cytosine-like pyrimidine ring, others on a purine ring.  
These purine analogues are often based on guanine as G.GC triplets are stable 




  8-oxoadenine (Figure 1.15 ii on the following page) and its derivatives form 
triplexes in a pH independent manner, with a similar affinity to protonated cytosine.  
They also have a larger surface area which may help to increase stability by 
utilising greater base stacking potential.  Unlike cytosine, these nucleotides are not 
destabilising when multiple substitutions are used as they don’t contain a positive 
charge, and can help make a triplex less sensitive to changes in pH (201;202).  
Many derivatives of 8-oxoadenine with improved binding characteristics have been 
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7-G.GC triplet      (iv)  P1.GC triplet. 
 
Figure 1.15: Purine analogues used to recognise guanine in a duplex GC pair. 
 
N
7 (Figure 1.15 iii) also shows higher stability than methylcytosine for GC 
recognition but only when contiguous runs are used as it is even less stable than 
C
+.GC or T.AT when isolated.  N
7 is a very selective nucleotide, binding almost 
exclusively to GC and only in the antiparallel motif (204-206).  P1 (3-methyl-5-
amino-1H-pyrazolo[4,3-d]-pyrimidine-7-one) is another promising analogue for 
binding GC as it will bind at neutral pH (Figure 1.15 iv).  It has been shown by 
NMR spectroscopy that P1 also binds to GC in an antiparallel conformation by 
mimicking the hydrogen bonding pattering in C
+.GC (64;200;207). 
Purine analogues generally work well when multiple clustered substitutions 
are used but are destabilising when interspersed with other bases such as T.AT, 
probably because these triplets are not isohelical with C
+.GC and T.AT and so 
cause distortions in the backbone.  Although these analogues have an increased 
pKa and therefore bind with higher stability at higher pH they have not been as 
useful as initially hoped as they only bind in the antiparallel conformation and Chapter 1: Introduction 
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therefore cannot be used in conjunction with the promising thymidine analogues 
(described below) as these can only be used in the parallel orientation (75). 
 
  Pyrimidine-based analogues 
 
Many pyrimidine analogues have also been designed to help overcome the 
problem of pH dependence.  The first studied nucleotide was 5’-methylcytosine 
(
5MeC
+), a naturally occurring cytosine analogue which is now widely used (Figure 
1.16 i on the following page) (30;71).  
5MeC
+ has a slightly higher pKa than naturally 
occurring cytosine and is therefore protonated at a higher pH (208).  The increase 
in stability however is thought to be partially due to base stacking interactions due 
to the spine of methyl groups in the major groove (30;208).  These methyl groups 
can also interact with the methyl groups of thymine, increasing the stacking 
interactions (209).  They may also act to displace water molecules creating a 
positive entropy change (45). 
Many of the other analogues in Figure 1.16 are based on this original 
structure with alterations to attempt to increase the pKa and stability even further. 
6-oxocytosine (Figure1.16 iii) demonstrates pH independent triplex formation, but 
is less stable than cytosine or 
5MeC
+ at low pH, possibly due to the loss of the 
positive charge or less favourable base stacking interactions.  This nucleotide also 
reduces triplex stability if long runs are used, despite not having the charge 
repulsion problems of protonated cytosine (210;211).  Some analogues of this 
base have been synthesised and show more favourable characteristics such as 5-
methyl-6-oxocytidine (212;213). 
Pseudoisocytosine (ψisoC) and its derivatives including 2’-O-methyl-
pseudoisocytidine have been successfully used for stable triplex formation, 
independent of pH (Figure 1.16 ii) (214).  They achieve this by having a permanent 
hydrogen atom to form the second bond, hence creating the same bonding pattern 
as protonated cytosine.  These analogues are also some of the only uncharged 
cytosine analogues that form stable triplexes when contiguous bases are used 
(214;215).  Unfortunately these nucleotides have not been widely used as they are 
difficult and expensive to synthesise (216;217). 
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Figure 1.16: Pyrimidine analogues of cytosine. 
 
Some of the most successful analogues created so far are 2-aminopyridine 
(P) and its derivatives (Figure 1.16 v) (45).  P has a pK of around 6.8 and so forms 
stable triplexes at higher pH than any of the previously mentioned nucleotides, but 
is also stable at low pH, demonstrating its chemical stability (218;219).  Despite its 
positive charge P is stable in contiguous blocks even at pH 7.0, unlike 
5MeC
+ (220). Chapter 1: Introduction 
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  In more recent work 
5MeC
+ and P, the two most promising analogues, have 






























MeP bound to GC
 
 
MeP has several advantages over the other analogues mentioned including: 
no tendency to self-associate, greater triplet stability at higher pH, increased 
specificity for GC and an inability to form standard Watson-Crick duplexes with 
guanine, making it ideal for triplex formation (218).  However it is still pH 
dependent, although not to as much of an extent as other protonated cytosine 
analogues (182). 
  With this analogue the goal of stable guanine recognition at physical pH has 
been achieved; the positive charge on the N3 group allows formation of the 
second hydrogen bond while extra stability is produced by using the methyl group 
to create extra base stacking interactions (218). 
 
1.3.3  Stability 
 
  When a TFO binds to its duplex target the three phosphodiester backbones 
are brought into close proximity, destabilising the complex.  Although this can be 
counteracted somewhat by the addition of cations such as magnesium it would be 
useful to be able to form more stable triplexes under physiological conditions 
(221).  The low stability of triplexes creates problems when considering the binding 
of a TFO to an in vivo target.  Without a high affinity, that is, a low kD, for its 
duplex target the TFO will not be able to compete against other DNA binding Chapter 1: Introduction 
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molecules such as transcription factors.  Other methods for increasing the stability 
of triplexes have therefore been investigated. 
 
1.3.3.1  Ions 
 
The concentration of various monovalent and divalent metal cations can 
dramatically alter triplex thermal stability (13;42).  They help to stabilise triplexes 
by screening the negative repulsion between phosphates in adjacent DNA strands.  
Magnesium salts in particular have been widely used to stabilise parallel triplexes 
(222).  Calcium and zinc ions are also promising parallel and antiparallel triplex 
stabilisers (109).  Potassium ions however have been shown to inhibit the 
formation of antiparallel triplexes, as they promote quadruplex formation in G-rich 
TFOs. 
Although cations have been useful for in vitro experiments to increase 
triplex stability it is important to develop nucleotide analogues which are less 
cation dependent for use in vivo.  Magnesium ions in particular are thought to have 
much lower concentrations in vivo than have been regularly used to increase TFO 
affinity (223).  With this aim, nucleotide analogues as already described have been 
designed containing positive groups to mimic the screening effect of cations 
(186;187;224;225). 
 
1.3.3.2  Modifications 
 
  Many different methods for increasing the stability of triplexes have been 
investigated, mainly revolving around alterations to third strand nucleotides to give 
them higher affinity for their duplex targets.  Sugar, phosphate and base 
analogues have been created in an attempt to increase stability, some of which 
are described briefly below (183;225-228). Much of the research into increased 
triplex stability has focused on either attaching positive groups to a TFO, or 
increasing base stacking interactions (76;186;187;224;225;229).  Two important 
modifications have been used in this report: bis-amino-U and propargylamino-dU.  
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Backbone 
 
  Most backbone modifications involve replacing all or part of the phosphate 
groups with other moieties in order to make the TFO less negatively charged and 
hence reduce repulsion between it and the duplex (13).  Unfortunately TFOs with 
neutral backbones tend to be difficult to solubilise and synthesise (13).  Cationic 
phosphoramidates, where the O3’ is replaced by NH, have shown some potential, 
as the positive charge helps to screen the negative repulsion between the strands; 
they also inhibit quadruplex formation (227).  This modification appears to be 
particularly effective with cytosine and allows triplex formation at a site containing 
six consecutive guanines at pH 7.0 (230).  A TFO containing this modification has 
also been used in vivo to inhibit transcription (231).  There have been several 
other modifications to the phosphate group of DNA backbones including 
phosphorothioates and methylphosphonates but neither of these is as stable as 
the phosphoramidate modification (232-234). 
One type of backbone modification which has been very successful is PNA 
(peptide nucleic acid); where the backbone resembles a peptide backbone rather 
than phosphodiester backbone (235).  This means that the molecule is neutral 
rather than negatively charged and therefore does not repel the two duplex 
strands, making a much more stable triplex.  PNA has a pseudopeptide backbone 
comprised of N-(2-aminoethyl)glycine with the base attached to the nitrogen of 
glycine via a carbonyl methylene linker (236). 
Rather than forming a PNA.DNA.DNA structure, thymidine-rich PNAs prefer 
to invade double stranded DNA forming a PNA.PNA.DNA complex – similar to the 
oligo-clamp method described in section 1.2.2.  C-rich PNA molecules tend to form 
PNA.DNA.DNA structures (237;238).  TG- or homopurine- PNAs also use strand 
invasion but form PNA.DNA duplexes with the purine DNA strand, displacing the 
pyrimidine DNA strand (237).  PNA can in fact form duplexes with DNA and RNA 
which are more stable than natural duplexes, and PNA monomers are very stable 
in vivo making them attractive tools for gene therapy techniques (236).  They also 
have a lessened tendency to bind to proteins, which can be a problem with 
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Sugar 
 
  2’-methoxy groups have been added to the sugars of several nucleotides 
and nucleotide analogues.  This modification, which was introduced in order to 
prevent nuclease digestion of antisense oligonucleotides, has been shown to 
stabilise triplex formation as it stabilises the RNA-like backbone conformation 
(12;239).  The 2’-aminoethoxy modification has also been investigated with the 
hope of positioning a positive charge so as to interact with the negative phosphate 
groups (225;240).  This analogue has been shown to increase association rate 
and affinity of TFOs due to close proximity with a phosphate group on the purine 
duplex strand (240).  The importance of this interaction has been emphasised by 
the large decrease in stability if the ethoxy arm is replaced with propoxy.  This 
would position the amino group differently, probably too far away,and break the 
ionic interaction with the phosphate group (225).  An NMR structure later 
confirmed the interaction between the amino group and phosphates in the purine 
duplex strand (240).  This modification has also been incorporated into the 
analogue bis-amino-U which is discussed in detail in section 1.6. 
  Using RNA instead of DNA has also been investigated; the very first 
triplexes investigated were in fact RNA rather than DNA.  RNA TFOs form more 
stable triplexes than DNA but are much more easily degraded by cells.  Also, 
antiparallel triplexes cannot form if any strand is RNA, and in the parallel 
conformation the central purine strand cannot be RNA (241).  Several RNA- type 
analogues have been successfully created.  These include 2’-methoxylation of the 
RNA TFO which stabilises the C3’-endo conformation of the sugar and provides 
protection from nuclease degradation (239;242).  2’-aminoethylribose combines 
this modification with a positive charge to increase stability (243). 
  Locked Nucleic Acid (LNA) TFOs increase triplex stability because the 
sugar is ‘locked’ into the C3’-endo conformation, which creates an entropic 
advantage (152;244;245).  However TFOs synthesised completely of LNA do not 
form stable triplexes, presumably because they are too rigid, so must be combined 
with natural or other modified monomers to allow flexibility (151).  Various groups 
have been attached to LNA monomers and investigated, a 2’-amino modification 
being among the most effective due to introduction of a positive charge (143).  
LNA molecules are also nuclease resistant and non-toxic, making them attractive 
for in vivo use (151;246). 
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Base 
 
The most successful base modifications involve the addition of positive 
groups to help counteract the negative phosphate repulsion (225-227;247).  The 
initial idea for this type of alteration stemmed from the discovery that the 
protonation of cytosine to create C
+.GC triplets increases the stability not just 
because of the extra hydrogen bond formed, but also because of the positive 
charge (80).  In fact protonated cytosine is more stable in a triplex than T.AT, so it 
was thought that the addition of similar positive groups to thymine might increase 
its affinity for the duplex as well (79;80;248). 
It has been demonstrated that predominantly homothymidine tracts fail to 
bind their target even at high concentrations (as T.AT is less stable than C
+.GC), 
but when a positive charge is incorporated, stable binding to a duplex is observed 
(80).  Various positions for the positive charge have been investigated with mixed 
results (167;249).  Propargylamino-dU is a particularly stable positive base 
analogue and has been investigated in this report.  The positive charge on this 
analogue virtually eliminates the need for the addition of divalent cations, but it 
does still demonstrate some pH dependence (12).  Propargylamino-dU and the 
sugar analogue 2’-aminoethoxy have been combined to form bis-amino-U, an 
extremely stable thymidine analogue which is discussed in more detail in section 
1.5. 
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1.4  Positively charged thymidine analogues 
 
  Many of the analogues discussed in the previous chapter contain positive 
groups to help counteract the negative repulsion between the phosphates in a 
DNA triple helix.  Two positively charged analogues in particular have been the 
focus of this thesis; propargylamino-dU and bis-amino-U. 
 
1.4.1  Propargylamino-dU 
 
  Propargylamino-dU is a positively charged analogue of thymine with an 
amine group on the 5’ position of the base.  The amino group is designed to 
interact with the phosphates in the backbone of the TFO strand, helping to screen 
the negative interactions between the three strands (224).  Because of the 
electron rich triple bond, the amino group should be easily protonated below about 
pH 8.0; so the important positive charge on the amine will be present at 













Figure 1.18: 5’ - Propargylamino-dU (protonated form). 
 
  Triplets formed with propargylamino-dU are pH dependent due to the 
protonation of the amino group, but it does confers considerable stabilisation 
compared with thymine (224).  Magnesium ions are still needed for triplex 
formation, although at around a ten times lower concentration (167). 
Experiments were first performed with 5-(1-propynyl)-2’-deoxyuridine (pdU); 
this is similar to propargylamino-dU but without the amino group (Figure 1.19 ii) 
(251).  Several other analogues have also been investigated and are shown 
below; Chapter 1: Introduction 
 
   
Page 39   































































(v)              (vi) 
 
Figure 1.19: Structure of a variety of thymidine analogues with 6 modifications to the 5’ 
position: 
(i) Propargylamino-dU (protonated) 
(ii) 5-(1-propynyl)-2’-deoxyuridine (pdU) 
(iii) 5-(3-hydroxyprop-1-ynyl)-2’-deoxyuridine 
(iv) Aminopropyl-dU (unprotonated) 
(v) 5-guanidinopropargyl-dU (GPdU) 
(vi) 5-dimethylaminopropargyl-dU (DMAPdU) 
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Like propargylamino-dU, pdU binds at neutral pH, decreases Mg
2+ 
dependence compared with thymine and increases intracellular targeting (166).  It 
is not as effective at stabilising triplex formation as propargylamino-dU however, 
indicating that both the propyne group and the charged amino group play a role in 
stabilisation (224).  In 1998 the NMR structure of a triplex containing pdU was 
solved (252).  This and other experiments have demonstrated that the propynyl 
group on pdU has increased entropy compared with the methyl group of 
thymidine, it contributes to base stacking, and has increased hydrophobicity which 
allows TFOs containing pdU to pass into cells more easily (228;251-253).  When 
used in conjunction with a phosphorothiate backbone, susceptibility to degradation 
by nucleases within cells was also reduced (254). 
In 1996 pdU was used to increase potency of an anti-sense oligonucleotide 
(ON) designed to inhibit luciferase expression in HeLa cells (253).  When pdU was 
incorporated, a much shorter ON could be used with the same potency; only 9 
nucleotides compared with a minimum of 15 with an unmodified ON (253).  The 
ON also retained its sensitivity to mismatches; one mismatch caused a 43% 
reduction in potency and two mismatches abolished inhibition (253). 
  Three years later, pdU was used in a TFO coupled with psoralen to study 
the ability of TFOs to cause mutation (166).  This investigation found that a TFO 
containing pdU caused mutations at physiologically low Mg
2+ concentration, unlike 
one comprised solely of natural nucleotides (166).  It also showed that the pdU 
containing TFO caused mutation at a rate four times higher than the natural TFO 
(166). 
Another important analogue for studying propargylamino-dU is 5-(3-
hydroxyprop-1-ynyl)-2’-deoxyuridine (Figure 1.19 iii).  This has the same structure 
as propargylamino-dU but with a hydroxyl group as an uncharged hydrogen donor 
instead of an amino group.  It has a slightly lower stability than propargylamino-dU 
indicating that the high stability of propargylamino-dU may arise from formation of 
a salt bridge rather than a simple electrostatic interaction (250).  The increase in 
stability from a hydroxyl to amino group is also consistent with a charge rather 
than electrostatic interaction.  This analogue is much more stable than pdU as the 
hydroxyl group can interact electrostatically with the phosphate backbone (250). 
Experiments have also been performed on aminopropyl-dU.  Although this 
does contain an amino group like propargylamino-dU the linker is different (see 
Figure 1.19 iv) (250).  Unlike the other analogues mentioned, TFOs containing Chapter 1: Introduction 
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aminopropyl-dU become less stable the more substitutions are made (250).  This 
is presumably due to the increased flexibility of this type of linker (255). 
In 2009 a new analogue called 5-dimethylaminopropargyl-dU (DMAPdU) 
was synthesised (see Figure 1.19 vi) (256).  This analogue has a slightly lower 
stabilisation effect than propargylamino-dU; however it is more stabilising than 
pdU and does not require amino protection during synthesis like the more powerful 
modifications (256;257).  It can therefore be used with other modifications as well 
as psoralen and other triplex ligands which require much milder deprotection 
conditions (257).  The lower stability of DMAPdU may be due to steric hindrance 
caused by the addition of two methyl groups at this position (257).  However, it 
may also be due to loss of the electrostatic interaction between the amino group 
and phosphate backbone; this is consistent with the good stabilisation produced 
by 5-(3-hydroxyprop-1-ynyl)-2’-dU (257). 
Another interesting analogue is 5-guanidinopropargyl-dU (GPdU), this is 
again similar to propargylamino-dU but with a guanidine group in place of the 
amine (see Figure 1.19 v) (257).  It has approximately the same stability as 
propargylamino-dU (257).  Propargylamino-dU, GPdU and DMPdU all increase 
triplex stability when targeted to GC compared with thymidine, although the 
stability of these triplets is still much lower than when targeted to AT (257).  The 
difference in stability of TFOs containing dispersed or clustered modifications has 
also been investigated; DMAPdU is less stable if the modifications are clustered, 
unlike PdU, propargylamino-dU and GPdU which are unaffected by placement 
(257).  This is possibly due to a steric clash between adjacent DMAPdU residues.  
However, GPdU also has a bulky 5’ substitution but is not affected by its dispersal 
within a TFO; therefore the preference of DMAPdU for a dispersed arrangement 
may be due to competition of protonation between adjacent DMAPdU nucleotides 
(257).  Many of these analogues have also been investigated for use in anti-sense 
technology with similar results (255). 
Each substitution of T to propargylamino-dU leads to an approximately 12 K 
stability increase and its use in TFOs does not appear to affect the stringency of 
binding compared with thymine (224).  Propargylamino-dU has been shown to 
interact with two phosphates in the backbone of the third strand (see Figure 1.23 
on page 47) (186).  The interaction between the amino group of propargylamino-
dU and phosphates on the same strand of DNA may reduce the flexibility of the 
molecule and therefore help to pre-arrange the TFO for duplex binding.  This might 
help to explain why aminopropyl-dU is less stable (186). Chapter 1: Introduction 
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Unfortunately it appears that placing propargylamino-dU adjacent to C
+.GC 
is unfavourable, probably due to repulsion between the positive charges (167).  
Unlike contiguous C
+.GC triplets however, runs of propargylamino-dU are not 
destabilising even though both containing positive groups; the positive charges on 
the propargylamino-dU residues are screened from each other by their interaction 
with the negative phosphates, whereas C
+ residues are not (167).  Adjacent 
propargylamino-dU residues are also stabilised by stacking interactions between 
the propynyl arms (224). 
Several of these analogues have been used in antisense oligonucleotides 
with similar advantages as well as increased protection against nuclease digestion 
(254).  Only propargylamino-dU has been investigated in this thesis. 
 
1.4.2  Aminoethoxy-U 
 
  Although 2’-aminoethoxy-U has not been used in this thesis it has been 
combined with propargylamino-dU to form bis-amino-U which is discussed in 
section 1.4.3.  Like propargylamino-dU this analogue has a positive group 
specifically designed to interact with the phosphate in the duplex purine strand 
(240).  The positive group has a pKa of around 8.5-9.0 and so should be 
























Figure 1.20: 2’-aminoethoxy-U 
 
As can be seen in Figure 1.20 above this analogue has an oxygen atom at 
the 2’ position of the sugar, making it a ribose rather than deoxyribose sugar.  This 
means that unlike the other analogues discussed in section 1.4, 2’-aminoethoxy 
has an N- (RNA-like) rather than S-type (DNA-like) sugar pucker (240).  This 
changes the structure of the TFO slightly, making it more rigid and requires less Chapter 1: Introduction 
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distortion of the purine strand upon triplex formation (240;259).  Another difference 
is a reduction of inter-phosphate distances within the third strand (240). 
Modifications at the ribose 2’ position were first investigated in 1998 after 
the observation that the 2’ hydroxyl groups of RNA TFOs appeared to be in close 
proximity with the purine strand phosphates (260).  It was therefore hoped that a 
positive group at this position could interact with the negative phosphates and 
reduce the repulsion between strands (225).  Before analogues with 2’ positive 
charges were synthesised however a methyl derivative was first investigated.  2’-
methyl-U forms a more stable triplex as part of a TFO, indicating that the carbon 
chain of 2’-aminoethoxy-U is also likely involved in stabilisation, possibly due to 
the altered sugar pucker pre-organising the TFO for triplex formation (242). 
Other 2’ modifications have also been investigated.  Extension of the chain 
from ethoxy to propoxy and beyond caused a distinct loss of stability, 
demonstrating that the amino group needs to be positioned in a specific way to 
interact with the backbone phosphates in the purine strand (225).  Like 
propargylamino-dU replacement with a simple hydrogen donor (hydroxyl) 
decreased affinity compared with 2’aminoethoxy-U, but is still more stable than 
thymine or a simple methyl substitution (225;261). 
2’-aminoethoxy-U increases triplex stability by up to 3.5°C per base 
substitution and TFOs containing this modification are much more effective in vivo 
(225;259;261).  It also retains sensitivity to mismatches in the target duplex and is 
unaffected by magnesium cation concentration (225;259).  TFOs containing 2’-
aminoethoxy-U have association rates around 1000 times faster than unmodified 
TFOs (225).  This confirms the presence of a specific interaction which not only 
reduces the negative repulsion between strands but also contributes to the 
nucleation-zipper mechanism (225;240).  This may also increase the bio-activity of 
TFOs containing 2’-aminoethoxy-U (188).  These TFOs also dissociate 40 times 
more slowly than natural ones (225). 
The interaction of the amino group with the phosphate of the purine strand 
has been confirmed by modelling studies, as shown in Figure 1.21 below: Chapter 1: Introduction 
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Figure 1.21: Molecular model showing the interaction of the 2'-aminoethoxy side chains 
(yellow) on the TFO (orange) with the phosphate oxygen atoms (red) of the purine strand 
(pink). Taken from reference (225). 
 
Another benefit is that 2’-aminoethoxy-U has been shown to have a high 
level of nuclease resistance (188).  Several studies have used 2’-aminoethoxy-U-
modified TFOs conjugated to psoralen for gene inhibition in vivo (188;262;263).  A 
similar study demonstrated the ability of TFOs containing 2’-aminoethoxy-U to 
displace proteins from their duplex DNA target (264).  Although studies have 
shown that the more 2’-aminoethoxy-U resides are included in a TFO the more 
stable it becomes, it has also been shown that having too high a proportion of 2’-
aminoethoxy can have a detrimental effect on bioactivity (265).  It is thought this 
might be due to the TFOs being too ‘sticky’ and adhering to proteins, other 
molecules or even non-specific DNA sequences (265). 
The addition of a 2’-aminoethoxy group to C also stabilises triplex 
formation, though a C5-propargylamino group decreases the pKa of this nucleotide 
(225).  2-aminoethoxy substituent’s are even more stabilising if long tracts are 
used, and this effect is also seen with bis-amino-U (188;225). 
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1.4.3  Bis-amino-U 
 
The synthesis of 2’-aminoethoxy-5-(3-aminoprop-1-ynyl)uridine (bis-amino-
U / BAU) came about by combining two thymine analogues which had shown 
promise in previous experiments: 2’-aminoethoxy-U and propargylamino-dU 
(sections 1.4.1 and 1.4.2) (186;224;266).  BAU was first synthesised in 2000 and 
was the first example of an analogue with two positively charged groups (249).  
The two positive groups were chosen specifically to act at different positions within 
the triplex (249).  Combining the two charged modifications in BAU increases the 
stability of the BAU.AT triplet more than the combined stability of the two separate 
analogues and its use in TFOs has been a big step towards more stable triple 






























Figure 1.22: BAU.AT base triplet.  The bis-amino-U is shown in red.  The 2’aminoethoxy 
modification interacts with the phosphate group on the purine strand (green) and the 
5’propargylamino group interacts with the phosphate on BAU (purple). 
 
  BAU has two positive charges.  One is attached to the sugar (2’-
aminoethoxy) and one to the pyrimidine base (5-propargylamino) (see Figure 1.22 
above).  These positively charged groups appear to interact with specific 
phosphates in the DNA backbones of the TFO and the duplex purine strands as Chapter 1: Introduction 
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described in the previous two sections.  Experimental evidence supports the 
suggestion that there are favourable interactions between both amino groups and 
separate phosphate groups (186;250).  A study carried out in 2002 compared the 
stabilising effects of propargylamino-dU, aminoethoxy-U and bis-amino-U (186).  
When the two positively charged groups are combined in BAU, an additive effect is 
observed indicating that each positive group is contacting a different phosphate 
(186).  TFOs with the same sequence and containing the same number of each 
modification were compared as follows, using melting curve analysis.  At pH 7.0 
propargylamino-dU and aminoethoxy-U produced ΔTm values of 27.1 and 12.5 K 
respectively, while the ΔTm value of BAU was 42.4 K, slightly higher than the two 
separate modifications combined (186). 
Bis-amino-U is also less pH dependent than the separate analogues, 
producing stable binding at pH 7.5, although stability decreases above pH 8.0 due 
to lack of protonation (186).  Like 2’-aminoethoxy-U BAU also appears to 
dissociate much more slowly than thymidine (187).  Unlike propargylamino-dU, 
where multiple substitutions are generally required before stabilisation is observed, 
a single BAU substitution enables triplex formation in the absence of magnesium 
ions; with two substitutions the complex is stable at pH 6.0 (267). 
  Unlike 2’-aminoethoxy-U, substitution with BAU does not appear to 
enhance the association rate.  However, the dissociation rate of TFOs containing 
BAU are much slower than thymine (243).  This is unfortunate as fast association 
rates are ideal in vivo, although slow dissociation rates are also beneficial.  There 
is some evidence to suggest that if multiple substitutions of BAU are used the 
association rate is increased slightly (243). 
  There is also compelling modelling evidence to confirm the interaction 
between the amino and phosphate groups (186).  NMR studies have already 
shown the close interaction of the 2’aminoethoxy group and a phosphate in the 
purine strand, with an N-O distance of approximately 2.8 Å (240;268).  The 5’-
propargylamino-dU group was then manually added to this structure to give an 
approximation of the amino-phosphate distances for this extra group (see Figure 
1.23 on the following page) (186).  This modelling showed a N-O distance of 3.0 Å 
between propargylamino-dU and the closest phosphate in the third strand, and 4.7 
Å to the next third strand phosphate suggesting a possible interaction with both of 
these phosphate groups, although the second interaction may not be as strong 
(186).  Additionally, the propyne chain of propargylamino-dU is 2.4 Å from the 
methyl group of the adjacent thymine suggesting a hydrophobic interaction Chapter 1: Introduction 
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between these chains (186).  The interaction of the propargylamino-dU group with 





Figure 1.23: Model of possible interactions of the amino groups of BAU based on the 
NMR structure of 2’aminoethoxy-U in a triplex.  (a) top down view, (b) and (c) side-on 
views.  The BAU residue is in yellow, the propargylamino group in orange with the amino 
group (blue) interacting with the phosphate (red).  The amino of the 2’-aminoethoxy group 
is also shown in blue interacting with a phosphate (not shown in red) in the purine strand 
(purple).  The thymine residue on the 5’ side of BAU is in green.  Possible hydrogen 
bonds are shown by white dotted lines. 
Taken from reference (186). 
 
BAU has been used in conjunction with several other nucleotide analogues 
(
MeP, S and 
APP) to recognise all four base pairs at physiological pH and without 
magnesium ions, a huge step forwards for the use of TFOs in vivo (182).  An 
interesting advantage of TFOs which interact with the backbone of the target as 
well as the bases is that they may compete better with DNA binding proteins as 
these generally interact with the DNA backbone (240). Chapter 1: Introduction 
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There is a growing body of evidence showing that the positioning of 
charged residues within a TFO can affect its binding affinity.  2’-aminoethoxy-U 
has been shown to be more stabilising if multiple clustered substitutions are used, 
although the use of too many substitutions in a TFO appears to reduce in vivo 
effectiveness even when it is very stable in vitro (188;265).  The hydroxyl version 
of 2’-aminoethoxy-U also appears to be detrimental in vivo and has unusual 
‘sticky’ properties in vitro if too many substitutions are used, indicating that 
perhaps the positive charge of 2’-aminoethoxy-U is not to blame for the reduction 
in effectiveness and it is a result of the extra hydrogen bonding potential of these 
nucleotides (261).  Propargylamino-dU is also more stable when multiple 
substitutions are used and TFOs containing only a few modifications show only a 
slight increase in binding affinity compared to TFOs comprised of natural 
nucleotides (167;224). 
Initial work on BAU-containing TFOs suggested that adjacent BAU residues 
were not destabilising, despite the large numbers of positive charges. This is 
possibly because unlike C
+, which is destabilising if contiguous residues are used, 
the positive charges in BAU interact directly with phosphate groups, not only 
screening the negative repulsion but also preventing the large numbers of positive 
charges from destabilising the complex (186). 
Later work conflicts with this theory however, showing that BAU residues 
are more effective if dispersed throughout the TFO, and clearly demonstrates that 
clustered residues can cause dramatic loss of binding affinity, particularly at 
physiological pH (267).  The TFOs used in this study also contained the cytosine 
analogue 
MeP however, so the decrease in affinity may have been due to 
clustering of these residues rather than BAU (267). 
Previous work has been carried out using two particular TFO sequences, 
and these are also used in this thesis, containing a run of six propargylamino-dU 
(P) or BAU residues.  The propargylamino-dU-containing TFO increases binding 
affinity by three orders of magnitude at pH 5.0 compared with an unmodified TFO, 
showing binding at nanomolar concentrations (224).  A TFO of the same sequence 
but containing only three substitutions rather than six failed to produce a footprint.  
In contrast, a TFO containing three BAU substitutions bound at nanomolar 
concentrations and was stable at pH 7.0 (186). Chapter 1: Introduction 
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1.5  Ligands 
 
Another method which has been widely used to increase the stability of 
triplexes is to use ligands which selectively bind to triplex (not duplex) DNA.  
These have been shown to increase the strength of TFO binding by up to 1000 
fold (37).  Duplex or triplex ligands can also be covalently attached to the TFO, 
while triplex binding ligands can be added in solution.  Ligands can also be used to 
promote the formation of triplexes which may not form under normal conditions; 
they can also help to stabilise mismatches and reduce cation dependence 
(37;171;269). 
Naturally occurring polyamines like spermine, spermidine and putrescine 
have been used to stabilise triplexes (270-273).  They are positively charged and 
so probably help to reduce the repulsion between the strands.  Some groups have 
also attached spermine to the N4 position of methylcytosine, which then becomes 
stable at pH 7.4 even though at this pH the N3 of methylcytosine is not protonated 
(226;247;271).  Unlike other cytosine analogues this monomer is actually less 
stable at lower pH and much less dependent on magnesium ions (45).  Spermine 
can also be attached to the 5’-end of a TFO molecule and this terminal substituent 
is more effective than when spermine is placed at the centre of a TFO (45;273). 
Positively charged benzopyridoindole derivatives such as BePI and BgPI 
are triplex-specific intercalating ligands which have been used to stabilise 
triplexes, particularly those comprising T.AT (274).  These ligands have large 
fused aromatic ring systems and can increase the melting temperature of short 
triplexes by over 20ºC; however they cannot bind near to C
+.GC due to ionic 
repulsion between the positive charges (274-276).  Acridine and coralyne are two 
other positively charged intercalating ligands which have often been tethered to 
TFOs (192).  When tethered to the end of a TFO acridine binds at the 
triplex/duplex junction and can increase stability around 100 fold.  Coralyne is 
another triplex-specific ligand which has slight preference for T.AT triplets over 
C
+.GC, though it can also bind to duplex DNA (274;274;277-279).  A few planar 
polycyclic aromatic chromophores such as pyrene, anthracene and dansyl have 
also been investigated (280). 
The intercalating ligands described above generally have large planar ring 
systems and it is probable that the size of these rings dictates whether a ligand is 
duplex or triplex specific, depending on how well they stack with the bases in a 
double or triple stranded DNA structure.  These ligands do not generally affect Chapter 1: Introduction 
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binding stringency but some have been used specifically to overcome pyrimidine 
recognition by increasing stability of the surrounding triplets (191;192;281).  Two 
ligands of particular interest have been used in this project and are covered in 
more detail below. 
 
1.5.1  Naphthylquinoline 
 
Naphthylquinoline is a triplex-specific ligand which can promote triplex 
formation at sites containing up to 3 consecutive inversions (171;269;282).  It is an 
intercalating ligand with a large aromatic area, which is unfused and so has 
torsional flexibility which allows it to intercalate between triplex nucleotides as it 
can adapt to any propeller twist.  Although antiparallel triplexes are pH 
independent, naphthylquinoline has a greater stabilising effect at low pH, 
suggesting that the active compound needs to be protonated (283).  It has also 
been shown to reduce the concentration of TFO needed to produce a footprint by 










Figure 1.24: Naphthylquinoline 
 
Naphthylquinoline is moderately selective for T.AT over C
+.GC, and 
stabilises parallel triplexes more effectively than antiparallel ones (269;283;284).  
As base stacking and base overlap are very similar in both the T.AT and C
+.GC 
triplets it is likely that the selectivity for T.AT over C
+.GC is due to charge repulsion 
between the ligand and the positively charged cytosines (283).  There are two 
nitrogen atoms in naphthylquinoline which can become protonated; one in the ring 
system and one on the aminoalkyl side chain.  The side chain nitrogen should be 
fully protonated at all pHs, but the ring nitrogen has a pK of 7.1.  It is therefore Chapter 1: Introduction 
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likely that the ring nitrogen is the cause of the apparent pH dependence, and that 
this protonation has an important effect on triplex stabilisation (283). 
Several derivatives of naphthylquinoline have been prepared which also 
effectively stabilise triplexes (269).  In the work described in this thesis 
naphthylquinoline has been used free in solution, though it can also be tethered to 
a TFO with slightly greater stabilising effect (285). 
Of crucial interest to this investigation, naphthylquinoline has been show to 
stabilise triplex mismatches even when the TFO would not normally bind the 
template, although higher TFO concentrations are required (269).  This 
stabilisation is limited to a few mismatches however, and unrelated TFO 
sequences cannot be forced to bind the template simply by addition of ligand 
(269).  One study indicated that if a TFO is comprised of two sections, one to bind 
a perfect site and one to bind an adjacent mismatch site, naphthylquinoline can 
induce triplex formation by anchoring the first section of the TFO (173). 
 
1.5.2  Anthraquinone 
 
  Bis-substituted anthraquinone molecules have been investigated as TFO-
tethered ligands to increase triplex stability (286;287).  A 2,6 disubstituted 
amidoanthraquinone derivative has been shown to bind triplex DNA preferentially 
over duplex DNA due to its extended planar surface, and can enhance triplex 
stability up to 200 fold (288).  However a similar 1,4 substituted analogue 
stabilises duplex DNA and so can be used to destabilise the triplex and cause 
dissociation of the third strand as it competes with the TFO for the major groove 
(45).  More recently another investigation has looked at a variety of anthraquinone 
substitutions and found the following order of stabilisation; 2,7 > 1,8 = 1,5 > 2,6, 
although there is only a six-fold difference between them (289).  They also 
examined mono-substituted anthraquinones and found these to be less effective 
than their disubstituted counterparts.  The variation between these derivatives is 
thought to arise from differences in DNA groove accessibility and base stacking 
(290).  The positively charged side chains of these derivatives seem to have a 
relatively minor role in stabilisation in terms of electrostatic interactions.  The 
stacking ability and position of the side chains is more relevant and evidently leads 
to the differences in binding preferences (288). 
  It is also interesting to note the difference in anthraquinone stabilisation 
between parallel and antiparallel triplexes; all the stabilisation properties discussed Chapter 1: Introduction 
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above are for parallel triplexes.  In the antiparallel conformation, anthraquinone 
stabilisation depends on the composition of the third strand.  TG-containing TFOs 
are stabilised by 1,8 and 2,7 derivatives but not 1,5 or 2,6.  AG-containing TFOs 
however show no stabilisation by 1,8 or 2,7 substitutions but are stabilised by 1,5 
and 2,6. 
Anthraquinone molecules can also be tethered directly to TFOs where they 
act to staple the triplex together, greatly increasing the overall TFO stability.  
Tethered anthraquinones have been used in this investigation to examine their 




















Figure 1.25: Structures of the two anthraquinone constructs used in this thesis. 
 
The 3’ anthraquinone modification has no substitutions and is tethered to 
the DNA backbone with a hexamethylenediamine linker.  The 5’ anthraquinone 
has a hexamethylenediamine group on the 5 carbon atom and is bound to the 
DNA backbone with a hexamethylenamine linker.   Chapter 1: Introduction 
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1.6  Secondary binding sites 
 
  The ability of different modifications to either stabilise or destabilise 
mismatches within a triplex is of particular importance in this thesis.  The binding 
of TFOs containing multiple substitutions of propargylamino-dU or BAU to 
secondary binding sites is examined and compared.  The high positive charge of 
these TFOs appears to allow them to bind at these secondary target sites. 
  Within a triplex comprised of purely natural nucleotides just one 
mismatched triplet can cause destabilisation of the complex (168;291).  
Mismatched bases in triplex DNA have been shown to be as destabilising as 
mismatches within duplex DNA, if not more so (45;292;293). They appear to 
reduce the stability of triplexes by increasing the dissociation rate rather than 
altering the rate of association (74).  The effect of a mismatch on triplex stability is 
subject to positional effects; they have a greater destabilising effect at the centre 
of a triplex than near the triplex-duplex junction (74;172;291).  They are also 
affected by the flanking bases, and different mismatches have different 
destabilising strengths (172;291). 
  Many of the analogues mentioned in this chapter have been tested against 
various mismatches.  For example spermine conjugated to cytosine residues 
within a TFO appears to allow the cytosine residue to bind AT as strongly as GC, 
although it still discriminates against pyrimidine bases (247).  The spermidine 
compensates for the loss of cytosine protonation at high pH but this reduces 
specificity (247). 
  Several investigations using a propargylamino-dU substitution in an anti-
sense oligonucleotide found that it showed similar sensitivity to mismatches 
compared with an unmodified oligonucleotide (253;255). 
  Although early experiments found that 2’-aminoethoxy-U was sensitive to 
mismatches in the target DNA (225), a later study on bioactivity showed that TFOs 
extensively modified with this substitution have low bioactivity despite appearing to 
be very effective in in vitro experiments (262).  The authors of this paper have 
speculated that this may be due to the high positive charge making the TFO 
‘sticky’ and allowing it to bind not only to non-target sequences but also to other 
molecules within the cell such as proteins.  They found that the TFO was difficult 
to manipulate in vitro and adhered to glass columns and tubes etc, substantiating 
this hypothesis (262).  A more recent paper has support the idea that TFOs highly Chapter 1: Introduction 
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modified with 2’-aminoethoxy-U show high activity in vitro but very low activity in 
vivo (265). 
  Studies on BAU triplex formation have generally shown similar results to 
those for other positively charged analogues. BAU appears to be more sensitive 
opposite pyrimidine mismatches than thymidine is, particularly at high pH 
(187;266).  Although BAU is highly selective against pyrimidine bases in the 
duplex it is no better than thymidine at discriminating against guanine (182;187).  
Also because it generally binds the duplex much more tightly than naturally 
comprised TFOs it can stabilise mismatches at other points in the triplex (182).  A 
TFO containing six substitutions of BAU was shown to be stable at unusual 
secondary sites which at first glance show very little relation to the TFOs expected 
target site (294).  It was this discovery which became the basis for the experiments 
discussed in this thesis. 
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1.7  Methods used in this thesis for studying triplex specificity 
 
1.7.1  Footprinting 
 
Footprinting was first used in 1978 for studying the interaction between 
proteins and DNA (295).  It has since been developed as a versatile method for 
identifying the sequence-specific interaction of many drugs, proteins and nucleic 
acids with their DNA targets.  Footprinting is a method for determining the 
sequence selectivity and affinity of DNA-binding compounds. Ligands such as 
TFOs are used to protect radiolabelled DNA from cleavage by agents like DNase I, 
which has been used in this thesis. 
The DNA template is cleaved in the presence and absence of a ligand such 
as a TFO, and the regions to which the ligand is bound are protected from 
digestion, creating a gap or ‘footprint’ in the ladder of cleavage products when 
these are resolved on denaturing polyacrylamide gels (see Figure 1.26 below). 
The reaction requires that each DNA molecule is only cleaved once (single hit 
kinetics). 
 
Figure 1.26: Footprinting basics.  The left side image is a representation of a duplex DNA 
template bound by a TFO (blue), the red star represents the radiolabel.  On the right is a 
schematic of a footprinting gel.  The region of duplex DNA bound by the TFO is protected 
from DNase I cleavage.  Once digested, the DNA is run on a denaturing polyacrylamide 
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DNase I is a monomeric glycoprotein with a molecular weight of about 
30,400 Da. It is a double strand-specific endonuclease, though it will cut single-
stranded DNA, albeit at a much lower rate. It requires the presence of divalent 
cations and makes single strand nicks in the DNA backbone, cleaving the O3’-P 
bond. Optimal cleavage is obtained using calcium or magnesium ions, while 
manganese ions enhance the activity. 
 
1.7.2  REPSA 
 
  A relatively novel selection method, REPSA (restriction endonuclease 
protection, selection and amplification), has been utilised in this study to identify 
the binding sites of the TFO of interest.  This technique was first devised by 
Hardenbol and Van Dyke in 1996 and has been used to study interactions of DNA 
with proteins, TFOs and small molecules (77;296-299).  Unlike previous selection 
techniques REPSA does not depend on physical separation of bound from 
unbound template.  This makes it ideal for non-covalent interactions such as DNA-
DNA and protein-DNA interactions. 
  Like a gel retardation assay REPSA is a method by which a population of 
possible target sequences can be separated into those that bind a TFO and those 
that don’t.  It also contains aspects of a protection assay, where a ligand is used to 
protect the DNA sequence it binds to from restriction enzyme digestion (3). 
In REPSA a synthetic population of random templates is tested with the 
ligand.  This template contains a randomised central region adjacent to a binding 
site for a Type IIS restriction enzyme, such as Fok I (which is used in this study).  
Type IIS restriction enzymes recognise a specific sequence but cut at a fixed 
distance from their binding site and so can be used to cleave a region with an 
unknown sequence.  This makes REPSA superior to other methods as no prior 
knowledge of the target sequence if required. 
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Figure 1.27: Typical REPSA experiment, using a double stranded template, primers and 
Type IIS restriction enzyme. 
 
The duplex targets are incubated with the ligand.  A small number of the 
randomised templates will be bound by the ligand, but the majority will not.  A type 
IIS restriction enzyme is then used to cleave both strands of any unbound 
templates, which are protected from cleavage by the TFO, and can then be 
amplified by PCR.  The amplified DNA is then purified and the protocol repeated 
around 10 times, each round of REPSA enriching for ligand-bound targets.  Once 
REPSA has been completed the selected templates can be cloned into plasmids, 
transformed into competent cells and plated out.  The colonies that grow should 
each contain a different template which can then be sequenced. 
 
1.7.3  Band shift 
 
A gel retardation assay involving the separation of triplex from duplex DNA in 
order to obtain the target sequences for a TFO was also investigated.  It relies on 
the principle that a DNA triple helix will have a marginally different mobility to that 
of duplex DNA when run on a non-denaturing polyacrylamide gel.  The purpose of 
this technique is the same as REPSA; to determine the binding site preferences of 
a TFO which exhibits some non-specific binding.  It was run alongside REPSA 
with the same TFOs in the hope of corroborating the REPSA results.   Chapter 1: Introduction 
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1.8  Aims and objectives 
 
  The main aim of this work was to examine how positively charged 
stabilising modifications affect triplex specificity, especially when multiple 
substitutions are included.  The first part of this thesis (Chapters 3 and 4) looks at 
the specificity of a TFO containing a high number of positively charged bis-amino-
U residues and uses REPSA and footprinting to elucidate and examine the 
primary and secondary binding sites of this TFO.  The second part (chapter 5) 
uses footprinting to examine the specificity of TFOs containing the positively 
charged intercalating ligand anthraquinone at different positions.  The preliminary 
optimisation experiments for REPSA are detailed in chapter 2 as well as an 
alternative band shift technique which was investigated but failed to yield results. 
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Chapter 2: Materials and Methods 
 
This thesis investigates the specificity of several TFOs containing positively 
charged nucleotides. The first part of this thesis (chapters 3 and 4) looks at the 
specificity of a TFO containing a large proportion of positively charged bis-amino-U 
residues and uses REPSA and footprinting to elucidate and examine its secondary 
binding sites.  The second part (chapter 5) examines the specificity of TFOs 
containing the positively charged intercalating ligand anthraquinone at different 
positions using footprinting.  The protocols for generating targets, preparing and 
labeling DNA, footprinting and REPSA can be found in section 2.2.  In sections 2.3 
and 2.4 the preparatory work prior to REPSA and a secondary band shifting 
method are detailed. 
 
2.1  Materials 
 
2.1.1  Footprinting templates 
 
Several DNA fragments have been used as footprinting templates in this 









Figure 2.1: Sequence of the tyrT template, the binding site for the TFOs used in chapters 
3 and 4 is shown in red (the binding site for the TFOs used in chapter 5 will be discussed 
later) the nucleotides bearing the 
32P are underlined. 
 
This template was originally created by cloning into the tyrT fragment 
between the EcoRI and SmaI sites of pUC18.  The 17 base pair oligopurine tract 
used in footprinting was then introduced into the sequence by mutation (142). 
A series of DNA fragments which emerged from REPSA selection have 
been used as footprinting templates in Chapter 4 and are detailed there.  The tyrT 
fragment shown above has also been mutated to create a range of similar Chapter 2: Materials and Methods 
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templates which are used in Chapter 5.  The technique and mutated fragments are 
detailed in section 2.2.8. 
 
2.1.2  Oligonucleotides 
 
Apart from noted exceptions all the oligonucleotides and TFOs listed below 
were synthesised by Prof. Tom Brown and his group (Department of Chemistry, 
University of Southampton).  The oligonucleotides were dissolved in water and 
stored at -20 ºC and at stock concentration on 20 mM. 
 
  2.1.2.1  Specificity of bis-amino-U (chapters 3 and 4) 
 
Three TFOs have been used in this thesis to determine the specificity of 
BAU and to compare this with T and propargylamino-dU: 
 
i)    5’ – TTTTTTCTT – 3’ 
ii)    5’ – BBBBBBCBT – 3’ 
iii)    5’ – PPPPPPCPT – 3’ 
 
Figure 2.2: Sequence of TFOs used to study the specificity of BAU and propargylamino-
dU compared to thymine. 
B = Bis-amino-U 
P = Propargylamino-dU 
T = Thymine 
 
  The TFO in Figure 2.2 i is a control TFO for reference; Figures 2.2 ii and iii 
show TFOs of the same sequence containing either propargylamino-dU or bis-
amino-U to compare the effect of one or two positive modifications respectively. 
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A single stranded oligonucleotide was synthesised for use as the template 








Figure 2.3: Above: Sequence of randomised single stranded template synthesised for 
REPSA.  N represents any base inserted at random during synthesis (in red). 
Below: Sequence of the primer used in primer extension, the red star indicates the 
position of the radiolabel. 
 
In this sequence N represents any base inserted randomly during synthesis 
thus creating a theoretical random pool of template sequences.  Primer extension 
was used to create double stranded DNA for use in REPSA from these single 
stranded synthetic templates (see sections 2.2.6 and 2.3.1). 
A similar sequence of the same length containing the exact TFO binding 
site was also synthesised along with its complement so that a double stranded 






Figure 2.4: Complementary single stranded synthetic templates containing the exact 
binding site for the TFOs shown in red. 
 
This was used for some of the preliminary REPA and band-shift 
experiments.  The sequence was subsequently cloned between the BamHI and 
HindIII sites of pUC19 to generate a fragment for use in footprinting experiments. 
Many other sequences have also been used for footprinting; these were 
selected from the random pool of oligonucleotides using REPSA and the 
sequences are shown in Chapter 4.  See sections 2.2.7 and 2.3 for more detail on 
REPSA. 
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  2.1.2.2  Specificity of anthraquinone (chapter 5) 
 
  Five TFOs were used for this part of the thesis, shown below in Figure 2.5; 
 
i  5’ –  TCCTTCTCTTTTTTCTTT  – 3’ 
ii  5’ – XTCCTTCTCTTTTTTCTTT  – 3’ 
iii  5’ –  TCCTTCTCTTTTTTCTTTX – 3’ 
iv  5’ – XTCCTTCTCTTTTTTCTTTX – 3’ 
v  5’ –  TCCTTCTCTTTTTTCTTSX – 3’ 
 
Figure 2.5: TFOs A-E.  Sequence of TFOs used to study specificity of anthraquinone. 
X = Anthraquinone 
S = S base (N-(4-(3-acetamidophenyl)thiazol-2-yl-acetamide) 
 
  Figure 2.5 i is a control (unmodified) TFO; ii-iv are TFOs with the same 
sequence but with an anthraquinone modification at the 5’, 3’ or 5’ and 3’ ends 
respectively.  TFO v has a similar sequence but with an S base at the 3’ end. 
  These TFOs were footprinted on several templates to investigate their 
selectivity.  The generation and sequence of these templates is described in 
section 2.2.8. 
 
2.1.3  Enzymes and chemicals 
 
  All enzymes, buffers and dNTPs used in this thesis were purchased from 
Promega.  Exceptions were AMV reverse transcriptase and DNase I which were 
purchased from Sigma-Aldrich.  Polynucleotide kinase, PNK buffer, Fok I, Fok I 
buffer and pUC19 were purchased from New England Biolabs.  The majority of 
chemicals were purchased from either Sigma-Aldrich.  However, sodium chloride, 
sodium hydroxide and ethanol were purchased from Fisher Scientific. 
  Radionucleotides were purchased initially from Amersham and later from 
Perkin Elmer as Amersham discontinued production of short life isotopes. All 
reagents for preparing polyacrylamide gels were purchased from National 
Diagnostics.  Hydrophobic ‘non-stick’ microcentrifuge tubes were from Alpha 
Laboratories.  Tryptone, carbenicillin, IPTG and Xgal were purchased from Melford 
Labs, and yeast extract and blood agar from Difco (Becton, Dickinson & Co.).  
Agarose and Ficoll were from Sigma-Aldrich. Chapter 2: Materials and Methods 
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  The Naphthylquinoline triplex binding ligand was a gift from Dr. L. 
Strekowski (Dept. of Chemistry, Georgia State University) and was stored at a 
concentration of 20 mM in dimethylsulphoxide at -20°C.  The source of any other 
materials is stated in the text.  All reagents were stored as recommended by the 
manufacturer. 
 
2.2  Protocols 
 
2.2.1  Transformation 
 
Competent cells were made for use in transformations using the following 
protocol.  A colony of E.coli TG2 cells was gown overnight at 37ºC in sterile 2YT 
media (16 g tryptone, 10 g yeast extract and 5 g sodium chloride per litre).  1 ml of 
this culture was then transferred to 100 ml of 2YT media and grown until an 
optimal density of 0.6-0.8 at 600 nm was reached.  The cells were harvested by 
centrifugation at 3000 rpm for 10 minutes in a sterile 25 ml tube.  The media was 
then decanted from the pelleted cells, which were then resuspended in 
approximately 20 ml of sterile transformation buffer (50 mM calcium chloride, 10 
mM Tris-HCl pH 7.5).  The resuspended cells were then placed on ice for at least 
30 minutes before being pelleted again and finally resuspended in approximately 5 
ml of transformation buffer and stored at 4ºC for up to two weeks. 
In transformations the exact quantities of cells and plasmid were varied 
over the course of this investigation in order to obtain different densities of cells.  
However, the general procedure is outlined below. 
1-5 µl of plasmid DNA (typically 100 µg/ml) was added to 20-200 µl of 
competent cells in a sterile 1.5 ml micro-centrifuge tube and placed on ice for at 
least 30 minutes.  This was heat shocked at 45 ºC for 1 minute to allow the 
plasmid to enter the cells, then placed back on ice for a few minutes.  The 
transformed cells were plated onto sterile 20 ml agar plates containing 100 µg/ml 
carbenicillin to select for cells containing plasmid DNA.  Transformants containing 
clones from REPSA experiments or other fragments were detected by blue-white 
selection on agar plates containing 1 mM IPTG and 5 µM Xgal in addition to the 
carbenicillin.  This allows selection between ‘empty’ plasmids and recombinant 
plasmids (which have had a new fragment ligated in).  The plates were incubated 
overnight at 37 ºC and then sealed with parafilm and stored at 4 ºC. 
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2.2.2  Plasmid Preparation 
 
Colonies were picked from the agar plates using either a sterile metal loop 
or sterile 2-200 µl pipette tips and grown overnight at 37 ºC in 5ml of 2YT media 
containing 100 µg/ml carbenicillin.  The cultures were then split into two or three 
1.5 ml micro-centrifuge tubes and centrifuged at 6000 rpm for 5 minutes to pellet 
the cells.  The supernatant was discarded and the plasmids were purified using a 
Qiagen QIAprep kit.  First the pellets were re-suspended in 250 µl Buffer P1 
containing RNase A and then lysed by addition of 250 µl Buffer P2.  The lysis was 
stopped by addition of 350 µl of Buffer P3 and the solution centrifuged at 13000 
rpm for 10 minutes.  The supernatant was then transferred to a Qiagen spin 
column and centrifuged three times for 30-60 seconds at 13000 rpm, discarding 
the flow through each time.  After the first and second centrifugation steps 500 µl 
of Buffer PB and 750 µl of Buffer PE were added respectively.  After the third 
centrifugation the column was placed in a 1.5 ml microcentrifuge tube and 50 µl of 
Buffer EB was added, the tube was then spun for 30-60 seconds to elute the 
plasmid.  Purified plasmids were stored in Buffer EB at -20 ºC; in some 
experiments water was used to elute the plasmid, for example in REPSA. 
 
2.2.3  Radiolabeling 
 
  Many of the techniques used during this project involve radiolabelled DNA 
fragments of varying lengths in which the radioactive isotope 
32P is attached to 
double or single stranded DNA at one or other end. 
  Two different radiolabeling methods were used in this project; one attached 
[ -
32P]-dATP to the 3’ end of a section of double stranded DNA, and the second to 
attach a radioactive phosphate group from [γ-
32P]-ATP to the 5’ end of a single 
stranded DNA sequence.  Alpha and Gamma refer to the placement of the 
radioactive phosphate in the ATP; 
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Figure 2.6: Diagram showing alpha and gamma labelling positions; the red phosphate 





2.2.3.1  3’ labelling 
 
3’ labelling is the method used to attach a dAMP molecule containing a 
radioactive phosphate, to the 3’ end of one strand of duplex DNA, by filling in 
sticky ends left after restriction digestion using [α-
32P]-dATP and a DNA 
polymerase.  The double stranded tyrT and REPSA fragments were labelled in this 
way. 
The plasmid DNA for labelling was obtained as described in section 2.2.2. 
For plasmids containing the tyrT sequence, 40 µl of purified plasmid was 
combined with 4 µl of Promega buffer B, 18 units of EcoRI and 15 units of AvaI.  
This mix was then incubated at 37  C for one hour.  1 µl of [ -
32P]-dATP, 10 units 
of AMV reverse transcriptase and 5 µl of reverse transcriptase buffer were added 
and incubated at 37 ºC for a further hour to fill in the sticky ends at the EcoRI site.  
The labelled fragment was then purified as described in section 2.2.3.3. 
The REPSA fragments were labelled in a similar way but the restriction 
enzymes EcoRI and HindIII were used to release the fragment of the desired 
length.  As these both leave exposed Ts in the 5’ overhang the plasmid was first 
cut with EcoRI and then labelled with α[
32P]-dATP using reverse transcriptase.  
The reverse transcriptase was then deactivated by heating at 65 ºC for 10 minutes 
before cutting with 15 units of HindIII for one hour. 
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2.2.3.2  5’ labelling 
 
This method was used to attach a phosphate from [γ-
32P]-ATP to the 5’-end 
of a single stranded DNA fragment.  The primer used to create the mixed 
sequence REPSA fragments and the band shift templates, as well as the TFO 
were labelled in this way. 
2 µl of 5 µM oligonucleotide was incubated with 2 µl [γ-
32P]-ATP, 2 µl T4 
polynucleotide kinase buffer (NEB), 20 units of T4 polynucleotide kinase (NEB) 
and 13 µl water at 37 ºC for one hour. The kinase attaches the radioactive terminal 
phosphate from the ATP onto the 5’ end of the DNA.  The radioactive DNA was 
then purified as described below. 
 
2.2.3.3  Purification 
 
After labelling the DNA was run on a 0.3 mm-thick polyacrylamide gel to 
purify it from the enzymes and other components.  For 3’-labelling, 20 µl of loading 
dye (20% Ficoll, 10 mM EDTA and 0.005% w/v bromophenol blue) was added and 
the sample loaded onto an 8% non-denaturing polyacrylamide gel (40 cm long) 
and run at 800 V for at least 90 minutes (until the dye reached the bottom of the 
gel).  For 5’-labelled single stranded DNA fragments 10 µl of DNase I stop solution 
(80% formamide, 10 mM EDTA, 10 mM NaOH and bromophenol blue) was added 
and the sample was heated to 95 ºC for 3 minutes.  It was then loaded onto a 14% 
denaturing polyacrylamide gel (containing 8 M urea) and run at 1500 V for around 
90 minutes. 
After running, the wet gel was exposed to X-ray film for about 3 minutes to 
locate the position of the radioactive DNA and the band was excised with a razor 
blade.  The DNA was eluted from the gel slice by submerging it in 300 µl of elution 
buffer containing 10 mM Tris-HCl pH 7.5 and 10 mM EDTA.  This was agitated 
overnight and the buffer containing the labelled DNA extracted. Approximately 1.3 
ml of ethanol was added and the sample left on dry ice for 10 minutes to allow the 
DNA to precipitate, then centrifuged at 15000 rpm for 10 minutes.  In early 
experiments 30 µl of 3 M sodium acetate was used in addition to ethanol to aid 
precipitation.  However this occasionally produced a pellet of excess salt during 
the centrifugation and it was discovered that omitting the sodium acetate did not 
unduly affect the efficiency of the precipitation.  After centrifugation the 
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which has not precipitated.  The purified DNA pellet was washed with 70% ethanol 
and dried.  The DNA was re-dissolved in 10 mM Tris-HCl pH 7.5 containing 0.1 
mM EDTA, at a concentration of about 10 cps per microlitre as estimated using a 
hand held Geiger counter. 
  When labelling the primer and the TFO some problems were encountered 
during purification.  As a result of their short length the DNA did not precipitate well 
and the supernatant still contained radiolabelled DNA.  To overcome this, the DNA 
was split into two or more reaction tubes before the addition of ethanol so that 
more ethanol could be added than normal at this point.  The DNA was then left on 
dry ice for at least 30 minutes (rather than 10), and spun for 15 minutes instead of 
10.  If any of the supernatant still contained radioactivity it was placed in a 
separate tube with more ethanol and the process was repeated. 
 
2.2.4  Footprinting 
 
DNase I footprinting is a technique which can be used to detect the binding 
sites and binding affinity of TFOs.  This technique was used in the initial stages of 
the project to investigate the binding of the bis-amino-U containing TFO on the 
tyrT fragment (chapter 3).  Footprinting experiments were also carried out on 
sequences isolated from REPSA (chapter 4) and to investigate the specificity of 
the anthraquinone containing TFOS (chapter 5). 
 
2.2.4.1  Incubation 
 
The TFO of interest was diluted in an appropriate buffer to give a range of 
six different concentrations which were 150% of the desired final concentration.  3 
µl of each of the TFO dilutions was combined with 1.5 µl of radiolabelled DNA and 
incubated to allow binding (usually overnight) at 20 ºC, although 1 hour 
incubations were also tested as described in the results chapters.  The majority of 
experiments were performed at pH 5.0 in 50 mM sodium acetate.  Any other 
buffers used are detailed with the results.  Magnesium chloride was added to the 
buffer to improve the binding for some experiments; concentrations are detailed 
with the results.  The naphthylquinoline triplex-binding ligand was also used for 
some experiments to enhance the affinity (see section 1.5.1) (282-284).  When 
this ligand was used the reaction mix was as follows; 1.5 µl of TFO at 300% of the Chapter 2: Materials and Methods 
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desired concentration, 1.5 µl of ligand at 300% desired concentration and 1.5 µl of 
duplex target.  This was then incubated and digested in the same way. 
 
  2.2.4.2  Digestion 
 
After incubation the template DNA was cleaved using the non-specific 
enzyme DNase I, in order to create fragments of DNA of different lengths.  2 µl of 
0.01 units/ml DNase I in DNase I buffer (20 mM NaCl, 2 mM MgCl2 and 2 mM 
MnCl2) was added to each of the incubation mixtures, and the reaction was 
terminated after 2 minutes by adding 4 µl of DNase I stop solution.  By using a low 
concentration of enzyme and limiting the digestion time, on average each duplex 
strand was cleaved only once (single hit kinetics).  In this way a population of 
radioactive template DNA strands cut are at every possible length should be 
created. 
 
  2.2.4.3  GA tract and control lane 
 
  In addition to the 6 reaction tubes containing different concentrations of 
TFO, a GA marker lane and control lane were included in each footprint.  The GA 
marker was prepared by mixing 1.5 µl of the radioactive DNA fragment, 5 µl of 
DNase I stop solution and 20 µl of dH2O.  This was heated at 100 ºC for 30 
minutes, with the Eppendorf cap open, before cooling on ice.  This process causes 
the DNA template to be cleaved at purine sites only.  The control lane (in the 
absence of added oligonucleotide) was prepared by combining 1.5 µl of 
radiolabelled DNA fragment with 3 µl of buffer.  This was digested in the same way 
as the TFO-containing mixtures. 
 
  2.2.4.4  Polyacrylamide gel 
 
The products of the DNase I digestion were run on 40 cm long, 0.3 mm 
thick denaturing polyacrylamide gels containing 8 M urea.  Footprints with the tyrT 
and tyrT-based templates were run on 9% polyacrylamide gels (chapters 3 and 5), 
while those using the REPSA fragments on 12.5% as they were shorter (chapter 
4).  After cleavage the samples were heated to 100 ºC for 3 minutes then cooled 
on ice before loading onto the gel.  The gels were run at 1500 V for between 1.5 
and 2 hours, depending on percentage acrylamide.  They were then fixed in 10% Chapter 2: Materials and Methods 
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(v/v) acetic acid and transferred to 3 MM Whatman paper for drying under vacuum 
at 86 ºC for 1-2 hours.  Once dried the gels were imaged using a Molecular 
Dynamics Storm 860 Phosphorimager. 
 
2.2.5  pH jump experiments 
 
The footprinting method detailed in 2.2.3 was altered slightly to carry out 
experiments in which the pH of the sample was rapidly increased (pH jump 
experiments - chapter 3).  Rather than using a range of TFO concentrations the 
same concentration was used in every lane.  The TFO and template were 
incubated together at pH 5.0 to allow binding, either overnight or for one hour.   1 
µl of Tris-HCl pH 8.0 was then added to jump the pH to around pH 7.0.  Samples 
were taken at various time points after the jump and were digested with DNase I 
as described in section 2.2.4.2.  One sample was digested before the pH jump. 
 
2.2.6  Site directed mutagenesis 
 
  As mentioned in section 2.1.1 several new templates were generated from 
the tyrT(43-59) fragment by site directed mutagenesis for use in Chapter 5.  The 
position and nature of these mutations is shown in Figure 2.7 on the following 
page.  TyrT42A, tyrT42A50T and tyrT41AT were generated in the course of this 
thesis by site directed mutagenesis.  The tyrT50T template was generated 
previously by D.A.Rusling et al by site directed mutagenesis of tyrT(43-59) and 
was used as a template for some of the mutagenesis experiments in this thesis 
(294). 
Quick-Change site directed mutagenesis was used to mutate the tyrT(43-
59) and tyrT50T templates to create three additional templates for footprinting of 
the anthraquinone TFOs used in chapter 5, these were tyrT42A, tyrT42A50T and 
tyrT41AT.  This technique involves designing primers which contain the desired 
mutation(s) then using PCR to synthesise the desired template.  To mutate the 
plasmids, 125 ng of each pair of primers was mixed with 1 µl of the start plasmid 
(tyrT(43-59) or tyrT50T) diluted 1 in 10 from a standard mini-prep, 1 µl of 25 mM 
dNTPs, 5 µl 10x Pfu buffer and 2-3 units of Pfu DNA polymerase (Promega).  This 
mixture was made up to 50 µl with distilled water and cycled in a PCR block under 
the following conditions; 
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Step 1   94°C    5 minutes 
Step 2   94°C    30 seconds 
55°C    1 minute 
68°C    3 minutes 
Cycle step 2 16 times 
Step 3   4°C    hold 
 
  10 units of DpnI was then added to digest the methylated template DNA 
and the sample was incubated at 37°C for 90 minutes.  The open-circle mutated 
plasmids were then transformed into competent E.coli TG2 cells and plated onto 
carbenicillin-containing plates as described in section 2.2.1.  Colonies were picked 
and sequenced as described in section 2.2.7.2 to confirm the presence of the 
desired mutation. 
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(i) 
tyrT      5’ – AACCAGTTCTTTTTTCTCTTCCTAACA – 3’ 
      3’ – TTGGTCAAGAAAAAAGAGAAGGATTGT – 5’ 
tyrT50T    5’ – AACCAGTTCTTTATTCTCTTCCTAACA – 3’ 
      3’ – TTGGTCAAGAAATAAGAGAAGGATTGT – 5’ 
tyrT42A    5’ – AACCATTTCTTTTTTCTCTTCCTAACA – 3’ 
      3’ – TTGGTAAAGAAAAAAGAGAAGGATTGT – 5’ 
tyrT42A50T   5’ – AACCATTTCTTTATTCTCTTCCTAACA – 3’ 
      3’ – TTGGTAAAGAAATAAGAGAAGGATTGT – 5’ 
tyrT41AT    5’ – AACCTATTCTTTTTTCTCTTCCTAACA – 3’ 
      3’ – TTGGATAAGAAAAAAGAGAAGGATTGT – 5’ 
(ii) 
Template  Primers 
tyrT42A  5’ AGAGAAAAAAGAAATGGTTGCGTAATTTTC 3’ 
   3’ TCTCTTTTTTCTTTACCAACGCATTAAAAG 5’ 
tyrT42A50T  5’ AGAGAATAAAGAAATGGTTGCGTAATTTTC 3’ 
   3’ TCTCTTATTTCTTTACCAACGCATTAAAAG 5’ 
tyrT41AT  5’ GTTAGGAAGAGAAAAAAGAATAGGTTGCGTAATTTTCATC 3’ 









Figure 2.7: (i) - Sequences of the five footprinting templates used in Chapter 5, with TFO 
binding sites shown in red. 
(ii) – Sequence of primers used to generate mutated templates with the desired mutation 
shown in red. TyrT42A and tyrT41AT were generated using tyrT(43-59) as the start 
template, while tyrT42A50T used tyrT50T as the start template. 
(iii) – Sequence of the tyrT(43-59) fragment showing the positions of mutations (red) to 
generate the footprinting templates used in Chapter 5.  A TA base pair was introduced at 
position UV ( to generate template tyrT41AT).  TA (tyrT41AT) or AT (tyrT42A and 
tyrT42A50T) base pairs were introduced at WX and a TA base pair had previously been 
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2.2.7  Primer extension 
 
In many of the experiments carried out in this thesis it was necessary to 
generate duplex DNA by primer extension using a chemically synthesised single 
stranded DNA template and primer to create the second strand.  For template and 
primer sequences see Figure 2.3 on page 61.  Because this contains a random 
region, simply annealing two complementary strands together was not possible as 
this would generate many duplexes that contain one or more mismatched base 
pairs.  It was therefore necessary to copy the single stranded template in order to 
generate a perfectly paired duplex. 
A complementary primer was allowed to anneal to the single stranded 
template (2.4 µM) and 5 units of Taq polymerase with Taq Buffer was used to 
extend from the primer using dNTPs (1 mM) to create a complementary strand of 
DNA.  The primer concentration was varied and was not quantified as it was 
radiolabelled prior to primer extension. 
The mixture was heated in a PCR block to 94 ºC for six minutes then cooled 
to 50 ºC for 30 minutes to allow annealing of the primer and extension by Taq 
polymerase before finally cooling to 4 ºC.  20 µl of loading dye (20% Ficoll, 10 mM 
EDTA 0.02 g bromophenol blue) was added and the mixture was run on a 6.4% 
non-denaturing polyacrylamide gel and purified as in section 2.2.3.3.  When a 
radiolabelled duplex template was required the primer was first labelled with [γ-
32P]-ATP using 5’ labelling as described in section 2.2.3.2.  The exact reaction 
conditions for primer extension were optimised after the first set of REPSA 
experiments.  This optimisation is described in detail in section 2.3.1. 
One of the key concepts for REPSA is that the population of starting 
template sequences should contain every possible sequence combination, so that 
every possible binding site for the TFO is represented.  Therefore some 
calculations have been done to ensure that this is true. 
  First the number of different sequences possible in a 15 base pair long 
random sequence was calculated; 
  4
15 = 1.07 x 10
9 
  This means that a minimum of a billion template molecules should be used 
in order to have one copy of every possible sequence present for REPSA 
selection.  Next the number of template molecules in 1 µl of template (47 µM) was 
calculated; 
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  (1x10
-6) x (47x10




13 molecules  
  So there are over 10000 times more molecules than needed for every 
possible sequence to be represented.  This means that even if some DNA is lost 
during the purification process after primer extension every possible template 
sequence should still be represented when the TFO is introduced and every 
binding site should be represented if DNA synthesis was random. 
 
2.3  REPSA 
 
Two REPSA protocols have been used in this thesis; an initial un-optimised 
method was used for the first set of REPSA experiments.  Three sequences 
selected using this initial protocol (shown in Figure 2.8 below) were footprinted 
with the BAU containing TFO (Figure 2.2 on page 60).  The TFO failed to produce 












Figure 2.8: Sequences of three templates from the first set of REPSA experiments, 
original random region shown in bold. 
 
After this REPSA protocol showed no obvious selection, experiments were 
carried out to optimise the Fok I cleavage step of the protocol.  This type of 
experiment is generally referred to as REPA (restriction endonuclease protection 
assay).  The second protocol is based on the results of these optimisation 
experiments.  More detail about the optimisation of REPSA reaction conditions can 
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based on the optimisation experiments.  Differences between this method and the 
original are described in section 2.3.2. 
 
2.3.1  Optimised REPSA Protocol 
 
After primer extension (see section 2.2.6) with radiolabeled primer the 
double stranded template containing the random sequence of bases was 
separated from the other elements of the reaction mixture on a 6.4% non-
denaturing polyacrylamide gel.  The DNA was then extracted from the gel slice as 
described in section 2.2.3.3 and resuspended in 10 µl 1x Fok I Buffer (50 mM KAc, 
20 mM Tris-Ac, 10 mM MgAc, 1 mM DTT). 10 µl of 10 µM TFO was then added 
and the mixture was left for an hour at 20°C to equilibrate.  Any unbound 
templates were then cleaved with 8 units of Fok I (NEB) at 37°C for 5 minutes after 
which the enzyme was deactivated by heating to 90°C for 3 minutes.  Theoretically 
sequences which were protected by binding to the TFO were not cleaved by the 
enzyme, these templates were then amplified by PCR; whereas cleaved templates 
(those to which the TFO did not bind) were not amplified.  To amplify the un-
cleaved templates 10 µl of the cleavage mixture was combined with 15 µl of 
labelled forward primer, 3 µM unlabelled reverse primer, 1 µl dNTP mix (25 mM), 5 
µl of 10x Taq Buffer and 5 units of Taq polymerase, the solution was made up to 
50 µl with water.  This mixture was then cycled in a PCR block under the following 
conditions; 
 
Step 1   92°C    30 seconds 
    50°C    3 minutes 
Cycle step 1 15 times 
Step 2   4°C    hold 
 
  At this point a further 1 µl of dNTPs and 5 units of Taq were added along 
with 2.5 µl of unlabelled forward primer.  This procedure ensures maximum 
utilisation of the labelled primer while preventing PCR products from annealing 
together (which could generate mismatched duplexes from the mixed population).  
Steps 1 and 2 were then repeated for two further rounds to ensure that all 
templates were double stranded. 
Once amplified, 20 µl of loading dye (20% Ficoll, 10 mM EDTA, 
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polyacrylamide gel.  The full length regenerated templates were then purified as 
described for preparing radiolabelled DNA in section 2.2.3.3. 
The purified templates were re-dissolved in 10 µl 1x Fok I buffer and 10 µl 
of 10 µM TFO was added, the whole process was then repeated 10 times to obtain 
optimum selection.  If too many rounds of REPSA are performed the template can 
start to lose bases from the random region; samples were taken after seven 
rounds to ascertain if enough selection had taken place and it was decided to 
carry out an additional three rounds.  Once REPSA had been completed, the 
selected templates were cloned into plasmids, transformed into competent cells 
(see below) and plated onto blue/white selection plates (section 2.2.7.1).  The 
colonies that grew each contained a different selected template which was then 
sequenced. 
 
  2.3.1.1  Cloning and Transformation 
 
After the final round of selection the remaining templates were re-dissolved 
in 20 µl of dH2O.  At the same time BamHI-cut pUC19 was prepared by mixing 1 
µg of pUC19 with 19 µl of dH2O.  The REPSA products and pUC19 were each 
mixed with 2 µl of buffer E (Promega) 10 units BamHI and 10 units Hind III at 37 
C for 1 hour before the DNA from both digests was precipitated with ethanol (as 
described in section 2.2.3.3).  The plasmid and REPSA fragments were each re-
dissolved in 10 µl dH2O and were mixed together, giving a final volume of 20 µl.  2 
µl of 10x ligase buffer (Promega) and 2 units of DNA ligase (promega) were then 
added and the DNA left to ligate overnight.  The ligated plasmid was mixed with 
competent TG2 cells (section 2.2.1), placed on ice for 30 minutes and then heat-
shocked at 45  C for 1 minute to allow the plasmids to enter the cells.  The cells 
were then plated out onto blue-white selection plates and placed in at 37 ºC 
overnight for colonies to grow (section 2.2.1).  Only cells which have taken up the 
plasmid are able to grow on the carbenicillin containing plates and only those 
plasmids which contain an insert appear as white colonies.  Bacteria containing 
unmodified pUC19 will be blue.  The white colonies were carefully picked off and 
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  2.3.1.2  Sequencing 
 
Once the DNA from a particular white colony had been grown and purified it 
was sequenced using a USB T7 sequencing kit.  40 µl of DNA from the purification 
was denatured using 10 µl of 2 M NaOH at room temperature for 20 minutes.  The 
denatured DNA was then precipitated by addition of 15 µl 3 M NaOAc and 1 ml 
ethanol.  This was left on dry ice for at least 10 minutes then spun at 13000 rpm 
for 15 minutes.  The supernatant was removed and the pellet washed with 100 µl 
of 70% ethanol.  The supernatant was removed and the samples were dried in a 
speed vac for 3 minutes before being re-dissolved in 10 µl dH2O.  2 µl each of 
annealing buffer and universal primer were added (USB T7 kit).  The primer was 
left to bind for 20 minutes at 37  C then 10 minutes at room temperature.  For 
each DNA sample 4 microcentrifuge tubes were prepared, each containing 2.5 µl 
of the 4 different dideoxynucleotides mixtures (kit).  A polymerase mix was also 
made up containing 1 µl [α-
32P]-dATP, 7 µl of dH2O and 12 µl of label mix A (kit).  
12 units of T7 polymerase (kit) and 6.5 µl of enzyme dilution buffer (kit) were 
mixed and added to the polymerase mix.  6 µl of the polymerase mixture was then 
added to each of the four annealed DNA samples and left at room temperature for 
5 minutes.  4.5 µl of this mixture was added to each of the dideoxynucleotide 
mixtures and left for 5 minutes at 37  C before the reaction was stopped with 5 µl 
of the stop solution.  The DNA was then denatured by heating to 95  C for 3 
minutes before running on a 9% denaturing polyacrylamide gel.  This was then 
fixed in 10% (v/v) acetic acid, dried and imaged (section 2.2.4.4). 
Each of the dideoxynucleotides causes the polymerase reaction to stop at a 
different nucleotide and by carefully controlling the incubation time and 
concentrations of the various components the reaction can be stopped at every 
point where a particular base is present.  The position of the different bases can 
then be read off the sequencing gel, from 5’-3’, bottom to top of gel. 
 
  2.3.1.3  Footprinting 
 
Footprinting experiments were carried out on DNA fragments that were 
derived from some of the sequences isolated from the REPSA experiments.  The 
method for this was essentially the same as that discussed earlier (section 2.2.4) 
with a few differences.  After purification, the plasmid containing the sequence for 
footprinting was cut with EcoRI and labelled with [α-
32P]-dATP using reverse Chapter 2: Materials and Methods 
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transcriptase (section 2.2.3.1).  The EcoRI and reverse transcriptase were then 
inactivated by heating at 65°C for 5 minutes, before releasing the fragment of 
interest by cutting with HindIII.  The labelled DNA was then run on a non-
denaturing polyacrylamide gel and the fragment purified as previously described 
(section 2.2.3.3). 
When footprinting with these labelled sequences it was also necessary to 
increase the percentage of the gel as the sequences are shorter and a 12.5% 
denaturing gel gave optimum separation of the bands. 
 
2.3.2  Original REPSA protocol 
 
  The REPSA method previously described incorporated the improved Fok I 
digestion protocol which resulted from the Fok I optimisation experiments (section 
2.3.3.3).  The original Fok I digestion protocol and other minor differences between 
the two protocols are described here.  Anything not discussed was the same for 
both protocols. 
To ensure a high yield of radiolabelled template from primer extension the 
concentration of radiolabelled primer was increased in the second set of 
experiments.  The original Fok I protocol was as follows; rather than resuspending 
the double-strand template DNA in 10 µl of 1x Fok I buffer, 18 µl of pH 5.0 buffer 
(50 mM Sodium Acetate) was used.  2 µl of 5 µM TFO was added to this and the 
mixture left for 1 hour at room temperature to equilibrate. 2 µl of 10x Fok I Buffer 
was then added with 3 units of Fok I and heated at 37°C for 5 minutes.  The Fok I 
was then deactivated by heating to 90°C for 3 minutes.  As for primer extension a 
higher concentration of radiolabelled primer was used for PCR. 
 
2.3.3  REPSA optimisation 
 
2.3.3.1  Primer extension 
 
Primer extension was used to generate a duplex DNA template from a 
single strand containing a random region of nucleotides (Figure 2.3 page 61) using 
a primer, as described in section 2.2.6.  Some optimisation was carried out before 
any REPSA experiments were carried out ensure generation of a high yield of 
duplex template. Chapter 2: Materials and Methods 
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Primer extension is similar to PCR and consists of binding a complementary 
primer to the non-random region of the single stranded template, then using Taq 
polymerase to extend from the primer with dNTPs to create a complementary 
strand of DNA.  For REPSA the duplex template needed to be radioactive, so the 
primer was first labelled with [γ-
32P]-ATP using 5’ labeling as described in section 
2.2.3.2.  The sequences of the single stranded random template and the 
radiolabelled primer are shown in Figure 2.3 on page 61. 
Initial attempts to synthesise the second DNA strand used one round of a 
standard PCR heating and cooling protocol, but these produced a poor yield of 
duplex DNA when run on an agarose gel.  It was thought that this might be due to 
the primer dissociating at the higher extension temperature.  It was decided to omit 
the extension step and simply have a longer anneal step to allow the primer to 
bind and the Taq to extend.  The following adapted protocol was designed to test 
this theory, with three different anneal/extension temperatures: 
 
 
Figure 2.9: Primer extension protocol; an initial denaturing stage was followed by 30 
minutes of combined annealing and extension followed by cooling. 
 
  Three versions of this protocol were tested with different annealing and 
extension temperatures indicated, based on the Tm of the primer (around 55°C).  
The products of these experiments were run on an 8% non-denaturing 
polyacrylamide gel along with two controls.  The first control contained template 
and radiolabelled primer which had been allowed to anneal using the protocol 
above (55°C); but without Taq polymerase present; this therefore represents 
annealed primer and template.  The other control contained only radiolabelled 
primer.  The results are shown in Figure 2.10 below: Chapter 2: Materials and Methods 
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Figure 2.10: Phosphorimage of non-denaturing polyacrylamide gel showing results from 
the three different protocols shown in Figure 2.9. 
 
  From this gel it was evident that the primer extension protocol was working 
with high efficiency and that the three different anneal/extension temperatures 
gave identical results.  The products of primer extension ran with lower mobility 
than just the template and primer annealed together, confirming that the Taq 
polymerase had synthesised a second strand of DNA. For a detailed protocol see 
section 2.2.6. 
 
2.3.3.2  PCR 
 
  As with primer extension this optimisation was carried out before the first 
set of REPSA experiments.  Several different PCR protocols were tested to ensure 
a good yield of amplification after the REPSA cleavage.  Three different 
temperature profiles were tested, each with 6, 10 or 15 cycles.  The first (A) is 
based on the primer extension profile shown in Figure 2.10 as the same template 
and primers were used.  Profiles B and C are based on previously used PCR 
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  A            B              C 
        
 




Figure 2.12: 1% Agarose gel showing DNA from different PCR protocols, the left hand 
lane contained a 50 bp DNA ladder.  Labels at the top indicate which PCR protocol each 
sample was from. 
 
  From the agarose gel in Figure 2.12 above, it is clear that lane three (profile 
A with 15 cycles) gives the highest yield, with 10 cycles giving a slightly lower 
yield.  Therefore this PCR protocol with 15 cycles was used in REPSA to amplify 
the uncut templates after Fok I digestion.  It is important not to over-amplify the 
products of Fok I digestion as this may generate mismatched duplexes if product 
anneals to product, therefore a protocol with more than 15 cycles was not tested 
and the last step of the protocol was an extension rather than annealing step.  For 
the exact protocol used in REPSA see section 2.2.7. 
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2.3.3.3  Fok I 
 
  A key aspect of REPSA was the Fok I cleavage of the template DNA.  This 
needed to be optimised so that the enzyme cleaved a high percentage of unbound 
templates (but not the bound ones) in both strands of the target.  Also the TFO 
concentration needed to be optimised so that it would bind target sites with 
sufficient affinity to protect from Fok I cleavage.  These optimisation experiments 
were carried out after the first set of REPSA experiments.  For these latter 
experiments a target sequence was used, which contained the exact binding site 
for the TFO.  The sequence is shown in Figure 2.4 on page 61. 
  Both strands of this template were synthesised separately and a double 
strand template created by annealing of the two complementary strands.  The TFO 
used in these experiments was the bis-amino-U containing TFO shown in Figure 
2.2 on page 60. 
The first experiment examined the time course of Fok I cleavage of the 
target DNA in the same conditions used for the first set of REPSA experiments.  
The exact DNA target was radiolabelled and cut with Fok I, samples were taken at 
different times after the start of the reaction and the reaction was stopped by 













Figure 2.13: 9% denaturing polyacrylamide gel showing samples of Fok I digested DNA, 
digestion times in minutes at the top.  Left hand lane contains a control of uncut DNA. 
 
From this experiment it can be seen that Fok I had begun to cleave the 
DNA after just one minute, however even after 10 minutes only around 50% of the 
targets had been cleaved.  Therefore different reaction conditions needed to be 
tested in order to obtain optimal cleavage. 
Different buffers and incubation times were tested in an attempt to discover 
conditions in which the TFO would bind to the DNA with high affinity, and the Fok I Chapter 2: Materials and Methods 
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would still cleave a high percentage of unbound templates.  In ideal conditions > 
90% of the targets would be cleaved without TFO present, and < 10% cleaved 
when TFO was added.  For these experiments an exact version of the random 
template was generated by primer extension on a single strand in the same way 
as the random template, in order to obtain a similar concentration after gel 
purification. 
 
Five different buffers were tested; 
 
Buffer  Composition 
1  50 mM Sodium Acetate, pH 5.0 
2  10 mM PIPES 50 mM NaCl, pH 6.5 
3  10 mM Tris-HCl 50 mM NaCl, pH 7.0 
4  0.1 mM EDTA, 10 mM Tris 
5  50 mM KAc, 20 mM Tris-Ac, 10 mM MgAc, 1 mM DTT 
 
Table 2.1: Buffers tested to optimise Fok I cleavage.  Buffers 1, 2 and 3 are buffers 
commonly used in footprinting, Buffer 4 is the DNA template re-suspension buffer and 
Buffer 5 is the same as the New England Biolabs Fok I Buffer (1x). 
 
The footprinting buffers (1, 2 and 3) and buffer 1 in particular should allow 
good TFO association, however they may not be optimal for Fok I cleavage.  
Buffer 5 should be optimal for Fok I cleavage but may not be suitable for triplex 
formation.  For each buffer tested two experiments were carried out.  The first 
consisted of just the template and Fok I incubated together for different lengths of 
time to test Fok I cleavage of unbound template.  In the second, the template was 
first allowed to associate with the TFO for one hour in the buffer being tested 
before cleavage with Fok I.  The template and 5 µM TFO / buffer were incubated 
for one hour at 20°C before Fok I cleavage. Chapter 2: Materials and Methods 
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Figure 2.14: Fok I cleavage patterns of the exact template with or without the 9mer TFO.  
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  The three sets of cleavage gels with buffers 1, 2 and 3 all shown similar 
results; good protection by the TFO for the whole hour, but only some cleavage 
(generally < 50%) in the absence of TFO.  This indicates that the triplex is forming 
but the Fok I enzyme is not working efficiently under these conditions.  With buffer 
4 cleavage in the absence of TFO was much higher, about 70-80% after 60 
minutes; however the TFO failed to protect the template from cleavage even after 
only two minutes. 
As expected, the Magnesium ions in buffer 5 gave the best cleavage of the 
template alone, and in the presence of the TFO there was only a small amount of 
cleavage after 5 minutes.  It was therefore decided to use this buffer in the next set 
of REPSA experiments; although some bound templates may be cleaved it was 
felt that it was more important to eliminate a high proportion of unbound templates. 
  A footprinting experiment was also carried out to test different TFO 
concentrations in order to find the optimal concentration for preventing cleavage 
by Fok I.  This footprinting experiment was carried out in buffer 5 using the tyrT 




Figure 2.15: DNase I cleavage pattern of exact REPSA template with the 9mer TFO.  TFO 
concentrations in µM are shown at the top of each lane.  A control lane shows the DNase I 
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From this footprint it is clear that the TFO binds down to concentration as 
low as 0.15 µM in this buffer.  In order to ensure that secondary binding sites were 
also selected (which occur at higher concentrations) a 5 µM concentration was 
used for selected experiments with REPSA.  For the exact reaction conditions 
used in REPSA see section 2.2.7. 
 
2.4  Band Shifts 
 
  As a secondary project to REPSA, an assay method based on gel 
retardation was also attempted.  This involved the separation of triplex from duplex 
DNA on a polyacrylamide gel in order to obtain the sequences to which the TFO 
had bound.  It relies on the principle that a DNA triple helix will have different gel 
mobility to that of duplex DNA.  The purpose of this technique was the same as 
REPSA; to determine the (secondary) binding sites of a TFO.  It was performed 
with the same TFOs in the hope of confirming the REPSA results.  Unfortunately, 
despite many attempts to optimise the conditions the two DNA species did not 
separate sufficiently to obtain reliable sequences.  The method and different 
reaction conditions tested are discussed in this section. 
  A population of sequences was created using a template containing a 
random central region, as with REPSA.  Every possible target sequence was 
represented within this population, so a TFO would bind to only a small fraction of 
the targets.  These sequences were chemically synthesised as single strands and 
primer extension was used with a radiolabelled primer to create duplex DNA (as 
with REPSA).  The TFO was mixed with this population of sequences and allowed 
to bind overnight before being run on a non-denaturing polyacrylamide gel to 
separate the triplex from duplex DNA.  The percentage of the gel and the buffer 
were varied during the course of the investigation in an attempt to obtain maximum 
separation.  In the preliminary experiments the gel was fixed and dried, as 
described for footprinting experiments, then imaged using a Molecular Dynamics 
Storm 860 Phosphorimager.  In the final experiment the band containing the triplex 
DNA was excised from the wet gel and purified for cloning and sequencing.  The 
initial optimisation experiments all used the exact TFO template rather than the 
random one so that the degree of separation could be easily visualised. 
For the initial experiment to test this method the exact template was 
radiolabelled and incubated with 3 µM TFO overnight at room temperature to allow 
triplex formation.  After addition of loading dye (20% Ficoll, 10 mM EDTA and Chapter 2: Materials and Methods 
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bromophenol blue) the mix was loaded onto a 4.5% non-denaturing 
polyacrylamide gel and run until the dye front reached the bottom.  The result of 
this gel is shown in Figure 2.16 I on page 88. 
  It is clear from this gel that a triplex had been formed and had a lower 
mobility than the duplex DNA; however the separation between the duplex and 
triplex was not very large.  The percentage of the gel was therefore increased to 
11% to attempt to get better separation.  For this experiment the TFO was also 
radiolabelled to better visualise how the duplex and TFO were interacting.  The 
labelled TFO was used as a tracer and the reaction was performed in the 
presence of 3 µM unlabelled TFO. The results of this experiment are shown in 
Figure 2.16 ii on the following page. 
  Unfortunately it appeared that increasing the gel percentage caused the 
triplex to disassociate in the gel as no triplex population was visible.  In order to 
increase triplex stability within the gel several changes were made to the protocol.  
The TFO concentration was increased to 10 µM and 10 µM of the triplex-binding-
ligand naphthylquinoline was added before incubation at 20°C overnight.  The gel 
percentage was also decreased to 8% and the gel buffer was altered from TBE 
(pH 8.3) to Tris-acetate pH 6.0.  This produced the result shown in Figure 2.16 iii 
on the following page. 
There is a clear triplex population which is well separated from the position 
of the duplex.  However the sample appears to have smeared on the gel.  Several 
alterations were made to the method in attempt to reduce this smearing effect 
including filtering all gel components, spinning the samples to reduce the effect of 
excess salt and using hydrophobic ‘no-stick’ microcentrifuge tubes.  None of these 
produced any significant improvements. 
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      (i)        (ii)           (iii) 
 
Figure 2.16: Band shift gels i, ii and iii.  Samples in each lane are labelled at the top, the * 
indicates that the DNA was radiolabelled. 
 
  It was eventually decided to use the experiment C conditions and see if it 
was possible to isolate the bound templates from the gel.  The template containing 
a random region was incubated with the TFO (10 µM) and naphthylquinoline 
ligand (10 µM) overnight at 20°C.  This was then run on an 8% non-denaturing 
polyacrylamide gel containing Tris-acetate buffer pH 6.0.  A control of the 
radiolabelled exact template and the TFO bound together under the same 
conditions was run alongside, so that the position of the triplex population could be 
determined (the fraction of the random sequence that would be bound by the TFO 
would be too low to visualise directly).  Another gel was run using the same 
samples but in the cold room at 4°C in an attempt to further stabilise triplex 
formation.  Two different TFOs were used for this final experiment; the TFO 
containing 6 bis-amino-U residues used in REPSA (Figure 2.17 i on the following 
page) and a second slightly longer TFO containing three bis-amino-U residues and 
three 2’-aminopyridine residues (Figure 2.17 ii); 
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i)  5’ – BBBBBBCBT – 3’ 
ii)  5’ – T2T2TBTBTB2T - 3’ 
 
2 = 2’-aminopyridine 
B = BAU 
 
Figure 2.17: Sequence of TFOs used in band shifts. 
 
After running overnight the gels were exposed to X-ray film so that the 
position of the bands could be seen; these were developed and scanned; the 






















































































































































































































       Room Temperature          4°C 
 
Figure 2.18:  Scanned X-ray films from final Band Shift experiment.  The single strand or 
duplex template was radiolabelled for all samples. 
 
  A variety of bands were excised from each of these gels, as shown in the 
diagram below. Chapter 2: Materials and Methods 
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Figure 2.19: Diagram of positions of gel slices, black bands indicate radioactive DNA, red 
boxes show the position of gel slices taken. 
 
  The DNA from all of these slices was purified as in section 2.2.3.3 and then 
cloned.  All slices produced clones, indicating that there was DNA present in every 
part of the gel.  Sequencing of these clones showed no correlation or indication 
that the triplex and duplex populations had been separated successfully. 
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Chapter 3: Initial footprinting experiments with tyrT DNA show 
evidence of secondary binding 
 
3.1  Introduction 
 
  This is a preliminary chapter covering the initial footprinting studies carried 
out on the tyrT template to examine the binding strength and specificity of the 
9mer TFO which contains 6 consecutive bis-amino-U substitutions. 
 
i) 










i) - Sequence of the BAU containing TFO. 
ii) - Sequence of the tyrT(43-59) fragment used in footprinting studies. Primary TFO 
binding site is shown in red, radiolabel is shown in blue. 
 
Bis-amino-U (BAU) is a nucleotide analogue developed to help counteract 
the negative repulsion between the three strands in a DNA triplex.  Each BAU 
nucleotide contains two positively charged amino groups which act to screen the 
negative phosphates in much the same way as divalent cations such as 
magnesium, and therefore increase the binding affinity of the TFO (see section 
1.4.3). The 9mer TFO used in this investigation was first designed as part of a 
range of TFOs to investigate whether clustered or dispersed BAU residues are 
more effective at stabilising triplexes.  It was found in this study that BAU-
containing TFOs formed more stable triplexes if the nucleotides were clustered 
within the TFO.  However, one of these initial footprinting experiments also 
revealed the presence of secondary binding sites for the clustered 9mer TFO 
(294).  The footprinting gel below has been taken from this initial study.   Chapter 3: Initial footprinting experiments with tyrT DNA 
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Figure 3.2: DNase I cleavage pattern of tyrT(43-59) with the BAU containing TFO at pH 
5.0 (50mM sodium acetate) with 10 mM magnesium chloride.  The complexes were left 
overnight at 20°C to equilibrate.  TFO concentrations in µM are shown at the top of each 
lane.  Lane labelled GA is a marker for purines (section 2.2.4.3) and control lanes show 
the DNaseI cleavage pattern in the absence of TFO.  The black filled box shows the 
primary TFO binding site and the black asterisks shows the primary enhancement.  Grey 
boxes and asterisks show the positions of secondary footprints and enhancements.  
Taken from (294). 
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The largest footprint in this gel is at the expected TFO binding site within 
the purine tract.  However at the highest TFO concentration there are also three 
faint secondary footprints accompanied by several additional enhancements.  All 
of these secondary footprints are smaller than the primary footprint and are only 
evident at the highest TFO concentration.  The primary footprint persists down to 
0.03 µM, indicating that these secondary interactions are significantly weaker than 
the primary one.  The primary footprint at 0.3 µM is also larger than the binding 
site of the TFO; it extends in the 5’ direction above the TFO binding site which is 
usual for triplex footprints.  However, when compared to footprints generated by 
other TFOs of the same length this footprint appears to extend further than 
expected (294).  There are also several secondary enhancements between the 
footprints in this gel, as indicated by asterisks, some of which also persist to 0.1 
µM. 
It appeared that the run of contiguous BAU residues within the TFO was 
adversely affecting the TFOs specificity, however it was unclear what the exact 
nature of these secondary binding sites was and why they were occurring.  The 
sequences of the secondary binding sites on this template are examined further in 
the discussion and shown in Figure 3.5 on page 99.  Using the tyrT template alone 
it was not possible to determine a consensus sequence for these secondary 
binding sites, so to fully investigate the binding preference of this TFO, REPSA 
experiments were carried out to select the preferred sequences from a pool of 
random templates (see Chapter 4). 
Before performing REPSA experiments however it was necessary to 
investigate the pH dependence of this secondary binding further, as the selecting 
type IIS restriction enzyme required higher pH. This has been examined in this 
chapter. 
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3.2  Experimental design 
 
The sequences of the TFO and the tyrT target duplex are shown in Figure 
3.1 on page 91 above.  TyrT was radiolabelled and purified as described in section 
2.2.3.1 then incubated overnight at 20ºC with the 9mer BAU TFO to allow 
association.  No Magnesium ions were used in any of the buffers in this chapter.  
The template was then digested with DNaseI to give a ladder of bands as 
described in section 2.2.4.  PH jump experiments were also performed using the 
same TFO and template, following the protocol from section 2.2.5. 
 
3.3  Results 
 
  The gels shown in Figure 3.3 on the following page confirm the initial 
footprinting experiment from Figure 3.2 (page 92) and extend the results to show 
the footprinting patterns of the BAU-containing TFO on tyrT at three pHs.   For 
these experiments the TFO was incubated with the tyrT template overnight in 
three different buffers; pH 5.0 (50mM sodium acetate), pH 6.0 (10mM PIPES 
50mM NaCl) and pH 7.0 (10mM Tris-HCl 50mM NaCl) before digestion with 
DNase I.  An additional footprinting experiment was carried out in the same pH 5.0 
buffer but with only a one hour incubation time instead of an overnight incubation. 
Figure 3.3 shows that there is a clear footprint at the intended target for the 
experiment at pH 5.0 and 6.0 and at pH 5.0 after 1 hour incubation.  At pH 7.0 the 
footprint is less clear, although the enhancement in the surrounding sites suggest 
that the TFO has bound in the same position as at lower pH, only not as strongly.  
At pH 5.0 this primary footprint and the enhancement below it are visible at 
concentrations down to 0.1 µM.  A secondary binding site with enhanced cleavage 
and a weak footprint can also be seen in this gel; the enhancement is visible down 
to 0.1 µM, while the two regions of attenuated cleavage above and below this only 
persist to about 0.3 µM. 
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Figure 3.3: DNase I cleavage pattern of tyrT(43-59) with the BAU containing TFO at three 
different pHs, shown above gels.  Two different incubation times were used; either 
overnight or only one hour.  TFO concentrations in µM are shown at the top of each lane.  
Lanes labelled GA are specific purine markers (section 2.2.4.3) and control lanes show 
the DNaseI cleavage pattern in the absence of TFO.  Filled boxes show the position of 
TFO binding sites and black asterisks show the primary position of on enhanced DNase I 
cleavage.  Grey asterisks show the position of secondary enhancements. 
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At pH 6.0 higher TFO concentrations were used, as the triplex is less stable 
at this higher pH.  The main footprint persists to 3 µM and the enhancement below 
can still be seen at 1 µM.  As with the pH 5.0 footprint a secondary enhancement 
can be seen, also down to 1 µM.  However there are no obvious regions of 
attenuated cleavage to indicate secondary binding sites.  At pH 7.0 the main 
footprint is much less clear and attenuated cleavage is only seen at the highest 
TFO concentration (5 µM), though a region of enhanced cleavage is visible to 3 
µM.  Again there is a secondary enhancement down to 3 µM but no evidence of 
secondary footprints. 
When the template and TFO were incubated at pH 5.0 for only one hour, 
the footprinting pattern is very similar to that seen with overnight incubation.  The 
primary footprint is less clear than after long incubation, presumably because the 
shorter incubation time has not been sufficient to allow equilibrium binding. 
When the overnight pH 5.0 gel is compared with the one in figure 3.2 (page 
92) from the original study, fewer secondary binding sites can be seen and the 
primary binding site has not been enlarged at the highest oligonucleotide 
concentration.  It is likely that this difference is due to the presence of magnesium 
chloride in the original experiment, which will have enhanced TFO binding.  This 
was not included in the experiments performed in this chapter. 
An interesting observation is that, although the cleavage pattern around the 
primary footprint is similar at all three pH’s (requiring higher concentrations at 
higher pH’s) the secondary binding is more obvious at pH 5.0.  Only the pH 5.0 
experiment has lighter bands indicating the position of secondary binding sites.  
This suggests that the TFOs propensity for binding these secondary sites is more 
sensitive to pH than binding to the primary site. 
Because of this observation footprinting experiments were carried out to 
investigate the effect of sudden changes in pH on TFO binding (Figure 3.4 on the 
following page).  These were also necessary as the REPSA experiments, 
described in the following chapters, require Fok I digestion of the complexes at a 
higher pH than the incubation at pH 5.0 necessary to form the triplexes. 
As before the TFO and tyrT template were incubated together overnight at 
20ºC in the pH 5.0 buffer (50 mM sodium acetate).  Before digestion with DNase I 
however the pH was jumped from pH 5.0 to around pH 7.0 by adding 1 µl of 1 M 
Tris-HCl pH 8.0.  Samples were then taken at various time points after the pH 
jump and digested to give the digestion pattern shown below.  The detailed 
protocol for pH jumping is described in section 2.2.5.   Chapter 3: Initial footprinting experiments with tyrT DNA 
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Figure 3.4: DNaseI cleavage patterns of tyrT(43-59) with the BAU containing TFO.  All 
footprint incubations were carried out overnight at pH 5.0 and four different TFO 
concentrations were used, as shown above the gels.  A pH jump from pH 5.0 to around 
pH 7.0 was carried out after the overnight incubation, numbers above each lane indicate 
minutes after the jump before digestion with DNase I.  Lanes labelled GA are markers 
specific for purines (section 2.2.4.3) and control lanes show the DNaseI cleavage pattern 
in the absence of TFO.  Black filled boxes and black asterisks show the position of 
primary TFO binding sites and primary enhancements, grey boxes and asterisks show the 
positions of secondary footprints and enhancements. 
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  All of these footprinting experiments were performed after overnight 
incubation at pH 5.0 (before the pH jump) but use higher TFO concentrations than 
the experiments shown in Figure 3.3 (page 95).  The primary and secondary 
binding sites are therefore clearer before the pH jump (lane 0) at these higher TFO 
concentrations.  It can be seen that after the pH jump the primary footprint persists 
at the higher TFO concentrations but all of the secondary footprints and 
enhancements have disappeared before the first time point after the jump. 
  As with the pH 5.0 footprint shown in Figure 3.3, the cleavage pattern at 0.3 
µM in Figure 3.4 (previous page) shows a primary footprint and enhancement 
before the pH jump, as well as three secondary enhancements with some 
evidence of secondary footprints.  However, after the pH jump all footprints and 
secondary enhancements have disappeared by the 1 minute time point, consistent 
with the pH 7.0 experiment shown in Figure 3.3 which showed no footprint with 0.3 
µM TFO.  The primary enhancement below the primary target site remains for the 
duration of the time course. 
  All three experiments at the higher TFO concentrations (1, 3 and 5 µM 
TFO) show an enlarged primary footprint and several clear secondary footprints 
and enhancements before the pH jump.  With 1 µM TFO three secondary 
footprints and enhancements can be seen before the pH jump, but all of these 
have disappeared by 1 minute after the jump.  The primary footprint has also 
disappeared by this point, although the primary enhancement persists for the 
course of the experiment, as with the 0.3 µM footprint. 
  The footprints with 3 and 5 µM TFO retain a primary footprint and 
enhancement for the duration of the time course, although after the jump the 
footprint shrinks back to the expected size.  This is again consistent with the pH 
7.0 experiment shown in Figure 3.3, which showed a primary footprint and 
enhancement at 3 and 5 µM TFO.  These two gels also show an additional 
secondary footprint and enhancement before the pH jump, making four of each in 
total, although all secondary binding is again eliminated by 1 minute after the 
jump. 
  The sequences of the primary and secondary footprints taken from Figure 
3.4 are shown on the following page.  The sequence of the TFO is also shown for 
comparison. 
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i)  5’ - TTCATATCAAATGACGCGCCGCTGTAAAGTGTTAGGAAGAGAAAAAAGAA 
  3’ - AAGTATAGTTTACTGCGCGGCGACATTTCACAATCCTTCTCTTTTTTCTT 
               *** *           ****                  * 
    CTGGTTGCGTAATTTTCATCCGTAACG – 3’ 
    GACCAACGAATTAAAAGTAGGCATTGC – 5’ 
       ****     **** 
 
ii)  5’ AAATGA 3’ 
  5’ AAAG 3’ 
  5’ AAAAAAGAA 3’  (main site) 
  5’ GGATGAAAA 3’ 
 
iii)  5’ BBBBBBCBT 3’ 
 
Figure 3.5; 
i)  Sequence of the tyrT template.  For footprinting gels in this chapter the upper 
strand (hence referred to as the purine strand) was radiolabelled at the 3’ end.  
The positions of footprints from the gels in this chapter are shown in red, and 
enhancements are indicated by asterisks under the sequence.  The exact primary 
binding site of the TFO is indicated by the double underline and possible 
secondary binding sites of the TFO are indicated by the single underlines. 
ii)  Summary of the possible TFO binding sites including the primary binding site, all 
shown from 5’ to 3’ 
iii)  Sequence of the TFO, B = Bis-amino-U.  Note: TFO binds in a parallel orientation 
to the template. 
 
  By comparing the size and position of the primary footprint with the known 
TFO binding site (double underline), we can make some suggestions about the 
nature of the secondary sites that are represented by the secondary footprints.  
These possible secondary binding sites are shown by the singly underlined 
sequences.  The two secondary sites to the left (in the 5’ direction on the purine 
strand) of the primary footprint contain a purine-rich region to the right (5’) of each 
footprint, consistent with the primary site, which also extends in the 5’-direction 
beyond the target.  However, for the two footprints close together to the right (in 
the 3’ direction on the purine strand) of the primary footprint there are no obvious 
purine-rich regions on the purine strand.  There is a purine rich region on the lower 
(pyrimidine) strand between the two footprints, which extends into the far right 
footprint (underlined).  This site may have bound a molecule of the TFO and 
resulted in both footprints. Chapter 3: Initial footprinting experiments with tyrT DNA 
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3.4  Discussion 
 
  TFOs containing BAU substitutions generate extremely stable triplexes and 
individual substitutions have been shown to be highly selective for AT (187).  The 
overall specificity of BAU is AT>GC>CG=TA.  BAU also has enhanced 
discrimination against YR bases in the duplex compared with T.  Although BAU is 
most stabilising against AT, BAU and T have similar stabilities at YR base pairs 
(187)  It is likely that the specific contacts between the positive charges on BAU 
and phosphate groups in the triplex do not occur when this modification is placed 
opposition a YR base pair.  BAU also shows high selectivity for AT over GC bases 
pairs in the duplex, although BAU.GC triplets are more stable than T.GC or 
BAU.YR triplets (187).  TFOs with the same sequence as the one used in this 
thesis but containing 3 or 4 BAU residues showed no evidence of secondary 
binding on tyrT (186).  It is therefore likely that BAU reduces the stringency of 
TFOs only when there are large numbers of consecutive substitutions. 
  The footprinting experiments shown in Figure 3.3 (page 95) reveal clear pH 
dependence for binding of this 9-mer BAU-containing TFO.  Higher TFO 
concentrations were needed to generate a footprint as the pH was increased.  The 
TFO appears to have high affinity for the template at pH 5.0 and 6.0 producing 
clear footprints, though there is still some evidence of binding at the highest 
concentration (5 µM) at pH 7.0.  All of the gels show some evidence for secondary 
binding sites at the highest concentrations; this is seen by either attenuated 
DNase I cleavage or the presence of enhanced cleavage. 
Although the primary footprint shows a similar cleavage pattern at all three 
pHs the secondary binding is more pronounced at pH 5.0.  While regions of 
secondary enhanced cleavage are seen at all pHs, the additional footprints (or 
attenuated cleavage) are only evident at pH 5.0.  This suggests that the TFO’s 
ability to bind these secondary sites may be more sensitive to pH than binding to 
the primary site. 
One reason for carrying out a footprint after only one hour incubation was to 
see if this shorter incubation would be appropriate for use in the REPSA 
experiments.  From the experiment in Figure 3.3 it can be seen that there is very 
little difference in the DNase I cleavage pattern between the overnight and one 
hour incubations.  However, the footprint is clearer with the longer incubation and 
the primary footprint persists to lower concentrations.  This is consistent with the Chapter 3: Initial footprinting experiments with tyrT DNA 
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known slow rate of triplex formation and indicates that TFO-binding has not 
reached equilibrium within this shorter time. 
In the pH-jump footprinting experiments (Figure 3.4 page 97) the secondary 
binding of the TFO can been seen more clearly as higher TFO concentrations 
were used.  Before the pH increase (lane 0) there is a clear footprint in the 
expected region and several secondary footprints and enhancements at the higher 
TFO concentrations.  But it is clear that at low concentrations the TFO dissociates 
rapidly from the secondary binding sites when the pH is increased as all the 
secondary footprints and enhancements have disappeared by the first (1 minute) 
time point for all concentrations of TFO.  However, with the two highest TFO 
concentrations the primary footprint persists after the pH jump for the length of the 
experiment.  The three highest TFO concentrations produce a primary footprint 
which is larger than the expected nine bases before the pH jump, but this 
decreases back to the expected size immediately after the jump. 
  This enlarged primary footprint can also be seen in the original experiment 
(Figure 3.2 page 92).  This enlargement of the primary footprint may be caused by 
‘slippage’ of the TFO allowing it to cover more of the purine rich region of the 
template.  Alternately TFO molecules bound at the primary and secondary sites 
may interact in such a way as to extend the apparent binding site, by restricting 
the access of DNase I to the DNA in this region.  In all gels the primary footprint 
shrinks back to its expected size as soon as the secondary footprints and 
enhancements disappear, lending weight to this theory.  Also enlarged footprints 
are not seen with similar TFOs which do not bind to secondary sites, even at very 
high concentrations (294). 
  In general the footprints in Figures 3.3 and 3.4 show the same binding 
pattern and pH dependence.  There is one small difference; in Figure 3.4 the 
primary enhancement persists at all TFO concentrations whereas in Figure 3.3 at 
pH 7.0 no enhancement is visible with 0.3 µM TFO.  This is most likely because in 
the pH jump experiments the TFO was already bound to the template before the 
pH was increased, and therefore may have been able to affect DNase I cleavage 
enough to cause the enhancement even after the increase in pH. 
  This set of experiments supports the suggestion that the TFO molecules 
bound at secondary sites dissociate more rapidly at high pH, in comparison with 
TFOs bound to primary sites. 
  Although these footprinting experiments give some useful information about 
the interaction of the BAU-rich TFO with secondary sites, the results are limited to Chapter 3: Initial footprinting experiments with tyrT DNA 
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this particular duplex DNA fragment and the sequences that it contains.  Therefore 
the next stage in the investigation was to use REPSA to find the preferred binding 
sites of the TFO.  The proposed position and sequence of the secondary footprints 
and enhancements described in this chapter are summarised in Figure 3.5 (page 
99) and allow us to make some suggestions about the essential features of the 
secondary sites.  They appear to be purine tracts of various lengths that share little 
similarity with the exact recognition site of the TFO.  To be able to draw 
meaningful conclusions about the specificity of this TFO it would be more useful to 
examine binding sites that differ only slightly from the exact recognition sequence, 
and this has been done in Chapter 4.  As noted earlier the triplexes formed on the 
secondary binding sites of the tyrT template are more sensitive to pH than the 
primary triplex. By keeping the pH relatively high during REPSA we may therefore 
be able to screen for only the most tightly bound secondary sites, which will 
presumably be the sites which are most similar to the exact recognition sequence. 
 Chapter 4: Footprinting on REPSA targets 
 
    Page 102 
 
   
Chapter 4: Footprinting on REPSA targets 
 
4.1  Introduction 
 
This chapter farther examines the sequences that were isolated from the 
REPSA experiments.  14 different templates were chosen from these REPSA-
selected templates and their interaction with the BAU-containing TFO was 
analysed by DNase I footprinting.  These results were compared with experiments 
using related TFOs with the same sequence but containing propargylamino-dU 
and T instead of BAU.  Propargylamino-dU is similar to BAU but contains only one 
of the positive groups found on BAU (see section 1.4 for more details).  It was 
thought that reducing the positive charge on the TFO would make it less likely to 
bind secondary sites.  A TFO with the same sequence but containing only T, with 
no modified bases, was also tested as a control. 
As well as footprinting these TFOs on the sequences selected by REPSA, 
two sets of control footprinting experiments were also carried out to compare the 
TFOs affinity for the primary and secondary binding sites under similar conditions.  
These two templates both contain the exact recognition site for the TFOs but in a 
different context; one is the tyrT template used in Chapter 3, and the other is the 
REPSA template with the exact sequence in place of the random region (see 
Figure 4.2 on the following page). 
Early summary of Results: 
The BAU substituted TFO was able to bind to all but one of the sequences 
isolated from the REPSA experiments, even though they do not contain the exact 
target site, down to concentrations between 1-0.1 µM.  The propargylamino-dU (P) 
and T containing TFOs failed to produce a footprint on any template even at 30 
µM, although some enhancements are seen.  In order to promote binding of these 
TFOs magnesium chloride and the naphthylquinoline triplex binding ligand were 
added to the incubation buffer.  Under these conditions the propargylamino-dU 
TFO was able to bind almost all of the templates.  However, the control TFO 
containing only T and C did not bind to the REPSA templates, even in the 
presence of the triplex binding ligand. 
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4.2  Experimental design 
 
The original and revised REPSA methods, the optimisation experiments 
and the results of the first set of REPSA experiments are described in section 2.3.  
Template sequences selected by REPSA are shown in the relevant sections of 
this chapter.  The sequences of the TFOs used for footprinting are shown below: 
 
B  5’ – BBBBBBCBT – 3’ 
P  5’ – PPPPPPCPT – 3’ 
T  5’ – TTTTTTCTT – 3’ 
 
Figure 4.1: Sequence of TFOs used in footprinting, abbreviations B, P and T used 
throughout this chapter. 
B = Bis-amino-U 
P = Propargylamino-dU 
T = Thymine 
 
  The two control templates used were the tyrT fragment and the exact target 
for the oligo (contained within the REPSA template), both of which were cloned 

















Figure 4.2: Sequence of the two control templates used in this chapter, TFO binding site 
shown in red and radiolabel in blue. 
i)  Sequence of the tyrT template 
ii)  Sequence of the synthesised exact REPSA template cloned into pUC19. Chapter 4: Footprinting on REPSA targets 
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  The templates were radiolabelled as described in section 2.2.3 and the 
footprinting experiments were carried out as described in section 2.2.4.  For 
separating the products of DNaseI digestion a 9% denaturing polyacrylamide gel 
was used for the tyrT sequence but for all REPSA templates and the exact 
template a 12.5% gel was used as these fragments are shorter.  For all 
footprinting experiments the template and TFO were incubated in pH 5.0 buffer (50 
mM sodium acetate) overnight at 20°C.  For some footprints 5 mM magnesium 
chloride or 5 or 10 µM naphthylquinoline triplex binding ligand were added to the 
incubation buffer. 
 
4.3  Results 
 
4.3.1  REPSA selection 
 
  Since the first set of REPSA experiments produced templates which 
showed no obvious selection (Section 2.3) and failed to bind the BAU containing 
TFO, optimisation experiments were then carried out (section 2.3.3) and REPSA 
was then repeated with the new protocol (section 2.3.1).  The templates 
sequenced at the end of this set of REPSA experiments are shown in Tables 4.1 i 
and ii on the following page. The original sequencing gels and files are shown in 
Appendix 1 and 2. 
  Out of 114 colonies picked for sequencing 37 contained no insert even 
though the colonies were white, possibly due to a mutation elsewhere in the 
plasmid. Eight of the colonies were unidentifiable and 37 contained an insert which 
couldn’t be fully sequenced (possibly because they adopt unusual structures).  
The other 32 colonies picked contained plasmids which were fully sequenced and 
these are shown in the tables on the following page.  14 of these sequences were 
chosen for footprinting (Table 4.1 i). 
  An interesting pattern emerged during sequencing; the selected templates 
were all in the same orientation, with the purine-rich strand visible on the 
sequencing gel (and therefore on the footprinting fragments as well).  Since the 
TFO binds to duplex DNA we would have expected an equal distribution of 
pyrimidine- and purine-rich strands.  This unexpected phenomenon will be 
considered further in the Discussion. Chapter 4: Footprinting on REPSA targets 
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  Due to constraints of time and materials it was not possible to study every 
template sequence isolated by REPSA.  As the aim of this work was to compare 
secondary binding sites of the TFOs with each other and the exact binding site it 
was decided to examine templates which were most similar to the exact target 
sequence.  These sequences are shown in Table 4.1 ii; they all contain a run of at 
least four consecutive A residues.  The only exception to this is sequence 6, which 
was originally thought to have a run of six As but was re-sequenced when the BAU 
TFO failed to produce a footprint and was found to contain a pyrimidine 
interruption. 
 
(i)              (ii) 
Number  Sequence 
 
Number  Sequence 
1  CAATCAAAAAAACAA 
 
15  GCTACAAGGTCGCAC 
2  AAAAAAAAGTTGCTCT 
 
16  GCCCAAAGAGACACA 
3  CCCCGAACAAAAAAA 
 
17  ATTTATCGGACAGAA 
4  CAAAAAAAGAGAGAC 
 
18  GACAACCGAAAGCAC 
5  TATTGCTAAAAAAGG 
 
19  TATCGCGAGCACAAC 
6  AAATAAACGGCCATTG 
 
20  GCGGGTGGGATAGCATA 
7  CCAGAGCACAAAAAACAA 
 
21  CGAGCTAAAGATCCA 
8  GGTAAAAAACCGGCA 
 
22  GCCTAACCAGATAGA 
9  CAACTCAAAAAATCA 
 
23  CCTAAAACCCATA 
10  CCCTAAAAATAACAA 
 
24  TATCGTAAGGCAAGT 
11  GCAGTAAAAAAACTA 
 
25  GCACAACCATGCAAGA 
12  AAGAAAAGCAATGGGATCT 
 
26  CTTTAGCCCAGGAAT 
13  CACACGCAAAAAAG 
 
27  ACCACCTAAAATCAT 
14  AAGAAAAAACAGCTCCTAC 
 
28  ACCTACCATGACTATA 
     
29  GTGCCCTCGGAGAAA 
     
30  AGATATCAGATAC 
     
31  GAATCCATACGACTT 
     
32  ACCAACCGATATAGC 
 
Table 4.1; 
i) Table of template sequences selected in the second set of REPSA experiments that 
have been used in footprinting experiments. 
ii) Sequences which were not used in footprinting 
 
  The sequences isolated by REPSA which were not investigated further are 
shown in Table 4.1 ii.  We considered that these were less likely to bind the TFO 
as they do not contain a run of As or purines.  These fragments may contain 
sequences which were very weakly bound by the TFO so were selected by Chapter 4: Footprinting on REPSA targets 
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REPSA, or they may be random sequences which were not screened out by 
REPSA as it is purposefully not 100% efficient; sequences which have not bound 
the TFO may still elude cleavage by Fok I for other reasons, such as formation of 
a secondary structure which prevents access by the enzyme (299).  Multiple 
rounds of REPSA are carried out for this reason, in order to give the enzyme 
multiple opportunities to cleave unbound templates.  REPSA cannot be continued 
indefinitely however; if too many rounds are carried out it can lead to mutations in 
the template sequences.  Indeed it can be seen that some of the sequences in 
Table 4.1 are not the same length as the random template with which REPSA was 
started.  This is an acknowledged limitation of the REPSA technique (299). 
 
4.3.2  Footprinting controls 
 
  As an initial control experiment the three TFOs shown in Figure 4.1 (page 
104) were footprinted on the two control templates shown in Figure 4.2 (page 
104); the tyrT fragment and the exact REPSA template.  Several different 
conditions were used for the experiments with the propargylamino-dU and 
thymidine-containing oligos in order to potentiate any possible interactions with the 
target binding site.  These included the addition of magnesium chloride and/or the 
naphthylquinoline triplex binding ligand.  It is important to note that the BAU 
footprint appears at a 100 times lower concentration than the footprints with all the 
other oligonucleotides in most of these Figures. 
  The following abbreviations are used to indicate the TFOs used and 
whether magnesium chloride or naphthylquinoline were added for all of the 
footprinting Figures presented in this chapter; 
 
Abbreviation  Meaning          TFO Sequence 
BAU    Bis-amino-U-containing TFO       5’ – BBBBBBCBT – 3’ 
P    Propargylamino-dU-containing TFO      5’ – PPPPPPCPT – 5’ 
P+M    P + 5 mM magnesium chloride      5’ – PPPPPPCPT – 5’ 
P+5L    P + 5 µM naphthylquinoline        5’ – PPPPPPCPT – 5’ 
P+10L   P + 10 µM naphthylquinoline       5’ – PPPPPPCPT – 5’ 
P+M+5L  P + 5 mM MgCl2 + 5 µM naphthylquinoline    5’ – PPPPPPCPT – 5’ 
P+M+10L  P + 5 mM MgCl2 + 10 µM naphthylquinoline   5’ – PPPPPPCPT – 5’ 
T    Thymidine-containing TFO        5’ – TTTTTTCTT – 3’ 
T+10L   T + 10 µM naphthylquinoline        5’ – TTTTTTCTT – 3’ Chapter 4: Footprinting on REPSA targets 
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Figure 4.3:  DNaseI cleavage patterns of TyrT(43-59) with the three TFOs shown in Figure 
4.1. The experiments were performed in 50 mM sodium acetate pH 5.0.  The TFO 
concentrations (µM) are shown above the gel lanes.  Lanes labelled GA are markers 
specific for purines.  Control indicates DNaseI cleavage in the absence of TFO.  Black 
rectangles show the position of the footprints, black asterisks indicate enhancements and 
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  DNase I cleavage patterns of the tyrT fragment after incubation with various 
TFOs are shown in Figure 4.3 on the previous page.  It can be seen that the BAU-
containing TFO produces a footprint on this fragment down to concentrations of 
about 0.1 µM, as shown in Chapter 3.  This footprint is accompanied by enhanced 
cleavage at the 3’- (lower) end of the target site at the triplex-duplex junction, also 
down to 0.1 µM.  At the highest TFO concentration (0.3 µM) a secondary 
enhancement can also be seen further down the gel and there are some slightly 
lighter bands, again as seen in the footprints in Chapter 3.  The position of the 
footprint and enhancements are shown below; 
 
                  5’ – BBBBBBCBT – 3’ 
  5’ - AAAGTGTTAGGAAGAGAAAAAAGAACTGGTTGCGTAATTTTCATCC – 3’ 
  3’ - TTTCACAATCCTTCTCTTTTTTCTTGACCAACGAATTAAAAGTAGG – 5’ 
                               *            **** 
 
Figure 4.4: TyrT sequence showing the binding of the BAU substituted TFO.  The upper / 
purine-rich strand was radiolabelled at the 3’ end in all the footprinting experiments 
described in this thesis.  The position of the footprint from the BAU gel in Figure 4.3 is 
shown in red and the enhancements are indicated by asterisks below the sequence.  The 
expected binding site of the TFO is underlined and the TFO is shown above the sequence 
in its anticipated binding position. 
 
  The footprint extends for several bases beyond the target site in the 5’-
direction on the purine strand, as noted in many other triplex footprinting 
studies(300). This extension is due to the size of DNase I and is also related to the 
fact that DNase I cuts from the minor, while the TFO is located in the major 
groove.  The footprint is accompanied by enhanced cleavage at the 3’-end of the 
purine strand at the triplex-duplex junction, as often noted in other studies(300). 
  The cleavage patterns of tyrT with the propargylamino-dU TFO alone or 
with addition of 5 mM magnesium chloride show a slight enhancement at the same 
position as the enhancement with the BAU TFO.  The thymidine TFO does not 
produce a footprint but shows enhanced cleavage at the triplex-duplex junction in 
the presence of the naphthylquinoline triplex binding ligand.  There is also no 
evidence of secondary footprints or enhancements in any of these experiments 
with the P or T TFOs. 
  All templates incubated with the propargylamino-dU TFO and 
naphthylquinoline show a footprint down to 3 µM TFO, at both ligand 
concentrations and with or without magnesium chloride.  They also show an Chapter 4: Footprinting on REPSA targets 
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enhancement at the same position as the previous gels, which persists down to 
around 1 µM TFO.  However there is also some (weaker) enhanced cleavage one 
band above this (in the 5’-diretion).  This may indicate that the terminal bases of 
the TFO are fraying from the target so that, for some of the time, the triplex-duplex 
junction is located one base pair higher. 
  From these footprints on the tyrT template it can be seen that the BAU 
substituted TFO binds at a 30-fold lower concentration than the propargylamino-
dU containing TFO in the presence of the triplex binding naphthylquinoline.  
Without the ligand only a slight enhancement can be seen with this TFO, even at 
300 times the concentration that produces a footprint with the BAU TFO.  The 
control TFO containing only thymidine also shows only a very slight enhancement 
at this concentration, and then only with the addition of naphthylquinoline. 
  Additional enhancements are evident when the BAU-containing TFO is 
footprinted on the tyrT fragment, which indicate secondary binding sites.  Although 
much higher concentrations of the propargylamino-dU containing TFO are 
required to affect the DNase I cleavage pattern, there is no evidence of secondary 
binding at these elevated concentrations.  The secondary enhancement also 
appears at a three times higher concentration than the primary footprint on the 
BAU gel, but there is no secondary binding even at 10 times the concentration of 
the primary footprint on the P+M+10L gel.  It is clear that the BAU-substituted TFO 
binds more strongly to these secondary sites and that this secondary (weaker) 
interaction is a feature of BAU-substitution. 
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Figure 4.5:  DNaseI cleavage pattern of the exact target (Figure 4.2 ii page 104), cloned 
into pUC19, footprinted with the three TFOs shown in Figure 4.1 (page 104).  The 
experiments were performed in 50 mM sodium acetate.  The TFO concentrations (µM) are 
shown above the gel lanes.  Lanes labelled GA are markers specific for purines.  Control 
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  The results of similar footprinting experiments with a fragment containing 
the exact target site within the context of the rest of the REPSA template are 
shown in Figure 4.5 on the previous page.  The complementary strands containing 
this sequence were synthesised, annealed and then cloned into the pUC19 
polylinker (sequence shown in Figure 4.2ii page 104).  One important thing to note 
is that in this fragment the sequence has been cloned so that the pyrimidine-rich 
strand is labelled and visualised in the gels.  In contrast, all the sequences isolated 
from the REPSA experiments were orientated so that the purine-rich strand was 
visualised.  This unexpected bias in the REPSA sequence, akin to directional 
cloning, is considered in the Discussion. 
  An important consequence of this difference is that no enhancements are 
visible on these gels in Figure 4.5.  This is often the case when looking at the 
pyrimidine-rich strand in footprinting experiments(284).  Unfortunately, this makes 
the results on this template slightly more difficult to compare with footprints on the 
REPSA templates or the tyrT fragment.  However this synthetic template contains 
the exact binding site for the TFOs, in the context of the same flanking sequences 
as used in the REPSA experiments. 
 
          5’ – BBBBBBCBT – 3’ 
5’ – AGGATCCTGACTGGATGAACGCAAAAAAGAAGCGTCTTCCTGACAAGCTT - 3’ 
3’ – TCCTAGGACTGACCTACTTGCGTTTTTTCTTCGCAGAAGGACTGTTCGAA - 5’ 
 
Figure 4.6: Sequence of the exact REPSA template showing the binding of the BAU 
substituted TFO.  The lower (pyrimidine-rich) strand has been radiolabelled at the 3’ end. 
The position of the footprint produced by the BAU-containing TFO (taken from the gel in 
Figure 4.5) is shown in red.  The expected binding site of the TFO is underlined and the 
TFO is shown above the sequence in its anticipated binding position. 
 
  The footprint produced by the BAU substituted TFO extends beyond the 
anticipated binding site by several bases at both ends.  This footprint is very 
unclear however; the bands within the footprint are fainter but still visible and the 
edges of the footprint are therefore difficult to determine.  Unfortunately this is not 
a particularly clear gel so the faint edges may simply be an artefact.  This footprint 
persists down to around 0.1 µM TFO.  Unlike with the tyrT fragment there is no 
evidence of secondary binding on this template. 
  There is no footprint visible with the propargylamino-dU TFO, but when 
magnesium chloride is added to the incubation a footprint can be seen at the Chapter 4: Footprinting on REPSA targets 
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highest concentration (30 µM).  This footprint is four bases shorter at the 5’ (upper) 
than the footprint with BAU where it appears to terminate at this upper triplex-
duplex junction; the lower (3’) of this footprint extends a few bases beyond (below) 
the target site, terminating at approximately the same position as the footprint 
generated by the BAU-containing TFO. 
  For all of the gels with P and ligand (with or without magnesium chloride) 
there are strong footprints which persist to 0.3 / 0.1 µM.  These footprints are four 
bases shorter than the BAU footprint at the 5’ (upper) end, as seen on the P+M 
gel.  However they are also two bases longer at the 5’ end than the footprint on the 
BAU or P+M gels.  This is atypical of triplexes with pyrimidine targets and 
naphthylquinoline; footprints are usually shorter at the 5’ end in the presence of 
the ligand(167). 
  As with tyrT there is no footprint produced by the thymidine TFO alone, but 
when ligand is added there is a clear footprint down to 10 µM.  Again the position 
of this footprint is slightly different to any of the others.  It extends to the same 
point as the P+L footprints at the 3’ end but is two bases shorter at the 5’ end. 
 
          5’ – PPPPPPCPT – 3’ 
          5’ – TTTTTTCTT – 3’ 
5’ – AGGATCCTGACTGGATGAACGCAAAAAAGAAGCGTCTTCCTGACAAGCTT - 3’ 
3’ – TCCTAGGACTGACCTACTTGCGTTTTTTCTTCGCAGAAGGACTGTTCGAA - 5’ 
 
Figure 4.7: Sequence of the exact REPSA template showing the position of footprints and 
enhancements generated by the P- and T- TFOs under various conditions.    The 
lower/pyrimidine strand has been radiolabelled at the 3’ end.  The bases in red and blue 
indicate the extent of the footprint on the P+M gel, the bases in all three colours show the 
size of the footprint in all experiments involving the P-TFO and the ligand, and red and 
green bases indicate the size of the footprint seen on the T+10L gel.  The bases in red are 
therefore the only ones found in all footprints, including the one generated by the BAU-
substituted TFO.  The TFOs are shown above the sequence in the anticipated binding 
position. 
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4.3.3  REPSA footprints 
 
Fragments containing the 14 chosen sequences (Table 4.1 i) were 
footprinted with the three TFOs shown in Figure 4.1 (page 104) to examine the 
effect of different substitutions on TFO binding to these punitive secondary sites.  
In each case the radiolabelled DNA fragment and the TFO were incubated 
overnight at 20°C in pH 5.0 buffer (50 mM sodium acetate).  The sequences of the 
relevant parts of the fragments are shown along the side of the first gel in each 
Figure.  In each case the purine-containing strand is visualised on the footprinting 
gel. 
Magnesium chloride or naphthylquinoline were added to the incubation 
buffer in some instances in order to enhance any weak binding and this is 
indicated above the gel.  In each case the positions of footprints are indicated by a 
black rectangle.  All incubation conditions (9 gels) are shown for the first template 
(Figure 4.8 on the following page).  For ease of comparison only four gels are 
shown for the remainder of the fragments (B, P, P+10L and P+M+10L). 
The templates are presented in the order of roughly how closely they 
resemble the exact target sequence starting with the one with the fewest 
mismatches. 
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Figure 4.8:  DNaseI cleavage patterns of template 1 from the REPSA experiment with the 
3 TFOs shown in Figure 4.1.  Template and TFOs were incubated overnight at 20°C in a 
pH 5.0 buffer containing 50 µM sodium acetate.  TFO concentrations (µM) are shown 
above the gels; lanes labelled GA are markers specific for purines.  Control lanes show 
the DNaseI cleavage pattern in the absence of TFO.  The sequence of the DNA fragment 
is shown along the left side; footprints are indicated by black boxes and enhancements by 
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  The DNase I cleavage patterns of template 1 after incubation with various 
TFOs are shown in Figure 4.8 on the previous page.  The BAU substituted TFO 
produces a footprint down to a concentration of around 0.3 µM, even though this 
template does not contain its correct binding site, confirming that REPSA had 
successfully selected for TFO-binding.  No enhancement is visible on this gel.  The 
position of the footprint (which is shorter than the TFO) is shown below; 
 
      5’ – BBBBBBCBT – 3’ 
      5’ – PPPPPPCPT – 3’ 
  5’ – AAGACAATCAAAAAAACAATTCA – 3’ 
  3’ – TTCTGTTAGTTTTTTTGTTAAGT – 5’ 
             * 
 
Figure 4.9: Template 1 sequence showing the locations of the footprints and 
enhancements produced by the TFOs.  Note that the upper (purine-rich) strand is 
visualised in Figure 4.8 and has been radiolabelled at the 3’ end.  The bases in red show 
the BAO-TFO generated footprint and the red and blue bases show the extended footprint 
in the P+L gels.  The enhancement was also only seen on these gels, not with the BAU-
TFO.  A possible location for the TFOs on this template is shown above the sequence and 
the complementary bases in the sequence are underlined. 
 
  Since triplex footprints are often shifted several bases in the 5’ direction 
compared with the actual binding site it seems possible that the six consecutive 
BAU substitutions have bound to six of the run of seven adenines in the template, 
perhaps excluding the one at the 5’ end. 
  In contrast, the propargylamino-dU-containing TFO does not produce a 
footprint in this region, and addition of magnesium chloride had no visible effect on 
the binding.  This indicates that this isolated secondary binding site is a feature of 
the multiple BAU modifications and is not produced by all oligos. Two bands show 
a slight enhancement on both of these gels with P at the 3’ end of the A tract, 
which persists down to around 3 µM TFO, maybe indicating that there is some 
weak interaction. 
  This double enhancement will be considered further in the Discussion and 
may indicate that the oligo has more than one binding location.  It is also 
interesting to note that there was no enhancement produced by the BAU-
substituted TFO.  On addition of 5 or 10 µM triplex-binding-ligand a clear footprint 
is evident with the propargylamino-dU substituted TFO (this is evident both with Chapter 4: Footprinting on REPSA targets 
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and without magnesium chloride), in a similar position to that produced by the 
BAU-containing TFO, but one base shorter at the 5’ end. 
  With 5 µM ligand the TFO binds down to a concentration of around 10 µM, 
while with 10 µM ligand the footprint persists to around 3µM.  The gels with ligand 
and magnesium chloride both show footprints at lower concentrations, down to 
around 0.3 µM of the P-containing TFO.  There is also an enhancement on the 
P+M+5L and P+M+10L gels at all concentrations, but not on the P+5L or P+10L 
gels.  The position of this enhancement is slightly different to the P or P+M gels; it 
is shifted three bases to the right.  This may indicate that under these conditions 
the TFO is binding at multiple sites; perhaps slipping along the A tract. 
  No clear footprints are produced by the T-containing TFO even in the 
presence of the naphthylquinoline ligand.  However on close examination of the 
T+10L gel it can be seen that, at the highest TFO concentration (30µM), the 
intensity of the bands is attenuated towards the top of the region where the BAU 
and P TFOs generated footprints; this may indicate a weak interaction with this 
TFO.  None of the other templates generated footprints or enhancements with this 
TFO, and the results for T and T+10L are therefore not shown for any of the other 
templates presented below. 
  As seen with the tyrT DNA fragment gels the footprint generated by the 
propargylamino-dU substituted TFO is shifted in the 5’ direction compared with the 
BAU footprint.  In this case however the footprint with the P-TFO is one base 
longer in the 5’ direction, whereas on tyrT it was one base shorter at the 3’ end. 
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Figure 4.10:  DNaseI cleavage patterns of template 7 with two of the TFOs shown in 
Figure 4.1. TFO concentrations (µM) are shown above the gels; lanes labelled GA are 
markers specific for purines.  Control lanes show the DNaseI cleavage pattern in the 
absence of TFO.  The sequence of the DNA fragment is shown along the left side, 
footprints are indicated by black boxes and asterisks indicate enhancements. 
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  The results of similar footprinting experiments with template 7 are shown in 
Figure 4.10 on the previous page.  Once again the BAU-containing oligonucleotide 
produces a footprint within the REPSA-selected region, even though it does not 
contain a canonical binding site for this TFO.  However this footprint is only seen 
at the highest TFO concentration (1 µM), though it is accompanied by a slight 
enhancement, which is visible down to 0.3µM. 
 
         5’ – BBBBBBCBT – 3’ 
         5’ – PPPPPPCPT – 3’ 
  5’ – AAGACCAGAGCACAAAAAACAACCCTTCA – 3’ 
  3’ – TTCTGGTCTCGTGTTTTTTGTTGGGCCGT – 5’ 
             * 
 
Figure 4.11; Sequence of template 7 showing the positions of the footprints and 
enhancements generated by the TFOs.  In Figure 4.10 the upper (purine-rich) strand of 
this sequence was radiolabelled at the 3’ end.  The red bases show the footprint with the 
BAU-TFO and the red and blue bases shown the extended footprint in the P+L gels.  The 
enhancement was only seen with the BAU-TFO.  The probable binding site of the TFOs is 
underlined and the TFO sequences are shown above. 
 
  When incubated with the P-substituted TFO alone no footprint was evident 
on this template, though addition of 10 µM ligand produced a clear footprint which 
persists to 10 µM TFO in the absence of magnesium chloride and about 3 µM in 
its presence.  No enhancements are visible on either of these gels, though the 3’ 
edge of the footprint is unclear; there are lighter bands extending much further 
down the gels which may indicate some further secondary binding (though there is 
no evidence for secondary binding with the BAU TFO).  Again the footprints 
generated by the P-TFO are one base longer at the 5’ end than the footprint in the 
BAU gel.  No footprint was produced by the T containing TFO, with or without 
ligand (not shown). 
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Figure 4.12:  DNaseI cleavage patterns of sequence 10 from the REPSA experiment with 
two of the TFOs shown in Figure 4.1. TFO concentrations (µM) are shown above the gels; 
lanes labelled GA are markers specific for purines.  Control lanes show the DNaseI 
cleavage pattern in the absence of TFO.  The sequence of the DNA fragment is shown 
along the left side, footprints are indicated by black boxes and asterisks indicate 
enhancements. 
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  The results of footprinting experiments with template 10 are shown in 
Figure 4.12 on the previous page.  With the BAU substituted TFO there is a 
footprint on this template at 1 µM only.  Three bands are enhanced at the 3’ end of 
this footprint, which are also visible down to 0.1 µM TFO. 
 
      5’ – BBBBBBCBT – 3’ 
  5’ – AAGACCCTAAAAATAACAATTCA – 3’ 
  3’ – TTCTGGGATTTTTATTGTTAAGT – 5’ 
          *** 
 
Figure 4.13; Sequence of template 10 showing the position of the footprint and 
enhancement with the BAU substituted TFO.  In Figure 4.12 the upper (purine-rich) strand 
was radiolabelled at the 3’ end.  The footprint is shown in red and the enhancements are 
indicated by an asterisk.  The probable binding site of the TFO is underlined and the TFO 
sequence is shown above. 
 
  No footprint or enhancement is visible on the P or P+10L gels, though the 
intensity of some bands is attenuated on the P+M+10L at 30 and 10 µM TFO.  
This is at the same position as the BAU footprint, although it is not so well defined.  
Three bands are also enhanced on this gel at the same position as seen with 
BAU, which persist to about 3-1 µM.  No footprint was seen with the T containing 
TFO, with or without ligand (not shown). 
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Figure 4.14:  DNaseI cleavage patterns of sequence 4 from the REPSA experiment with 
two of the TFOs shown in Figure 4.1. TFO concentrations (µM) are shown above the gels; 
lanes labelled GA are markers specific for purines.  Control lanes show the DNaseI 
cleavage pattern in the absence of TFO.  The sequence of the DNA fragment is shown 
along the left side, footprints are indicated by black boxes and asterisks indicate 
enhancements. 
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  Figure 4.14 on the previous page shows the results of similar experiments 
with sequence 4.  The BAU-substituted TFO produces a very clear footprint on this 
template at 1 µM and some attenuation is visible down to 0.1 µM.  There is also a 
single enhancement at the 3’ end of this footprint, which persists to 0.1 µM.  An 
unusual feature of this gel is that the intensities of some of the bands below the 
enhancement are also attenuated at 1 - 0.1 µM TFO, indicating that there may be 
secondary binding of this TFO, this is indicated in green in the Figure below; 
 
     5’ – BBBBBBCBT – 3’ 
     5’ – PPPPPPCBT – 3’ 
  5’ – AAGACAAAAAAAGAGAGACTTCA – 3’ 
  3’ – TTCTGTTTTTTTCTCTCTGAAGT – 5’ 
         **** 
 
Figure 4.15; Sequence of template 4 showing the positions of the footprints and 
enhancements generated by the different TFOs.  In Figure 4.14 the upper (purine-rich) 
strand of this sequence was radiolabelled at the 3’ end.  The bases in red and blue show 
the footprint in the BAU gel, red and green show position of the footprint on the P+L gels.  
The black asterisk shows the position of the enhancement with the BAU-TFO, the red 
asterisks show the additional enhancements on the P+L gel, and the blue asterisk shows 
a further additional enhancement only seen on the P+M+L gel.  The probable binding site 
of the TFOs is underlined and the TFO sequences are shown above.  The base pair in 
italics indicates a possible secondary binding site. 
 
  With P only there is no visible footprint on this template but a slight 
enhancement can be seen at the same position as on the BAU gel at 30 and 10 
µM TFO.  Addition of naphthylquinoline produces a clear footprint; without 
magnesium chloride this extends to 10 µM TFO, with three enhancements at the 3’ 
end which persist to 1 µM.  This footprint is also one base shorter at the 3’ end 
than the BAU footprint.  With ligand and magnesium chloride the footprint is also 
visible to 10 µM; it starts at the same position as the previous gel at the 3’ end, but 
extends two bases further than the BAU or P+L gels at the 5’ end.  There are also 
four enhancements visible at the 3’ end on this gel, down to round 1 µM.  No 
footprint was seen with the T-containing TFO, with or without ligand (not shown). 
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Figure 4.16:  DNaseI cleavage patterns of sequence 5 from the REPSA experiment with 
two of the TFOs shown in Figure 4.1. TFO concentrations (µM) are shown above the gels, 
lanes labelled GA are markers specific for purines.  Control lanes show the DNaseI 
cleavage pattern in the absence of TFO.  The sequence of the DNA fragment is shown 
along the left side, footprints are indicated by black boxes and asterisks indicate 
enhancements. 
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  The results of footprinting experiments with template 5 are shown in Figure 
4.16 on the previous page.  There is a clear footprint with the BAU-substituted 
TFO down to a concentration of 1 / 0.3 µM, and this is accompanied by enhanced 
cleavage at the 3’- (lower) end, which persists to around 0.1 µM. In this instance 
two bands show enhanced DNase I cleavage and this effect is also seen with the 
other TFOs on this template.  The location of the footprint and enhancements from 
the gels are shown in Figure 4.17 below; 
 
       5’ – BBBBBBCBT – 3’ 
       5’ – PPPPPPCPT – 3’ 
  5’ – AAGATATTGCTAAAAAAGGTTCA – 3’ 
  3’ – TTCTATAACGATTTTTTCCAAGT – 5’ 
           *** 
 
Figure 4.17; Sequence of template 5 showing the positions of footprints and 
enhancements with different TFOs.  In Figure 4.16 the upper (purine-rich) strand of this 
sequence was radiolabelled at the 3’ end.  The bases in red show the position of the 
footprint generated by the BAU-TFO; the green base pair shows how the footprint was 
extended in the P+L gels.  The enhancements are indicated by asterisks, red and black 
show enhancements on the BAU and P+L gels, black and green show the enhancements 
on the P+M+L gel only (shifted one base in the 5’ direction).  The probable binding site of 
the TFOs is underlined and the TFO sequences are shown above. 
 
  The propargylamino-dU-containing oligonucleotide does not produce a 
footprint on this template, even at a concentration of 30 µM, though enhanced 
cleavage is evident at the same positions as seen with the BAU-containing TFO at 
the highest concentration. On addition of the triplex-binding ligand a clear footprint 
is evident with the propargylamino-dU-containing oligo which appears to extend for 
one base further in the 5’-(upper) direction compared to the BAU TFO.  This 
footprint is seen with and without magnesium chloride; without magnesium the 
TFO binds down to around 3 µM and with magnesium to about 0.3 µM.  The 
enhancement is different between these two gels; without magnesium there is a 
double enhancement at the same position as seen for BAU and P down to 1 µM, 
with magnesium the enhancement shifts one base in the 3’ direction and is seen at 
all TFO concentrations.  This may indicate that the TFO is slipping on the A tract 
and binding slightly further down the sequence.  No footprint can be seen with the 
T containing TFO, with or without ligand (not shown).   Chapter 4: Footprinting on REPSA targets 
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Figure 4.18:  DNaseI cleavage patterns of sequence 2 from the REPSA experiment with 
two of the TFOs shown in Figure 4.1. TFO concentrations (µM) are shown above the gels, 
lanes labelled GA are markers specific for purines.  Control lanes show the DNaseI 
cleavage pattern in the absence of TFO.  The sequence of the DNA fragment is shown 
along the left side, footprints are indicated by black boxes and asterisks indicate 
enhancements. 
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  Figure 4.18 on the previous page shows the results of similar footprinting 
experiments on template 2.  With the BAU-substituted TFO a footprint can be seen 
at 1 µM, which is accompanied by two enhancements at its 3’ end, visible down to 
around 0.1 µM.  There are also some lighter bands below the enhancement at 1 
and 0.3 µM TFO, indicating the possible presence of a secondary binding site on 
this template (shown in italics in Figure 4.19 below).  With the propargylamino-dU 
containing TFO the same two enhancements are visible down to around 3 µM but 
there is only a slight attenuation of bands within the footprinting region at the two 
highest concentrations. 
 
        5’ – BBBBBBCBT – 3’ 
        5’ – PPPPPPCPT – 3’ 
  5’ – CAGGAAGAAAAAAAAGTTGCTCTTTCA – 3’ 
  3’ – GTCCTTCTTTTTTTTCAACGAGAAAGT – 5’ 
            **** 
 
Figure 4.19; Sequence of template 2 showing the positions of footprints and 
enhancements with different TFOs and under different conditions.  In Figure 4.18 the 
upper (purine-rich) strand of this sequence was radiolabelled at the 3’ end.  Bases in red 
show the BAU-TFO footprint, the bases from orange to green show how the footprint is 
extended one base in the 5’ and two bases in the 3’ direction on the P+L gel.  Bases in 
red, green and blue show the footprint on the P+M+L gel.  Enhancements are indicated by 
asterisks, black and red show the enhancements on the BAU gel, black and green are 
enhancements on the P+L gel, and all four enhancements are seen on the P+M+L gel.  
The probable binding site of the TFOs is underlined and the TFO sequences are shown 
above.  A possible secondary footprint on the BAU gel only is shown in italics. 
 
  When the triplex binding ligand naphthylquinoline is added to the incubation 
a footprint becomes visible with the P TFO at 30 µM along with two enhancements 
at the 3’ end; the footprint is also extended by a further two bases in the 3’ 
direction compared with the BAU footprint.  The enhancement is also shifted one 
base down in comparison with the BAU and P gels.  The footprint on the P+M+10L 
gel appears to be completely different; the footprint extends all the way to the top 
of the gel down to 1 µM and there are now four enhancements at the 3’ end at all 
concentrations.  This is likely to be an artefact of the gel, but may indicate that the 
TFO is binding at multiple sites all the way up the template.  This is unlikely as this 
part of the sequence is the same on all the fragments, as it was not part of the 
random region of the original REPSA template.  The footprint is also one base 
shorter at the 3’ end compared with the P+10L gel.  The T containing TFO did not Chapter 4: Footprinting on REPSA targets 
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produce any footprints or enhancements with this fragment, both with or without 




Figure 4.20:  DNaseI cleavage patterns of sequence 13 from the REPSA experiment with 
two of the TFOs shown in Figure 4.1. TFO concentrations (µM) are shown above the gels; 
lanes labelled GA are markers specific for purines.  Control lanes show the DNaseI 
cleavage pattern in the absence of TFO.  The sequence of the DNA fragment is shown 
along the left side, footprints are indicated by black boxes and asterisks indicate 
enhancements. 
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  Figure 4.20 on the previous page shows the results of similar experiments 
with sequence 13.  The BAU-substituted TFO produces a footprint on this template 
at 1 µM only, but two bands of enhanced cleavage are visible below this, down to 
0.3 µM.  With the propargylamino-dU substituted TFO alone there was no 
evidence of binding, however when in the presence of the triplex binding ligand a 
footprint is visible to around 3 / 1 µM with or without magnesium chloride.  The 
same two enhancements as seen with BAU are also evident again down to about 
3 / 1 µM.  As with previous templates the footprint with the P-TFO is slightly 
different to the BAU containing TFO and it extends one base further in the 5’ 
direction.  No footprint was seen with the T-containing TFO, with or without ligand 
(not shown). 
 
       5’ – BBBBBBCBT – 3’ 
       5’ – PPPPPPCPT – 3’ 
  5’ – AAGACACACGCAAAAAAGTTCA – 3’ 
  3’ – TTCTGTGTGCGTTTTTTCAAGT – 5’ 
           ** 
 
Figure 4.21; Sequence of template 13 showing the positions of footprints and 
enhancements with different TFOs and under different conditions.  In Figure 4.20 the 
upper (purine-rich) strand of this sequence was radiolabelled at the 3’ end.  The bases in 
red show the position of the footprint generated by the BAU-TFO, the base in blue shows 
an additional base in the footprints on the P+L and P+M+L gels.  Enhancements are 
indicated by asterisks, these were the same on all gels.  The probable binding site of the 
TFOs is underlined and the TFO sequences are shown above. 
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Figure 4.22:  DNaseI cleavage patterns of sequence 11 from the REPSA experiment with 
two of the TFOs shown in Figure 4.1. TFO concentrations (µM) are shown above the gels, 
lanes labelled GA are markers specific for purines.  Control lanes show the DNaseI 
cleavage pattern in the absence of TFO.  The sequence of the DNA fragment is shown 
along the left side, footprints are indicated by black boxes and asterisks indicate 
enhancements. 
 
   


























































































































* * * * * * * *Chapter 4: Footprinting on REPSA targets 
 
    Page 130 
 
   
  Figure 4.22 on the previous page shows the results of similar experiments 
with sequence 11.  The BAU-substituted TFO produces a footprint on this template 
down to 0.3 µM with two enhanced bands at the 3’ end, visible at the same 
concentrations.  No footprint is visible with the P-TFO, though enhancements can 
be seen at 30 and 10 µM at the same positions as produced with the B-TFO. 
 
         5’ – BBBBBBCBT – 3’ 
         5’ – PPPPPPCPT – 3’ 
  5’ – AAGAGCAGTAAAAAAACTATTCA – 3’ 
  3’ – TTCTCGTCATTTTTTTGATAAGT – 5’ 
          *** 
 
Figure 4.23; Sequence of template 11 showing the positions of footprints and 
enhancements with different TFOs and under different conditions.  In Figure 4.22 the 
upper (purine-rich) strand of this sequence was radiolabelled at the 3’ end.  Footprints are 
shown in red and enhancements are indicated by asterisks, the blue asterisk indicates an 
enhancement which was only seen on the P+L and P+M+L gels.  The probable binding 
site of the TFOs is underlined and the TFO sequences are shown above. 
 
  When naphthylquinoline is added there is a clear footprint with the P-TFO 
which covers the same region as the B-TFO, down to 3 µM.  Enhanced cleavage 
is also evident at these concentrations but in this case three enhanced bands can 
be seen; the two seen on the B and P gels plus an addition enhancement to the 3’ 
(lower) side of these.  The P+M+10L gel shows the same footprint and 
enhancement pattern, again to around 3 µM.  Unlike the previous templates the 
position and size of the footprint has not been affected by the type of substitution; 
however an extra enhancement can be seen on addition of ligand.  With the 
control T-containing TFO no footprint or enhancement was seen, with or without 
ligand (not shown). 
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Figure 4.24:  DNaseI cleavage patterns of sequences 14 from the REPSA experiment with 
two of the TFOs shown in Figure 4.1. TFO concentrations (µM) are shown above the gels; 
lanes labelled GA are markers specific for purines.  Control lanes show the DNaseI 
cleavage pattern in the absence of TFO.  The sequence of the DNA fragment is shown 
along the left side and footprints are indicated by black boxes. 
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  The results of similar experiments with sequence 14 are shown in Figure 
4.24 on the previous page.  On this template there is a clear footprint with the 
BAU-substituted TFO at 1 µM and also a slight footprint at 0.3 µM.  However, no 
enhancements are evident and the P-TFO does not produce a footprint under any 
conditions.  The T-containing TFO also does not footprint on this template, with or 
without ligand (not shown). 
 
     5’ – BBBBBBCBT – 3’ 
  5’ – AGGAAGAAAAAACAGCTCCTACTTCA – 3’ 
  3’ – TCCTTCTTTTTTGTCGAGGATGAAGT – 5’ 
 
Figure 4.25; Sequence of template 14 showing the positions of footprints with the BAU 
substituted TFO.  In Figure 4.24 the upper (purine-rich) strand of this sequence was 
radiolabelled at the 3’ end.  Footprints are shown in red, the probable binding site of the 
TFO is underlined and the TFO sequence is shown above 
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Figure 4.26:  DNaseI cleavage patterns of sequence 9 from the REPSA experiment with 
two of the TFOs shown in Figure 4.1. TFO concentrations (µM) are shown above the gels; 
lanes labelled GA are markers specific for purines.  Control lanes show the DNaseI 
cleavage pattern in the absence of TFO.  The sequence of the DNA fragment is shown 
along the left side, footprints are indicated by black boxes and asterisks indicate 
enhancements. 
   





































































































































* * * * * * *
* * *Chapter 4: Footprinting on REPSA targets 
 
    Page 134 
 
   
  The results of similar experiments with sequence 9 are shown in Figure 
4.26 on the previous page.  The BAU-substituted TFO does not produce a clear 
footprint on this sequence, though there are four enhancements at the 3’ end of 
the A tract at the highest concentration. 
 
      5’ – BBBBBBCBT – 3’ 
      5’ – PPPPPPCPT – 3’ 
  5’ – AAGACAACTCAAAAAATCATTCA – 3’ 
  3’ – TTCTGTTGAGTTTTTTAGTAAGT – 5’ 
          **** 
 
Figure 4.27; Sequence of template 9 showing the positions of footprints and 
enhancements with different TFOs and under different conditions.  In Figure 4.26 the 
upper (purine-rich) strand of this sequence was radiolabelled at the 3’ end.  The position 
of the footprints seen on the P+L and P+M+L gels are shown in red and enhancements on 
these gels are indicated by black asterisks, these enhancements were also seen on the 
BAU gel, along with an additional enhancement indicated by the blue asterisk.  The 
probable binding site of the TFOs is underlined and the TFO sequences are shown above. 
 
  There is no evidence of binding with the propargylamino-dU containing TFO 
alone, but a clear footprint is produced when the ligand is added.  However, a 
footprint is seen with P+10L and P+M+10L at the highest TFO concentration (30 
µM).  These footprints are also accompanied by several enhancements at the 3’-
(lower) end, which extend to around 3 µM TFO.  No footprint was seen with the T-
containing TFO, with or without ligand (not shown). 
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Figure 4.28:  DNaseI cleavage patterns of sequence 8 from the REPSA experiment with 
two of the TFOs shown in Figure 4.1. TFO concentrations (µM) are shown above the gels; 
lanes labelled GA are markers specific for purines.  Control lanes show the DNaseI 
cleavage pattern in the absence of TFO.  The sequence of the DNA fragment is shown 
along the left side, footprints are indicated by black boxes and asterisks indicate 
enhancements. 
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  The results of similar experiments with sequence 8 are shown in Figure 
4.28 on the previous page.  The BAU-substituted TFO produces a footprint at the 
highest concentration only (1 µM) on this template and produces two enhanced 
bands at the 3’-end, visible to around 0.1 µM.  The enhancements have different 
intensities; the upper one at the end of the A6 tract is much stronger than the one 
located one band further down the gel.  This may indicate that the 3’-end of the 
TFO is either binding in more than one location (slippage) or that it is fraying for a 
significant proportion of the time.  With the P-substituted TFO there is no evidence 
of a footprint, though the bands are slightly attenuated in the presence of the 
ligand at the highest concentration (30 µM) in both the presence and absence of 
magnesium chloride.  Again a double enhancement is visible with the top band 
darker than the lower one.  This pattern is also seen on the BAU gel.  Without 
magnesium these enhancements are only visible to around 3 µM, but with 
magnesium they extend down to 1 µM.  Unlike many of the other templates the 
footprints with BAU or P appear to cover the same area.  No footprint was seen 
with the T-containing TFO, with or without ligand (not shown). 
 
      5’ – BBBBBBCBT – 3’ 
      5’ – PPPPPPCPT – 3’ 
  5’ – AAGAGGTAAAAAACCGGCATTCA – 3’ 
  3’ – TTCTCCATTTTTTGGCCGTAAGT – 5’ 
          ** 
 
Figure 4.29; Sequence of template 8 showing the positions of footprints and 
enhancements with different TFOs and under different conditions.  In Figure 4.28 the 
upper (purine-rich) strand of this sequence was radiolabelled at the 3’ end.  The positions 
of footprints seen on the BAU, P+L and P+M+L gels are shown in red, enhancements are 
indicated by asterisks, the blue asterisk indicates an enhancement only seen with the 
BAU-TFO.  The probable binding site of the TFO is underlined and the TFO sequence is 
shown above. 
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Figure 4.30:  DNaseI cleavage patterns of sequence 3 from the REPSA experiment with 
two of the TFOs shown in Figure 4.1. TFO concentrations (µM) are shown above the gels; 
lanes labelled GA are markers specific for purines.  Control lanes show the DNaseI 
cleavage pattern in the absence of TFO.  The sequence of the DNA fragment is shown 
along the left side, footprints are indicated by black boxes and asterisks indicate 
enhancements. 
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  Figure 4.30 on the previous page shows the results of similar footprinting 
experiments with sequence 3.  Although there is evidence of TFO binding on this 
template the footprints are slightly unusual as there is a strong band in the centre 
of the footprint with all TFOs.  With the BAU substituted TFO there is a reasonably 
clear footprint on the A tract at the highest TFO concentration, which is 
accompanied by three enhancements, persisting to around 0.1 µM. 
 
         5’ – BBBBBBCBT – 3’ 
         5’ – PPPPPPCPT – 3’ 
  5’ – AAGACCCCGAACAAAAAAATTCA – 3’ 
  3’ – TTCTGGGGCTTGTTTTTTTAAGT – 5’ 
             *** 
 
Figure 4.31; Sequence of template 3 showing the positions of footprints and 
enhancements with different TFOs and under different conditions.  In Figure 4.30 the 
upper (purine-rich) strand of this sequence was radiolabelled at the 3’ end.  The position 
of the footprint generated by the BAU-TFO is shown in red; an addition base in the 
footprints in the P+L and P+M+L gels is shown in blue.  Enhancements are indicated by 
asterisks, these were the same on all gels.  The probable binding site of the TFOs is 
underlined and the TFO sequences are shown above. 
 
  With the P TFO alone there is a very faint enhancement at the 3’ end at 30 / 
10 µM TFO, at the same position as the highest enhancement on the BAU gel.  
When the naphthylquinoline ligand is added there is again an attenuation of the 
bands in the expected region at the highest concentration.  Three enhancements 
at the same position as the BAU gel are also visible to around 3 µM.  When 
magnesium chloride are also added to the incubation mix the footprint becomes 
slightly clearer and it is seen down to 10 µM TFO.  Three bands of enhanced 
cleavage are again visible at the 3’-end of the footprint, which persist down to 3 
µM. 
  The three enhanced bands show a different concentration dependence in 
each case.  The one at the 3’ end (bottom on the gel) is the darkest and extends to 
the lowest concentrations; it is visible at all concentrations on both of the P-TFO 
and ligand gels, and down to around 0.1 / 0.03 µM on the BAU gel.  The two 
higher enhancements seem to persist to around the same concentration; about 3 / 
1 µM on the last two gels and around 0.1 µM with the BAU TFO.  No evidence of 
TFO binding was seen with the T-containing TFO (not shown).   Chapter 4: Footprinting on REPSA targets 
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Figure 4.32:  DNaseI cleavage patterns of sequences 12 from the REPSA experiment with 
two of the TFOs shown in Figure 4.1. TFO concentrations (µM) are shown above the gels; 
lanes labelled GA are markers specific for purines.  Control lanes show the DNaseI 
cleavage pattern in the absence of TFO.  The sequence of the DNA fragment is shown 
along the left side, footprints are indicated by black boxes and asterisks indicate 
enhancements.   
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  Figure 4.32 on the previous page shows the results of similar experiments 
with sequence 12.  On this template the BAU-substituted TFO shows a slight 
footprint at the highest concentration (1 µM) with an enhancement that persists 
down to 0.3 µM.  Unlike all the other templates almost half of this footprint actually 
lies outside of the original random region of the REPSA template, meaning that it 
has actually bound to part of the sequence common to all the templates (the 
original random region is shown in italics in Figure 4.33).  This template contains 
one of the shortest A-tracts which is only four bases long. 
 
    5’ – BBBBBBCBT – 3’ 
  5’ – AGGAAGAAAAGCAATGGGATGGGATCTTTCA – 3’ 
  3’ – TCCTTCTTTTCGTTACCCTACCCTAGAAAGT – 5’ 
        * 
 
Figure 4.33; Sequence of template 12 showing the positions of footprints and 
enhancements with the BAU substituted TFO.  In Figure 4.32 the upper (purine-rich) 
strand of this sequence was radiolabelled at the 3’ end.  Footprints are shown in red and 
enhancements are indicated by asterisks.  The probable binding site of the TFO is 
underlined and the TFO sequence is shown above.  The original random region of the 
REPSA template is in italics. 
 
  The P- and T- containing TFOs failed to produce a footprint or 
enhancement under any conditions with this sequence. 
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Figure 4.34:  DNaseI cleavage patterns of sequence 6 from the REPSA experiment with 
two of the TFOs shown in Figure 4.1. TFO concentrations (µM) are shown above the gels; 
lanes labelled GA are markers specific for purines.  Control lanes show the DNaseI 
cleavage pattern in the absence of TFO.  The sequence of the DNA fragment is shown 
along the left side. 
   




































































































































AChapter 4: Footprinting on REPSA targets 
 
    Page 142 
 
   
  The results of similar footprinting experiments with sequence 6 are shown 
in Figure 4.34 on the previous page.  It can be seen that none of the TFOs alter 
the DNase I cleavage pattern of this template under any conditions.  This template 
contains an A tract like the other templates but with a pyrimidine interruption in the 
centre (see sequence in Table 4.2 on the following page).  It is probably because 
of this interruption that even the BAU-containing TFO does not produce a footprint 
on this template. 
 
4.4  Discussion 
 
  Binding of TFOs comprised of solely natural nucleotides to secondary sites 
has been seen previously at high TFO concentrations (82).  Binding of TFOs to 
these sites involved one or two mismatches, fraying of the third strand away from 
the duplex or loop formation of the TFO (82).  TFOs containing BAU substitutions 
however were shown to generate extremely stable triplexes and individual 
substitutions have are highly selective for AT (187).  BAU has enhanced 
discrimination against YR bases in the duplex compared with T.  BAU also shows 
high selectivity for AT over GC bases pairs in the duplex, although BAU.GC triplets 
are more stable than T.GC or BAU.YR triplets (187).  TFOs with the same 
sequence as the one used in this thesis but containing 3 or 4 BAU residues 
showed no evidence of secondary binding on tyrT (186).  It is therefore likely that 
BAU reduces the stringency of TFOs only when there are large numbers of 
consecutive substitutions.  The most likely model for the interaction of the TFOs 
used in this thesis on secondary sites is binding of the run of modified nucleotides 
to the run of As and fraying of the 3’ end CXT sequence. 
  The experiments described in this chapter have examined TFO binding to 
the templates selected by REPSA.  From these templates 14 were chosen for 
footprinting with the TFOs shown in Figure 4.1 on page 104.  Magnesium chloride 
and the triplex binding ligand naphthylquinoline were also added for some of the 
footprinting experiments in order to promote binding.  It was hoped that a pattern 
of binding affinity might emerge from these experiments to indicate the TFOs 
preference for differences in template sequence. 
  On the following page is a table showing the lowest concentration at which 
the footprints and enhancements are visible on each template, colour coded by Chapter 4: Footprinting on REPSA targets 
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concentration.  It is important to note that the BAU TFO was footprinted at a lower 
concentration range than the propargylamino-dU TFO. 
 
TFO  Sequence of 
probable 
binding site 
BAU  P  P + 10L  P + M + 10L 
Template  Ftp  Enha  Ftp  Enha  Ftp  Enha  Ftp  Enha 
tyrT  AAAAAAGAA  0.1  0.1     10  3  3  3  1 
Exact  AAAAAAGAA  0.1           0.3     0.3    
1  AAAAAAACAA  0.3        3  3     0.3  0.1 
7  AAAAAACAA  1  0.3        10     3    
10  AAAAATAA  1  0.1              10  1 
4  AAAAAAAGAG  0.1  0.1     10  10  1  10  1 
5  AAAAAAGGT  0.3  0.1     30  3  1  0.3  0.1 
2  AAAAAAAAGTT  1  0.1     3  30  0.3  1  0.1 
13  AAAAAAGTT  1  0.3        3  1  3  1 
11  AAAAAAACTA  0.3  0.3     10  3  3  3  1 
14  AAAAAACAG  0.3                      
9  AAAAAATCA     1        30  3  30  3 
8  AAAAAACCG  1  0.1           3     1 
3  AAAAAAATTC     0.1     30     3  10  3 
12  AAGAAAAGC  1  0.3                   
6  AAATAAAC                         
 
Table 4.2; Tthe lowest TFO concentration in µM that footprints and enhancements are 
visible at on different gels.  Colour coded by concentration, Ftp = footprint, Enha = 
enhancement. 
 
  The BAU-TFO produces clear footprints and / or enhancements on all but 
one of the REPSA templates tested, indicating that the REPSA process was 
successful in selecting for sequences which were bound by the TFO.  The highest 
concentration of the BAU-substituted TFO used for footprinting in this chapter was 
1 µM, whereas 5 µM TFO was used for REPSA selection.  However the conditions 
used in REPSA were much less conducive to binding than those used in the 
footprints in this Chapter, so a higher TFO concentration was needed. 
  Looking at Table 4.2 there are several general observations that can be 
drawn.  None of the TFOs produced footprints or enhancements on all templates; 
not all footprints were accompanied by enhancements and on some gels there are 
only enhancements and no footprints.  The enhancement (if present) is always 
seen at the same or lower concentration than the footprint.  The BAU TFO only 
footprints down to 0.1 µM even on the exact template, although concentrations as 
low as 0.003 µM were used. Chapter 4: Footprinting on REPSA targets 
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  Significantly higher concentrations of the P TFO were used, and 
magnesium chloride and / or the triplex binding ligand naphthylquinoline were 
needed to promote binding.  Binding of the propargylamino-dU TFO is always 
improved by addition of ligand and / or magnesium.  This TFO does not bind to 
any template without the ligand, but did produce an enhancement on some 
templates.  The P TFO binds more than half of the templates on addition of 10 µM 
ligand, and when 5 mM magnesium chloride is also added only four templates 
remain unbound.  Under these conditions this TFO actually binds down to the 
same concentration as the BAU TFO on some templates (1, 5 and 2). 
  The BAU-TFO failed to produce a footprint on only three of the templates 
and enhancements were seen on two of these.  Template 6 contains a pyrimidine 
interruption in the A tract and shows no evidence of binding by any of the TFOs 
under any conditions.  Templates 9 and 3 also show no footprint with the BAU-
TFO although there is an enhancement on both of these gels and footprints are 
produced by the P-TFO in the presence of the ligand.  This is difficult to explain as 
there is little difference between these templates and several of the others.  They 
both contain six or more As and the three bases at the 3’ end are similar to several 
other templates.  They do both contain a T and C in these final three bases, but so 
too does template 11.  It may be that the flanking bases of the TFO binding site 
may have impeded binding in some way, resulting in very weak binding so that 
only an enhancement was seen at these concentrations. 
  The BAU-TFO footprints down to the same concentration on the tyrT and 
exact templates, there is no enhancement on the exact template, but this is not 
unusual for triplex footprints with fragments labelled on the pyrimidine-rich strand 
(284).  The P-TFO does not footprint on either of these control templates, although 
again there is an enhancement on tyrT.  Surprisingly, on addition of ligand the P 
TFO binds more strongly to the exact template (E) than to tyrT, even though both 
of these templates containing the exact recognition sequence for the TFO.  This 
difference in binding intensity must therefore arise from the difference in flanking 
sequences between the two templates.  As there is no difference in the binding 
intensity of BAU on these two templates, this difference may be limited to the P 
TFO, or perhaps is only seen on addition of the ligand. 
  The REPSA sequences in this chapter were presented in the order of how 
much they resembled the exact binding site of the TFOs, and how well they bind 
the BAU TFO.  Templates 1, 7 and 10 contain a run of 5-7 As followed by a single 
uncomplementary base, then two more As.  This means that all of the nucleotides Chapter 4: Footprinting on REPSA targets 
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in the TFOs, except for the C residue, can potentially bind to a complementary 
base in the duplex.  Templates 1 and 7 contain the same sequence, though the 
run of As in template 1 is longer than in template 7 and the flanking sequences are 
different.  Template 1 is bound slightly better than template 7 by the BAU TFO, 
presumably because of these differences.  Template 10 contains a very similar 
sequence to 1 and 7; all have a pyrimidine interruption in place of the G in the 
exact binding site, but in template 10 this is a T rather than a C as in templates 1 
and 7.  Template 10 also has a shorter run of As (only 5) which means it cannot 
bind the whole run of BAU residues in the TFO.  Despite this template 10 does 
bind the BAU TFO with a similar affinity to template 7. 
  Templates 4, 5, 2 and 13 all contain a run of 6-8 As followed by a G which 
could bind the C in the TFO.  The final two bases are varied and only template 4 
contains any complementary bases in this region.  Templates 2 and 13 have the 
same sequence except that the run of As in 13 is one base shorter (7 rather than 
8).  Out of these four sequences template 4 binds the BAU TFO the strongest, 
presumably because the G in this sequence is followed by an A to bind the final 
BAU residue in the TFO, so this template has only one mismatch opposite the 3’ T 
base in the BAU TFO which would be the weakest binding (T.AT) triplet.  As might 
be expected the BAU-TFO binds to this template with the highest affinity out of all 
of the REPSA templates; producing a footprint at the same concentration as the 
two control templates. 
  Templates 11, 14, 8, 9 and 3 all contain runs of 7 or 8 As, but have no 
similarity to the final three bases of the TFO.  Templates 12 and 6 both contain an 
interruption in the run of As and neither of these bind the P TFO under any 
conditions.  Template 6 is also the only template to show no evidence of binding 
by the BAU TFO. 
  Table 4.2 (page 145) shows that despite the differences in template 
sequence there does not appear to be a strong pattern in the binding intensities of 
the TFOs on the different templates.  However, some conclusions have been draw 
from these data.  The BAU substituted TFO does not bind to the majority of the 
REPSA templates as well as it binds to tyrT or the exact template.  Template 4 is 
the only template that shows a footprint and enhancement down to the same 
concentration as these two controls.  This template also contains the longest run 
of bases contiguous with the exact binding site of the TFO, only the final 3’ base is 
a mismatch.  Templates 1, 7 and 10 also match 8 out of the 9 exact template 
bases, but the mismatch is opposite the C in the TFO rather than the 3’ end T.  Chapter 4: Footprinting on REPSA targets 
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Complementary binding of the C base therefore appears to be more important to 
triplex stability than binding of the terminal T. 
  As mentioned before none of the templates, including the controls, bind the 
propargylamino-dU TFO alone, although several gels show enhanced cleavage in 
similar regions to the BAU-TFO.  When 10 µM ligand was added 10 out of the 16 
templates were bound by this TFO and two of the others show some 
enhancements.  The exact template is bound at the lowest concentration of all by 
a factor of 10.  The tyrT template however is only bound as strongly as several of 
the other templates.  The addition of magnesium chloride as well as ligand does 
not improve TFO binding to either of the control templates, however many of the 
other templates are bound at lower concentrations under these conditions.  
Several templates now appear to bind the TFO more strongly than tyrT, even 
though this is an exact match, and templates 1 and 5 are now bound at the same 
concentration as the E template. 
  Surprisingly it appears from these data that the BAU TFO actually 
discriminates better than P against non-exact binding sites.  There is a large 
difference in BAU-TFO concentrations required to bind the exact sequence 
compared to the REPSA templates, whereas with the P-TFO the concentrations 
required to generate footprints (and hence have a measurable dissociation 
constant) are all similar and many templates are bound with higher or the same 
affinity as the exact templates.  The sequence of the three nucleotides at the 3’ 
end of the binding site appear to have relatively little effect on binding affinity; so 
long as there is a run of As the TFOs bind at similar concentrations.  The run of As 
does have to be at least 5 long however; the templates containing only three or 
four consecutive As  (12 and 6) do not bind the P TFO, although with four As the 
BAU TFO still binds relatively well (template 12). 
  Out of all of the REPSA sequences template 4 is bound with the highest 
affinity by the BAU-TFO.  The only mismatch with this template is against the T at 
the 3’ end of the TFO.  Templates 1, 7 and 10 also only contain one mismatch but 
this is against the C base in the BAU TFO and this appears to be more 
destabilising.  There are six templates which have two mismatches out of the three 
3’ terminal bases 5, 2, 13, 11, 14 and 9.  The sequence of the 3’ end of the TFO is 
CBT, and should bind the sequence GAA.  Templates 5, 2 and 13 have a GXX 
pattern (X being a mismatch in relation to the TFO), 11 and 9 XXA and 14 XAX.  
There does not seem to be any correlation between the type of mismatch and the Chapter 4: Footprinting on REPSA targets 
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binding intensity from these footprints.  The templates with three mismatches at 
the 3’ end are bound the least strongly (templates 8 and 3). 
  Apart from differences in binding intensity there were several other 
interesting differences between the BAU and P gels, as well as anomalies such as 
multiple enhancements and secondary binding sites. 
  The BAU TFO generated a footprint 11 bases long on tyrT and around 16 
bases long on the exact template, although this footprint is unclear.  This 
difference may be due to one being labelled on the purine and the other on the 
pyrimidine strand, rather than an actual difference in the number of bases bound 
by the TFO.  All of the footprints generated by the BAU TFO on REPSA templates 
were shorter than either of these, generally 7 or 8 bases long; indicating that in all 
cases the TFO was only partially bound.  This is presumably because the 3’ end 
(CBT) of the TFO was not bound, or bound only partially.  Template 12 was the 
template with the most mismatches, including an interruption of the A tract, that 
still produced a footprint.  The footprint generated by the BAU TFO on this 
template was the shortest of all; only 6 bases long. 
  On all of the REPSA templates the TFO appears to favour binding at the 3’ 
end of the A tract, leaving any superfluous As at the 5’ end.  This is possibly due to 
the TFO sequence at the 3’ end being different (CXT with X being B, P or T 
depending on the TFO).  This may bind preferentially to non-A bases. 
  Only two of the templates showed the same size and position of footprint 
with the BAU and P TFOs (11 and 8).  All but one of the others was either shorter 
at the 3’ end or longer at the 5’ end.  On tyrT and template 4 the footprint with 
P+10L covered one base less at the 3’ end than the footprint with BAU.  On 
templates1, 7, 5, 13 and 3 the footprint is one base longer at the 5’-end with 
P+10L compared to B.  With the exact template the footprint with P+10L with or 
without magnesium chloride is four bases shorter at the 3’ end and 2 bases longer 
at the 5’ end than the BAU TFO generated footprint.  However the edges of the 
footprints on this template are indistinct, especially with the BAU TFO. 
  Template 2 also shows a different pattern; with the P-containing TFO with 
ligand the footprint is 1 base longer at the 5’ end like many other templates, but 
unlike any other it is also two bases longer at the 3’ end, compared to the BAU 
TFO generated footprint.  This is exaggerated on addition of magnesium chloride; 
the footprint is now one of the longest seen on any template at 14 bases; at least 
six bases longer at the 5’ end, but now only one base longer at the 3’ end 
compared to the BAU footprint.  This template contains the same sequence as Chapter 4: Footprinting on REPSA targets 
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template 13, but template 13 does not produce any of these irregularities in 
footprinting size.  Template 2 is the only template with a run of eight As (template 
13 has only 6); the majority of the other templates contain 6 or 7.  It’s possible that 
this particularly long run of As allows the TFO to bind at several different positions 
on different template molecules; producing the unusually large footprint under 
these conditions.  There are also multiple enhancements on these gels indicating 
that the TFO is binding at multiple sites on the A tract. 
  Most of the templates show the same footprint size with P+10L and 
P+M+10L, however in a few the shift in the 5’ direction is exaggerated.  Template 
2 is one of these and has already been discussed, template 4 is the other.  With 
P+10L the footprint is 1 base shorter at the 3’ end compared to the footprint 
generated by the BAU TFO, with P+M+10L however the footprint is also two bases 
longer at the 5’ end. 
  Templates 14 and 9 show an interesting footprinting pattern with different 
TFOs.  These templates have similar sequences but only the BAU TFO produced 
a footprint on 14, and the P-TFO only produced a footprint on 9 in the presence of 
the triplex ligand. 
  The bands showing enhanced cleavage by DNase I found at the 3’ end of 
many of the footprints are also affected by the sequence of the template and the 
nature of the TFO.  With purine labelled templates a single enhanced band is 
usually found at the 3’ end of the footprint, caused by increased cleavage by 
DNase I, which is thought to be due to slight unwinding of the DNA strands at this 
position. 
  TyrT shows the usual pattern of enhancement with both TFOs; a single 
enhanced band at the 3’ end of the footprint.  As the footprint is one base shorter 
at the 3’ end with the P-TFO compared to the BAU-TFO the enhancement is 
actually one base higher with this TFO, but still at the 3’ end of the footprint.  This 
suggests that the terminal T base in the P-TFO is not bound to the template, but 
the T in the BAU-TFO is, indicating stronger binding.  Sequence 13 is the only 
other template which shows the same enhancement under all conditions; in this 
case the footprint stops at the same point at the 3’ end with both TFOs, so the 
enhancement is in the same position on all gels. 
  The exact template, template 14 and template 6 don’t show any 
enhancement with either of the TFOs.  This is expected for the exact template as 
the pyrimidine strand is labelled.  Neither of the TFOs produced a footprint on 
template 6 so the lack of enhancements is not surprising.  However, there is a Chapter 4: Footprinting on REPSA targets 
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footprint with the BAU TFO on template 14, but no enhancement.  This is seen on 
two other gels; template 1 with the BAU TFO and template 7 with the P TFO.  In all 
of these a footprint is visible but no enhancement.  On template 1 both TFOs 
produce a footprint but the enhancement is only seen with the P TFO.  On 
template 14 only the BAU-TFO produces a footprint but no enhancement is visible.  
Template 7 shows the opposite pattern; both TFOs produce a footprint but the 
enhancement is only visible with the BAU-TFO.  With template 7 there is evidence 
of possible secondary binding with the P-TFO (discussed later in this section) and 
this may be the reason for the lack of enhancement; if the TFO is binding at 
multiple overlapping sites on different templates molecules.  Despite no secondary 
binding being obvious on the other templates (1 and 14), this may also be the 
cause of the lack of enhancements. 
  Both TFOs produce multiple enhancements on many of the templates.  
There are four enhancements visible on templates 4 and 2 with the P TFO, 
magnesium chloride and ligand, and also on template 9 with BAU.  Most of the 
other templates show two or three enhancements.  These multiple enhancements 
are presumably caused by the TFO binding at multiple sites 1 base apart on the 
template. 
  On many of the templates the enhancements are not directly at the end of 
the footprint as would be expected.  On some templates the enhancement can be 
up to four bases from the end of the footprint.  The 3’ end of the triplex is where 
the TFO is most likely to be frayed; the terminal three bases of the TFOs are CBT 
or CPT only containing one modified base.  This is also where the majority of the 
mismatched between the TFO and the duplex occur.  Therefore although the 
footprint does not appear to extend as far as the enhancement on many of the 
gels, it may be that these three bases are partially bound to the duplex.  This 
interaction may be enough to shift the enhancements in the 3’ direction, but not 
enough to produce a footprint. 
  As with the footprints there are also variations between enhancements 
between the two TFOs on each template.  The tyrT template and template 13 are 
the only two where the number and position of the enhancements relative to the 
footprint stays the same with both TFOs and under all conditions.  On templates 4, 
2 and 11 the number of enhancements increases in the order B, P, P+10L, 
P+M+10L.  With templates 9, 8 and 3 the reverse pattern is seen.  On template 5 
there are the same number of enhancements on all gels but with P+M+10L the 
enhancements are shifted two bases away from the end of the footprint.  These Chapter 4: Footprinting on REPSA targets 
 
    Page 150 
 
   
differences may be caused by the variation in binding affinity of the TFOs, and the 
sequence of the templates, however there does not seem to be any clear pattern. 
  As well as the secondary binding by the BAU TFO on tyrT that is discussed 
in chapter 3, there are also indications of secondary binding by the BAU and P 
TFOs on three of the REPSA templates.  Templates 2 and 4 both show lighter 
bands below the enhancement at the 3’ end of the primary footprint with the BAU 
TFO which may indicate secondary binding.  On template 7 there is no 
enhancement with the P substituted TFO, but there are lighter bands extending 
beyond the edge of the primary footprint.  Looking at the sequences of these three 
templates it is not clear why the TFOs should bind at any of these positions.  The 
lightening of bands may perhaps be due to folding of the template caused by 
binding of the TFO in the primary site.  Secondary binding with the BAU-TFO has 
been seen previously but was not expected with the P-TFO and it is surprising to 
see a secondary interaction with this TFO but not the BAU-TFO. 
  An interesting pattern emerged during sequencing; the templates were all in 
the same orientation and the purine strand always appeared on the sequencing 
gel to the 3’-side of the asymmetric Fok I cleavage site.  This may be due to 
unintentional selection by the Fok I enzyme for one strand, as shown on the 
following page. 
  Also Fok I cuts much more efficiently as a dimer which may influence the 
direction of cleavage in some way.  There is a possibility that the BAU TFO could 
be binding by strand displacement rather than forming a triplex.  This could distort 
the DNA in such a way that the Fok I enzyme could only cut if the TFO had bound 
to one strand rather than the other.  This theory is considered unlikely however. 
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(i)                 (ii) 
   
 
         (iii) 
 
 
Figure 4.35: Diagram of a possible explanation for why only one strand is seen in the 
sequenced REPSA products.  Straight black lines are the DNA, the blue box is the Fok I 
binding site, the red box is the TFO binding site and the yellow box is the TFO.  The two 
blue circles are the binding and cleavage domain of the Fok I enzyme. 
i and ii: If the TFO binds to the same strand as the Fok I binding site the enzyme can 
access the other strand and cleave the template. 
iii: If the TFO binds to the opposite strand however the structure of the enzyme means 
that it cannot access the DNA to cut as the TFO is in the way. 
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Chapter 5: Selectivity of TFOs containing anthraquinone 
modifications 
 
5.1  Introduction 
 
  The previous chapters in this thesis have examined the effect of TFOs 
containing multiple positively charged nucleotide analogues.  In contrast this 
chapter examines the TFO tethered ligand anthraquinone.  Anthraquinone 
intercalates between DNA bases in duplex DNA and can be tethered to the end of 
a TFO to increase triplex stability (see Section 1.5.2 for more details).  Specificity 
and stringency of TFOs containing anthraquinone have been examined using 
DNase I footprinting experiments.  Four TFOs with the same sequences have 
been examined in this chapter; a control TFO with no anthraquinone, TFOs with 
an anthraquinone molecule at either the 3’ or 5’ end and a TFO with an 
anthraquinone tethered to both ends.  These TFOs have been footprinted on the 
tyrT template and other templates have been generated by mutating tyrT to 
examine the stringency of the TFOs.  Mismatches at the 3’ end or in the centre of 
the triplex were examined.  Anthraquinone and other ligands are known to 
preferentially intercalate at YpR sites; a TFO containing a 3’ S-base was therefore 
also used to allow binding to a YpR step at the 3’ end of the triplex (287). 
 
5.2  Experimental Design 
 
  The footprinting method used in this investigation is described in Section 
2.2.4.  Templates and TFOs were incubated overnight at 20°C in sodium acetate 
pH 5.0 buffer.  The TFOs and templates used in footprinting experiments are 
shown in Figure 5.1 below and the mutagenesis method used to generate the 
templates from tyrT is described in section 2.2.6.  The naming of the templates 
(Figure 5.1ii) reflects the position of the mutation in the tyrT sequence and the 
naming of the TFOs (Figure 5.1i) reflects the position of the anthraquinone or other 
modifications. 
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i) 
T  5’ –  TCCTTCTCTTTTTTCTTT  – 3’ 
3  5’ –  TCCTTCTCTTTTTTCTTTX – 3’ 
5  5’ – XTCCTTCTCTTTTTTCTTT  – 3’ 
3/5  5’ – XTCCTTCTCTTTTTTCTTTX – 3’ 
S3  5’ –  TCCTTCTCTTTTTTCTTSX – 3’ 
 
ii) 
tyrT      5’ – AACCAGTTCTTTTTTCTCTTCCTAACA – 3’ 
      3’ – TTGGTCAAGAAAAAAGAGAAGGATTGT – 5’ 
tyrT50T    5’ – AACCAGTTCTTTATTCTCTTCCTAACA – 3’ 
      3’ – TTGGTCAAGAAATAAGAGAAGGATTGT – 5’ 
tyrT42A    5’ – AACCATTTCTTTTTTCTCTTCCTAACA – 3’ 
      3’ – TTGGTAAAGAAAAAAGAGAAGGATTGT – 5’ 
tyrT42A50T   5’ – AACCATTTCTTTATTCTCTTCCTAACA – 3’ 
      3’ – TTGGTAAAGAAATAAGAGAAGGATTGT – 5’ 
tyrT41AT    5’ – AACCTATTCTTTTTTCTCTTCCTAACA – 3’ 
      3’ – TTGGATAAGAAAAAAGAGAAGGATTGT – 5’ 
 
Figure 5.1: 
i) Sequence of TFOs. 
X = Anthraquinone 
S = S-base 
ii) Sequence of footprinting templates with TFO binding site shown in red. 
 
  TFOs T, 5, 3 and 3/5 have the same sequence with different anthraquinone 
modifications.  TFO S3 has an S-base, which binds T in the duplex, in place of the 
3’ T found in the other TFOs.  This allows this TFO to bind to a sequence with a 
YpR step at the 3’ end, the preferred site for anthraquinone intercalation (better 
than RpY or RpR) (287).  The exact binding site for the first four TFOs is TyrT42A, 
but the exact binding site for the S3 TFO is TyrT41AT.  The relationship between 
the TFOs and each template is reflected in the table below: 
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T, 5, 3, 3/5  S3 
tyrT42A  Exact template  3' mismatch 
tyrT42A50T  Central mismatch  Central and 3' mismatch 
tyrT  3' mismatch  3' mismatch 
tyrT50T  Central and 3' mismatch  Central and 3' mismatch 
tyrT41AT  3' mismatch  Exact template 
 
Table 5.1: Relationship between each of the TFOs and templates used in this chapter. 
 
  The stringency of each of the TFOs when footprinted against templates with 
different mismatches has been examined. 
 
5.3  Results 
 
  Each of the templates has been footprinted in turn with each of the TFOs 
shown in Figure 5.1 on page 155.  The experiments in Figure 5.2 below show the 
control TFO T (see Figure 5.1) footprinted on all of the templates. 
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Figure 5.2: DNaseI cleavage patterns of templates TyrT42A, TyrT42A50T, TyrT, TyT50T 
and TyrT41AT with control TFO T (sequences shown in Figure 5.1). The experiments 
were performed in 50 mM sodium acetate pH 5.0.  The TFO concentrations (µM) are 
shown above the gel lanes.  Lanes labelled GA are markers specific for purines.  Control 
indicates DNaseI cleavage in the absence of TFO. 
 
  There is no evidence of binding on any of these templates, in contrast to 
previous experiments with similar TFOs (187).  As this control was expected to 
bind to the exact template (tyrT50A) this experiment was repeated multiple times 
but with the same result.  The template was also re-sequenced and the 
sequencing data is shown in Figure 5.3 on page 159.  This confirmed that the 
sequence of this template was an exact match for the TFO.  The TFO was also 
synthesised multiple times but this also had no effect on binding.  There may be 
something about the sequence of this TFO which prevents binding to the template; 






























































































































































































































































































Figure 5.3: Sequence of template TyrT50T. 
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Figure 5.4: DNaseI cleavage patterns of TyrT42A with TFOs 3, 5 and 3/5 (sequences 
shown in Figure 5.1 page 155). The experiments were performed in 50 mM sodium 
acetate pH 5.0.  The TFO concentrations (µM) are shown above the gel lanes.  Lanes 
labelled GA are markers specific for purines.  Control indicates DNaseI cleavage in the 
absence of TFO.  Rectangles show the position of footprints and asterisks indicate 
enhancements. 
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Figure 5.5: DNaseI cleavage patterns of TyrT42A50T with TFOs 3, 5 and 3/5 (sequences 
shown in Figure 5.1). The experiments were performed in 50 mM sodium acetate pH 5.0.  
The TFO concentrations (µM) are shown above the gel lanes.  Lanes labelled GA are 
markers specific for purines.  Control indicates DNaseI cleavage in the absence of TFO.  
Rectangles show the position of footprints and asterisks indicate enhancements. 
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Figure 5.6: DNaseI cleavage patterns of TyrT with TFOs 3, 5 and 3/5 (sequences shown 
in Figure 5.1). The experiments were performed in 50 mM sodium acetate pH 5.0.  The 
TFO concentrations (µM) are shown above the gel lanes.  Lanes labelled GA are markers 
specific for purines.  Control indicates DNaseI cleavage in the absence of TFO.  
Rectangles show the position of footprints and asterisks indicate enhancements 
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Figure 5.7: DNaseI cleavage patterns of TyrT50T with TFOs 3, 5 and 3/5 (sequences 
shown in Figure 5.1). The experiments were performed in 50 mM sodium acetate pH 5.0.  
The TFO concentrations (µM) are shown above the gel lanes.  Lanes labelled GA are 
markers specific for purines.  Control indicates DNaseI cleavage in the absence of TFO.  
Rectangles show the position of footprints and asterisks indicate enhancements 
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  The experiments in Figure 5.4 on page 160 show footprints of TFOs 3/5, 3 
and 5 on template TyrT42A.  This is the exact template for these TFOs and clear 
footprints are visible with all three TFOs.  The footprints with TFOs 3 and 5 are 
similar, both binding strongly at 10 µM TFO.  In addition TFO 5 also shows slight 
attenuating of bands at 3 µM.  The double modified TFO (3/5) produces a clear 
footprint at 3 µM and there is some evidence of binding at 1 µM. 
  The size of the footprints in this Figure is slightly different for each TFO.  
This is expected as the addition of an anthraquinone can potentially increase the 
area of the duplex protected from cleavage by DNaseI (287).  The 5’ ends of all 
footprints are similar, with no apparent increase in size caused by the 
anthraquinone modification on TFOs 5 or 3/5.  However with TFOs 3/5 and 5 there 
is an enhancement at this end of the footprint which is not seen with TFO 3.  The 
3’ ends of the footprints vary between the experiments; with TFO 3/5 or 3 the 
footprint extends about 2 bases further than the footprint with TFO 5.  At the 3’ end 
of the footprint with TFO 5 there is enhanced cleavage which appears one base 
higher than the enhancement seen with TFOs 3/5 and 3. 
  The template in Figure 5.5 on page 161 (TyrT42A50T) has a mismatch in 
the centre of the purine tract, which would be expected to abolish triplex formation 
with these TFOs.  Despite this TFO 3/5 still binds down to 3 µM and TFO 5 
produces a slight footprint at 10 µM, though TFO 3 does not show any evidence of 
binding.  There are also enhancements at both ends of the footprints produced by 
TFOs 3/5 and 5.  They are in the same position at the 5’ end but there is the same 
one base difference at the 3’ end as seen previously. 
  The template used for experiments in Figure 5.6 on page 162 (TyrT) has a 
triplex mismatch at the 3’ end for all these oligonucleotides.  Only TFO 3/5 
produces a footprint on this template, and only at the highest concentration (10 
µM).  Unlike the previous two sets of experiments there is no enhancement at the 
3’ end of the footprint, but possibly a slight enhancement at the 5’ end. 
  The template used in Figure 5.7 on the previous page (TyrT50T) combines 
the two mismatches from Figures 5.5 and 5.6; one at the 3’ end and one in the 
centre of the TFO binding site.  As in Figure 5.6 only TFO 3/5 produces a footprint, 
again only at 10 µM, and the footprint is also fainter than the previous experiment.  
There is an enhancement at the 5’ end of this footprint, but not at the 3’ end. 
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Figure 5.8: DNaseI cleavage patterns of templates TyrT42A, TyrT42A50T, TyrT, TyT50T 
and TyrT41AT with TFO S3 (sequences shown in Figure 5.1). The experiments were 
performed in 50 mM sodium acetate pH 5.0.  The TFO concentrations (µM) are shown 
above the gel lanes.  Lanes labelled GA are markers specific for purines.  Control 
indicates DNaseI cleavage in the absence of TFO.  Rectangles show the position of 
footprints. 
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  Figure 5.8 on the previous page shows footprinting experiments carried out 
with TFO S3 which contains an S-base at the 3’ end and therefore has a different 
recognition sequence to the other TFOs used in this chapter.  This TFO was 
designed to investigate the intercalation preference of anthraquinone.  It has 
previously been shown that anthraquinone intercalates preferentially at YpR steps 
(287).  TFO S3 has an S-base at the 3’ end followed by a tethered anthraquinone 
molecule which can then intercalate at a TpG step. 
  This TFO has been footprinted on all of the templates used in this chapter; 
templates TyrT42A, TyrT42A50T, TyrT and TyrT50T all contain mismatches in 
comparison to this TFO, either at the 3’ end, in the centre, or both (see Table 5.1 
on page 156).  TyrT41AT is an addition template containing the exact recognition 
sequence for this TFO which was generated by site-directed mutagenesis.  TFO 
S3 only produces a footprint on this exact template (down to 3 µM) and does not 
appear to interact with any of the templates containing mismatches at the 
concentrations used.  Binding of this TFO does not appear to induce enhanced 
cleavage at either end of the footprint.  The size of the footprint is slightly different 
to the experiments with other TFOs; the 5’ end looks the same as previous 
experiments but the 3’ end of the footprint is very indistinct. 
 
5.4  Discussion 
 
The table below summarises the concentration at which footprints were produced 
by the TFOs on the various templates. 
   
Table 5.2: Summary of footprinting concentrations of the TFOs on the various templates. 
Concentration shown in µM. 
 
  The five TFOs used in this chapter show different stringencies when 
footprinted with templates containing mismatches.  The control TFO does not 
T 3/5 3 5 S
tyrT42A No ftp 1 10 10 No ftp
tyrT42A50T No ftp 3 No ftp 10 No ftp
tyrT No ftp 10 No ftp No ftp No ftp
tyrT50T No ftp 10 No ftp No ftp No ftp
tyrT41AT - - - - 3
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produce a footprint even at 30 µM, despite previous work which indicates that it 
should (187).  This does not appear to be due to the sequence of the template or 
TFO being incorrect, and may due to the TFO forming a secondary structure that 
precludes binding to the template.  Although this result is unexpected and cannot 
be explained within this work, it is still possible to compare the footprints with the 
modified TFOs which clearly do bind to the target. 
  The doubly modified TFO, 3/5, binds to all four of the templates tested.  The 
strongest binding is seen on the exact template TyrT42A (Figure 5.4 page 160) 
where the TFO shows evidence of binding down to 1 µM.  This TFO binds down to 
3 µM on template TyrT42A50T which contains a mismatch in the centre in 
comparison to the TFO (Figure 5.5 page 161).  When footprinted against template 
TyrT which contains a mismatch at the 3’ end, this TFO only binds down to 10 µM 
TFO (Figure 5.6 page 162).  With the final template (TyrT50T Figure 5.7 page 163) 
which contains both of the previous mismatches, one at the 3’ end and one in the 
centre, this TFO still footprints down to 10 µM, although the footprint is relatively 
faint.  This indicates that for this doubly modified TFO the position of a mismatch 
has an effect on the strength of binding.  Any mismatch reduces the binding 
affinity, but a mismatch at the centre is less detrimental than a mismatch at the 3’ 
end in this case which is surprising considering previous literature (82).  This may 
be due to the distance from the anthraquinone modification. 
  TFO 5 which has an anthraquinone molecule at the 5’ end binds down to 3 
µM on the exact template (TyrT42A, Figure 5.4).  It also shows some evidence of 
binding at 10 µM on the template containing a central mismatch (TyrT42A50T 
Figure 5.5).  There is no evidence of binding on templates TyrT with a mismatch at 
the 3’ end, or TyrT50T with two mismatches (Figures 5.6 and 5.7).  This again 
indicates that mismatches at the end of the binding site have a greater effect than 
mismatches at the centre. 
  The TFO with an anthraquinone molecule at the 3’ end only binds to the 
exact binding site in this set of experiments (Figure 5.4).  It also does not bind as 
strongly to the exact template as the 5’ modified TFO (10 µM compared to 3 µM 
with TFO 5).  This may be because either the position of the anthraquinone or the 
intercalation site are affecting the strength of binding to the template.  Unlike TFO 
5 the TFO with a 3’ anthraquinone does not interact with the template containing a 
3’ mismatch, presumably as the mismatch is at the same position as the 
anthraquinone and prohibits intercalation. Chapter 5: Selectivity of TFOs containing anthraquinone modifications 
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  There are also differences observed in the size of the footprints and the 
position of enhancements with the TFOs on each of the templates.  The footprints 
all terminate at the same position at the 5’ end; however enhanced cleavage is 
only seen at this end of the footprint with TFOs containing a 5’ anthraquinone 
modification.  Modifications at the 3’ end of the TFO appear to affect the size of the 
footprint and the position of the enhancement at this end.  The TFOs containing an 
anthraquinone molecule at this end create footprints around 2 bases longer and 
push the enhancement 1 base down the gel.  With the S base at the 3’ end of the 
TFO the edge of the footprint is indistinct and there is no enhancement visible.  In 
the experiments where there is a mismatch at the 3’ end of the footprint no 
enhancement is seen, this may be because this end of the TFO is fraying away 
from the duplex because of the mismatch. 
  Overall it is clear that the doubly modified TFO binds with the highest 
affinity and is most tolerant of mismatches.  Mismatches at the centre of the 
template have a lesser effect on binding affinity than mismatches at the 3’ end.  
The effect of a 3’ mismatch is also greater if the anthraquinone molecule is at this 
end, this would presumably be the same for a mismatch at the 5’.  The presence 
of an S-base at the 3’ end allowing intercalation of the anthraquinone at a YpR 
step increases the binding affinity on the exact template in comparison to TFO 3 
which is the same but does not contain the S-base (3 µM with TFO S3 compared 
to 10 µM with TFO 3).  It does not bind quite as well as the doubly modified TFO 
however. 
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Chapter 6: Discussion 
 
  Triplex-forming oligonucleotides (TFOs) have been the subject of extensive 
research in recent years.  They have potential applications in many areas such as 
gene-based therapies, site directed mutation and as biochemical tools 
(97;98;110;111;155-157;159;162-165).  However triplex technology has been 
hampered by several problems, including low stability due to electrostatic 
repulsion between strands. 
  This thesis has investigated two methods for stabilising triplex DNA: the 
positively charged analogue bis-amino-U, and the triplex stabilising ligand 
anthraquinone.  A TFO containing six consecutive BAU molecules has previously 
been shown to interact with non-target sites (294).  REPSA (Restriction Enzyme 
Protection, Selection and Amplification) has been used to select for the binding 
sites of this TFO.  These sequences selected by REPSA have then been 
footprinted with the TFO and two TFOs with the same sequence but containing 
less heavily modified substitutions.  Magnesium chloride and the triplex binding 
ligand naphthylquinoline have been used to promote binding of the TFOs to the 
non-specific templates. 
  The final part of this thesis examines TFOs with anthraquinone molecules 
tethered at either end to increase binding stability.  These have been footprinted 
against a number of templates containing different triplex mismatches. The 
emphasis throughout this thesis has been on the stringency of triplex formation 
when highly modified TFOs are used. 
 
6.1  REPSA 
 
  REPSA has been used in this thesis to select for templates which are 
bound by a 9mer TFO containing six bis-amino-U residues.  Two sets of REPSA 
experiments have been undertaken.  The first set was performed using a largely 
un-optimised protocol and showed no selection for templates bound by the TFO.  
Optimisation of TFO binding and Fok I cleavage was then carried out and an 
optimised protocol was generated from the results.  Experiments were designed 
and performed to find buffer conditions optimal for both TFO binding and Fok I 
cleavage.  This presented a problem as both the BAU and cytosine resides are 
protonated at relatively low pH, but Fok I cleavage is optimal at around pH 8.0.  
Several different conditions were tested with the exact binding site of the TFO.  Chapter 6: Discussion 
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The majority of these buffer conditions either only permitted limited binding of the 
TFO so that some templates were cleaved by Fok I, or were not optimal for Fok I 
cleavage so that a significant proportion of the templates remained un-cleaved in 
the absence of the TFO.  The standard Fok I buffer was found to give the best 
results; all templates were cleaved in the absence of TFO within two minutes, but 
very little of the template was cleaved in the presence of the TFO after 60 minutes.  
The concentrations of Fok I and the TFO were also optimised for REPSA (see 
section 2.3 for details). 
 
6.2  Footprinting and pH jumping 
 
  Chapter 3 was a preliminary chapter investigating the pH dependence of 
the BAU containing TFO.  These experiments showed that considerably higher 
TFO concentrations were needed to generate a footprint as the pH was increased.  
The TFO had a high affinity for the exact template (tyrT) at pH 5.0 and 6.0 and 
showed some evidence of binding at 30 µM at pH 7.0.  These gels also showed 
evidence of the secondary binding evident in previous studies, this was 
considerably more evident at pH 5.0 however, suggesting that the secondary 
binding may be more sensitive to pH than the primary binding (294).  Different 
incubation times, either overnight or one hour, were also tested to determine the 
optimum time for the REPSA experiments.  Little difference was observed 
between the overnight and one hour incubations at pH so a one hour incubation 
was used in REPSA. 
  The next step was to carry out pH-jump experiments to determine the effect 
of the increased pH used in REPSA on binding stability.  A range of TFO 
concentrations were used for these footprinting experiments and the secondary 
binding on the tyrT template was much more pronounced.  The TFO and template 
were incubated at pH 5.0 and the pH was then jumped to around pH 8.0.  Samples 
were taken and digested with DNase I to assess the reaction of the triplex to the 
change in pH.  The TFO molecules bound at secondary sites were seen to 
dissociate much more rapidly when exposed to high pH, even at high TFO 
concentrations, suggesting that the secondary binding of this TFO is more 
sensitive to pH than the primary interaction. 
  On all of the gels in chapter 3 where high concentrations of TFO have been 
used the primary footprint is enlarged, possibly caused by slippage of the TFO 
along the purine-rich region of the template.  This enlarged footprint is only seen at Chapter 6: Discussion 
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concentrations which also generate secondary interactions so this effect may also 
be caused by an interaction between the primary and secondary binding sites. 
 
6.3  Footprinting on REPSA templates 
 
  14 sequences were chosen for footprinting with TFOs containing BAU, 
propargylamino-dU or T.  Two templates containing the exact recognition 
sequence of the TFO were also used as controls.  Magnesium chloride and the 
triplex binding ligand naphthylquinoline were added for some of the footprinting 
experiments in order to promote binding.  It was hoped that a pattern of binding 
affinity might emerge from these experiments to indicate the TFOs preference for 
differences in template sequence.  The BAU-TFO produced clear footprints on all 
but three of the REPSA templates tested, indicating that the REPSA process was 
successful in selecting for sequences which were bound by the TFO.  On these 
however the BAU TFO only footprinted down to 0.1 µM even on the exact 
template, although concentrations as low as 0.003 µM were used.  The BAU-TFO 
failed to produce a footprint on the three remaining templates, although 
enhancements were seen on two of these. 
  Significantly higher concentrations of the P-TFO were used, and 
magnesium chloride and / or the triplex binding ligand naphthylquinoline were 
needed to promote binding.  This TFO does not bind to any template without the 
ligand, but did produce an enhancement on some templates.  The P-TFO bound 
more than half of the templates on addition of 10 µM ligand, and when 5 mM 
magnesium chloride was also added only four templates remained unbound.  
Under these conditions this TFO actually bound down to the same concentration 
as the BAU TFO on some templates. 
  The BAU-TFO generated a footprint down to the same concentration on the 
tyrT and exact templates.  There was no enhancement on the exact template, but 
this is not unexpected for triplex footprints with fragments labelled on the 
pyrimidine-rich strand (284).  The P-TFO did not footprint on either of these control 
templates, although again there was an enhancement on tyrT.  Surprisingly on 
addition of ligand the P TFO bound more strongly to E than to tyrT, even though 
both of these templates contained the exact recognition sequence for the TFO.  
This difference in binding intensity must therefore arise from the difference in 
flanking sequences between the two templates.  As there was no difference in the Chapter 6: Discussion 
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binding intensity of BAU on these two templates, this difference may be limited to 
the P TFO, or perhaps is only seen on addition of the ligand. 
  Despite the differences in template sequence there does not appear to be a 
strong pattern in the binding intensities of the TFOs on the different templates.  
However, some conclusions have been draw from the footprints in Chapter 4.  The 
BAU-substituted TFO did not bind to the majority of the REPSA templates as well 
as it binds to tyrT or the exact template.  Template 4 was the only template that 
showed a footprint and enhancement down to the same concentration as these 
two controls.  This template also contained the longest run of bases contiguous 
with the exact binding site of the TFO, only the final 3’ base was a mismatch.  
Templates 1, 7 and 10 also matched 8 out of the 9 exact template bases, but the 
mismatch was opposite the C in the TFO rather than at the 3’ end T.  
Complementary binding of the C base therefore appears to be more important to 
triplex stability than binding of the terminal T. 
  None of the templates, including the controls, bound the propargylamino-dU 
TFO alone, although several gels showed enhanced cleavage in similar regions to 
the BAU-TFO.  When 10 µM ligand was added 10 out of the 16 templates were 
bound by this TFO and two of the others showed some enhancements.  The exact 
template was bound at the lowest concentration of all, a factor of 10 tighter than 
the next best REPSA template.  The tyrT template however was only bound as 
strongly as several of the other templates.  The addition of magnesium chloride as 
well as ligand did not improve TFO binding to either of the control templates, 
however many of the other templates were bound at lower concentrations under 
these conditions.  Several templates then appeared to bind the TFO more strongly 
than tyrT, even though this was an exact match, and templates 1 and 5 were 
bound at the same concentration as the E template under these conditions. 
  Surprisingly it appears from these data that the BAU TFO actually 
discriminates better against non-exact binding sites.  There was a large difference 
in BAU-TFO concentrations required to bind the exact sequence compared to the 
REPSA templates, whereas with the P-TFO and ligand the concentrations 
required to generate footprints were all similar and many templates were bound 
with higher or the same affinity as the exact templates.  The sequence of the three 
nucleotides at the 3’ end of the binding site appeared to have relatively little effect 
on binding affinity; so long as there was a run of As the TFOs bound at similar 
concentrations.  The run of As did have to be at least 5 long however; the 
templates containing only three or four consecutive As  (12 and 6) did not bind the Chapter 6: Discussion 
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P-TFO, although with four As the BAU TFO still bound relatively well (template 
12). 
  Out of all of the REPSA sequences, template 4 was bound with the highest 
affinity by the BAU-TFO.  The only mismatch with this template was against the T 
at the 3’ end of the TFO.  Templates 1, 7 and 10 also only contained one 
mismatch but this was against the C base in the BAU-TFO and this appears to be 
more destabilising.  There were six templates which had two mismatches out of 
the three 3’ terminal bases 5, 2, 13, 11, 14 and 9.  The sequence of the 3’ end of 
the TFO was CBT, and should have bound the sequence GAA.  Templates 5, 2 
and 13 had a GXX pattern (X being a mismatch in relation to the TFO), 11 and 9 
XXA and 14 XAX.  There did not seem to be any correlation between the type of 
mismatch and the binding intensity from these footprints.  The templates with three 
mismatches at the 3’ end were bound the least strongly (templates 8 and 3). 
  On all of the REPSA templates the TFO appeared to favour binding at the 
3’ end of the A tract, leaving any superfluous As at the 5’ end.  This is possibly due 
to the TFO sequence at the 3’ end being different (CXT with X being B, P or T 
depending on the TFO).  It may be that the C at this end of the TFO discriminates 
against binding to an A in the duplex in the context of this TFO. 
  Apart from differences in binding intensity there were several other 
interesting differences between the BAU and P gels, as well as anomalies such as 
multiple enhancements and secondary binding sites.  These are discussed in 
detail in Chapter 4 but did not a show any pattern based on template sequence.   
  Not all of the templates which emerged from the REPSA selection process 
were footprinted with the TFOs due to a lack of time and materials.  Table 4.1 ii 
(page 107) shows the sequences which were not footprinted; none of these 
contain a run of As.  It may be that these templates were bound by the TFO at the 
concentration used in REPSA, or this may be a limitation of the REPSA protocol 
that not all unbound templates are excluded from selection.  An acknowledged 
limitation of REPSA is that there are factors which can inhibit Fok I cleavage other 
than TFO binding, for example formation of secondary structures by the template 
DNA (77).  It is interesting that REPSA did not pull out the exact binding site of the 
TFO, although there are several templates which contain sequences only one 
base different from the exact template.  It is possible that REPSA did pull out this 
template but that it was not sequenced. 
  Previous work on BAU-containing TFOs has shown that when single 
substitutions are made, the TFO retains specificity (187;243).  However this is the Chapter 6: Discussion 
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first work examining the stringency of TFOs containing multiple, clustered BAU 
residues.  It has been shown that BAU demonstrates more stringent binding than 
unmodified TFOs (187).  This has been confirmed by the experiments presented 
here; almost all of the templates examined contain a run of six As.  Templates 
which contain fewer than 6 As are not bound as strongly by the TFO, or are not 
bound at all.  Also all of the footprints on the REPSA templates are smaller than 
the footprint produced by this TFO on the exact templates.  This indicates that 
some or all of the run of six BAU residues are binding to the run of As, and the 
three other bases (CBT) at the 3’ end of the TFO are fraying away from the 
template.  So the BAU residues are not in themselves less stringent; they simply 
bind so strongly to the template that the specificity of the remaining TFO no longer 
dominates the binding interaction. 
  Binding of TFOs comprised of solely natural nucleotides to secondary sites 
has been shown at high concentrations (82).  Binding of TFOs to these sites 
involved one or two mismatches, fraying of the third strand or loop formation (82).  
TFOs containing BAU substitutions however were shown to generate extremely 
stable triplexes and individual substitutions were highly selective for AT (187).  
BAU has enhanced discrimination against YR bases in the duplex compared with 
T.  BAU also shows high selectivity for AT over GC bases pairs in the duplex, 
although BAU.GC triplets are more stable than T.GC or BAU.YR triplets (187).  
TFOs with the same sequence as the one used in this thesis but containing 3 or 4 
BAU residues showed no evidence of secondary binding on tyrT (186).  It is 
therefore likely that BAU reduces the stringency of TFOs only when there are large 
numbers of consecutive substitutions.  The mostly likely model for the interaction 
of the TFOs used in this thesis on secondary sites, is binding of the run of modified 
nucleotides to the run of As and fraying of the 3’ end CXT sequence. 
 
6.4  Selectivity of anthraquinone TFOs 
 
  Chapter 5 examines footprinting experiments using TFOs containing 
anthraquinone modifications.  Anthraquinone intercalates between DNA bases in 
duplex DNA and can be tethered to the end of a TFO to increase stability.  The 
specificity of five TFOs with different anthraquinone modifications was examined in 
this chapter by footprinting against various fragments.  Mismatches at the 3’ end or 
in the centre of the triplex were examined.  Anthraquinone is known to Chapter 6: Discussion 
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preferentially intercalate at YpR sites; a TFO containing a 3’ S-base was therefore 
also used to allow binding to a YpR step at the 3’ end of the triplex. 
  The doubly modified TFO with an anthraquinone modification at either end 
bound to all four of the templates tested, even with two triplex mismatches.  TFO 5 
which has an anthraquinone molecule at the 5’ end bound down to 3 µM on the 
exact template and showed some evidence of binding at 10 µM on the template 
containing a central mismatch.  However there was no evidence of binding on the 
templates with a mismatch at the 3’ end or containing two mismatches.  This 
indicates that mismatches at the end of the binding site have a greater effect than 
mismatches at the centre.  The TFO with an anthraquinone molecule at the 3’ end 
only bound to the exact template and did not bind as strongly to this as the 5’ 
modified TFO.  This may be because either the position of the anthraquinone or 
the intercalation site affected the strength of binding to the template.  Unlike TFO 5 
the TFO with a 3’ anthraquinone did not interact with the template containing a 3’ 
mismatch, presumably as the mismatch is at the same position as the 
anthraquinone and prohibits intercalation.  Modifications at the 3’ end of the TFO 
appeared to affect the size of the footprint and the position of the enhancement at 
this end, and in experiments with a mismatch at the 3’ end of the footprint no 
enhancement was seen, this may be because this end of the TFO was fraying 
away from the duplex. 
  Overall it was clear from these experiments that the doubly modified TFO 
bound with the highest affinity and was most tolerant of mismatches.  Mismatches 
at the centre of the template had a lesser effect on binding affinity than 
mismatches at the 3’ end.  The effect of a 3’ mismatch was also greater if the 
anthraquinone was at this end.  The presence of an S-base at the 3’ end allowing 
intercalation of the anthraquinone at a YpR step increased the binding affinity on 
the exact template in comparison to TFO 3 which did not contain the S-base.  The 
TFO containing the S base did not bind quite as well as the doubly modified TFO 
however. 
 
6.5  Implications 
 
  In general although the BAU modification undoubtedly provides a dramatic 
increase in affinity for the target sequence, it needs to be incorporated carefully to 
ensure that the TFO does not lose specificity.  As TFOs containing single or few 
BAU substitutions show high fidelity for the target sequence, substituting every Chapter 6: Discussion 
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other T with a BAU molecule may be a better way to prevent non-specific binding 
(187).  Using a less heavily modified nucleotide such as the propargylamino-dU 
examined here does not necessarily alleviate this problem.  In the experiments in 
this thesis the P-TFO in conjunction with the triplex-binding ligand 
naphthylquinoline actually shows less discrimination between exact and secondary 
binding sites (see Table 4.2 page 145).  This may be partially because of the 
contribution of the ligand however as it was not possible to quantitate how much 
the P substitution contributed to specificity with just the TFO alone. 
  The results from experiments with anthraquinone modified TFOs have two 
implications for their future incorporation.  TFOs containing this modification at 
both ends are more tolerant of mismatches than TFOs with only one 
anthraquinone molecule.  Also it appears that the closer the mismatch is to the 
anthraquinone the less stable the triplex becomes.  This may be of use if the target 
for the TFO is one of two similar templates which have only slight differences in 
sequence for example. 
  In general the use of positively charged nucleotide analogues and 
attachment of intercalating moieties to TFOs continue to have great potential in the 
field of triplex technology, but will have to be used with care to ensure there is no 
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Appendices 




Sequencing gels of templates 1-4. 
 
1:  TTGTTTTTTTGATTG 
 
2:  AGAGCAACTTTTTTT 
 
3:  TTTTTT????????? 
 
4:  GTCTCTCTTTTTTTG   
ATGC     ATGC     ATGC     ATGC
1             2             3            4Appendices 
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Sequencing gels of templates 5, 7-9. Template 6 would not sequence. 
 
5:  CCTTTTTTAGCAATA 
 
7:  AGGGTTGTTTTT??? 
 
8:  T?CCGGTTTTT?ACC 
 
9:  T??TTTT?T?A?CTTTG 
   
ATGC     ATGC     ATGC     ATGC
5             7             8            9Appendices 
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Sequencing gels of templates 10-12, 14. 
 
10:  TTGTTATTTTTAGGG 
 
11:  TAGTTTTTT????GC 
 
12:  AGATCCCATT?TTTT 
 
14:  GTAGGAGCTGTTTTT 
 
As many of the sequencing gels were unclear but indicated a run of T’s plasmid 
samples were sent to MWG for sequencing. The traces from the sequencing are 
shown in Appendix 2 below.
ATGC     ATGC     ATGC     ATGC
10           11           12          14 
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